
<html lang="en"     class="pb-page"  data-request-id="fb5f737b-3983-4011-a22c-63e363267889"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm3007257;issue:issue:10.1021/jmcmar.2012.55.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis" /></meta><meta name="dc.Creator" content="Alexander G.  Dossetter" /></meta><meta name="dc.Creator" content="Howard  Beeley" /></meta><meta name="dc.Creator" content="Jonathan  Bowyer" /></meta><meta name="dc.Creator" content="Calum R.  Cook" /></meta><meta name="dc.Creator" content="James J.  Crawford" /></meta><meta name="dc.Creator" content="Jonathan E.  Finlayson" /></meta><meta name="dc.Creator" content="Nicola M.  Heron" /></meta><meta name="dc.Creator" content="Christine  Heyes" /></meta><meta name="dc.Creator" content="Adrian J.  Highton" /></meta><meta name="dc.Creator" content="Julian A.  Hudson" /></meta><meta name="dc.Creator" content="Anja  Jestel" /></meta><meta name="dc.Creator" content="Peter W.  Kenny" /></meta><meta name="dc.Creator" content="Stephan  Krapp" /></meta><meta name="dc.Creator" content="Scott  Martin" /></meta><meta name="dc.Creator" content="Philip A.  MacFaul" /></meta><meta name="dc.Creator" content="Thomas M.  McGuire" /></meta><meta name="dc.Creator" content="Pablo Morentin  Gutierrez" /></meta><meta name="dc.Creator" content="Andrew D.  Morley" /></meta><meta name="dc.Creator" content="Jeffrey J.  Morris" /></meta><meta name="dc.Creator" content="Ken M.  Page" /></meta><meta name="dc.Creator" content="Lyn Rosenbrier  Ribeiro" /></meta><meta name="dc.Creator" content="Helen  Sawney" /></meta><meta name="dc.Creator" content="Stefan  Steinbacher" /></meta><meta name="dc.Creator" content="Caroline  Smith" /></meta><meta name="dc.Creator" content="Madeleine  Vickers" /></meta><meta name="dc.Description" content="Directed screening of nitrile compounds revealed 3 as a highly potent cathepsin K inhibitor but with cathepsin S activity and very poor stability to microsomes. Synthesis of compounds with reduced ..." /></meta><meta name="Description" content="Directed screening of nitrile compounds revealed 3 as a highly potent cathepsin K inhibitor but with cathepsin S activity and very poor stability to microsomes. Synthesis of compounds with reduced ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 10, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3007257" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3007257" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3007257" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3007257" /></link>
        
    
    

<title>(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3007257" /></meta><meta property="og:title" content="(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0001.jpeg" /></meta><meta property="og:description" content="Directed screening of nitrile compounds revealed 3 as a highly potent cathepsin K inhibitor but with cathepsin S activity and very poor stability to microsomes. Synthesis of compounds with reduced molecular complexity, such as 7, revealed key SAR and demonstrated that baseline physical properties and in vitro stability were in fact excellent for this series. The tricycle carboline P3 unit was discovered by hypothesis-based design using existing structural information. Optimization using small substituents, knowledge from matched molecular pairs, and control of lipophilicity yielded compounds very close to the desired profile, of which 34 (AZD4996) was selected on the basis of pharmacokinetic profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3007257"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3007257">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3007257&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3007257&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3007257&amp;href=/doi/10.1021/jm3007257" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6363-6374</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300305c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3003679" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">(1<i>R</i>,2<i>R</i>)-<i>N</i>-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-<i>b</i>]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+G.++Dossetter">Alexander G. Dossetter</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Howard++Beeley">Howard Beeley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Bowyer">Jonathan Bowyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Calum+R.++Cook">Calum R. Cook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+J.++Crawford">James J. Crawford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+E.++Finlayson">Jonathan E. Finlayson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola+M.++Heron">Nicola M. Heron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Heyes">Christine Heyes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Highton">Adrian J. Highton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julian+A.++Hudson">Julian A. Hudson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anja++Jestel">Anja Jestel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+W.++Kenny">Peter W. Kenny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephan++Krapp">Stephan Krapp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Martin">Scott Martin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+A.++MacFaul">Philip A. MacFaul</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+M.++McGuire">Thomas M. McGuire</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pablo+Morentin++Gutierrez">Pablo Morentin Gutierrez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+D.++Morley">Andrew D. Morley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+J.++Morris">Jeffrey J. Morris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ken+M.++Page">Ken M. Page</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lyn+Rosenbrier++Ribeiro">Lyn Rosenbrier Ribeiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen++Sawney">Helen Sawney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Steinbacher">Stefan Steinbacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Smith">Caroline Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Madeleine++Vickers">Madeleine Vickers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">AstraZeneca R&D, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Proteros Biostructures, Am Klopferspitz 19, D-82152 Martinsried, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +44 (0) 1625 517673. Fax: +44 (0) 1625 516667. E-mail: <a href="/cdn-cgi/l/email-protection#b2d3de9cd6ddc1c1d7c6c6d7c0f2d3c1c6c0d3c8d7dcd7d1d39cd1dddf"><span class="__cf_email__" data-cfemail="77161b591318040412030312053716040305160d12191214165914181a">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3007257&amp;href=/doi/10.1021%2Fjm3007257" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6363â6374</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 28, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2012</li><li><span class="item_label"><b>Published</b> online</span>10 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3007257" title="DOI URL">https://doi.org/10.1021/jm3007257</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6363%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlexander%2BG.%2BDossetter%252C%2BHoward%2BBeeley%252C%2BJonathan%2BBowyer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D14%26contentID%3Djm3007257%26title%3D%25281R%252C2R%2529-N-%25281-Cyanocyclopropyl%2529-2-%25286-methoxy-1%252C3%252C4%252C5-tetrahydropyrido%255B4%252C3-b%255Dindole-2-carbonyl%2529cyclohexanecarboxamide%2B%2528AZD4996%2529%253A%2BA%2BPotent%2Band%2BHighly%2BSelective%2BCathepsin%2BK%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BOsteoarthritis%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6374%26publicationDate%3DJuly%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3007257"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2978</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3007257" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;G. Dossetter&quot;},{&quot;first_name&quot;:&quot;Howard&quot;,&quot;last_name&quot;:&quot;Beeley&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Bowyer&quot;},{&quot;first_name&quot;:&quot;Calum&quot;,&quot;last_name&quot;:&quot;R. Cook&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. Crawford&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;E. Finlayson&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;M. Heron&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Heyes&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Highton&quot;},{&quot;first_name&quot;:&quot;Julian&quot;,&quot;last_name&quot;:&quot;A. Hudson&quot;},{&quot;first_name&quot;:&quot;Anja&quot;,&quot;last_name&quot;:&quot;Jestel&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;W. Kenny&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;Krapp&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Martin&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;A. MacFaul&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;M. McGuire&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;Morentin Gutierrez&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;D. Morley&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;J. Morris&quot;},{&quot;first_name&quot;:&quot;Ken&quot;,&quot;last_name&quot;:&quot;M. Page&quot;},{&quot;first_name&quot;:&quot;Lyn&quot;,&quot;last_name&quot;:&quot;Rosenbrier Ribeiro&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;Sawney&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Steinbacher&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Madeleine&quot;,&quot;last_name&quot;:&quot;Vickers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6363-6374&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3007257&quot;},&quot;abstract&quot;:&quot;Directed screening of nitrile compounds revealed 3 as a highly potent cathepsin K inhibitor but with cathepsin S activity and very poor stability to microsomes. Synthesis of compounds with reduced molecular complexity, such as 7, revealed key SAR and demonstrated that baseline physical properties and in vitro stability were in fact excellent for this series. The tricycle carboline P3 unit was discovered by hypothesis-based design using existing structural information. Optimization using small substituents, knowledge from matched molecular pairs, and control of lipophilicity yielded compounds very close to the desired profile, of which 34 (AZD4996) was selected on the basis of pharmacokinetic profile.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007257&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007257" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007257&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007257" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007257&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007257" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3007257&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007257&amp;href=/doi/10.1021/jm3007257" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3007257" /></input><a href="/doi/pdf/10.1021/jm3007257" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3007257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3007257%26sid%3Dliteratum%253Aachs%26pmid%3D22742641%26genre%3Darticle%26aulast%3DDossetter%26date%3D2012%26atitle%3D%25281R%252C2R%2529-N-%25281-Cyanocyclopropyl%2529-2-%25286-methoxy-1%252C3%252C4%252C5-tetrahydropyrido%255B4%252C3-b%255Dindole-2-carbonyl%2529cyclohexanecarboxamide%2B%2528AZD4996%2529%253A%2BA%2BPotent%2Band%2BHighly%2BSelective%2BCathepsin%2BK%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BOsteoarthritis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D14%26spage%3D6363%26epage%3D6374%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jmcmar.2012.55.issue-14/production/jmcmar.2012.55.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Directed screening of nitrile compounds revealed <b>3</b> as a highly potent cathepsin K inhibitor but with cathepsin S activity and very poor stability to microsomes. Synthesis of compounds with reduced molecular complexity, such as <b>7</b>, revealed key SAR and demonstrated that baseline physical properties and in vitro stability were in fact excellent for this series. The tricycle carboline P3 unit was discovered by hypothesis-based design using existing structural information. Optimization using small substituents, knowledge from matched molecular pairs, and control of lipophilicity yielded compounds very close to the desired profile, of which <b>34</b> (AZD4996) was selected on the basis of pharmacokinetic profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Osteoarthritis (OA) is made up of a group of degenerative disorders characterized by joint pain and loss of function in the absence of chronic autoimmune or autoinflammatory mechanisms.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> With a global aging population, coupled with other risk factors such as obesity,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> the disease represents a growing socioeconomic burden.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Pharmacological treatment is largely confined to symptomatic pain relief with intraarticular corticosteroid injection, analgesics, and NSAIDs,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> to the point where, in severely advanced disease, joint replacement surgery is often performed, but is not always successful in alleviating pain and restoring function.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Articular cartilage breakdown is a prominent feature of joint degeneration and has consequently received significant attention from the pharmaceutical industry, where focusing on identifying targets, such as overexpressed proteases has led to drug development programs.</div><div class="NLM_p">Cathepsin K (Cat K), a 24 kDa lysosomal cysteine protease, is expressed at high levels in osteoclasts and plays a key role in bone resorption by degradation of type I cartilage.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Cat K knockout mice exhibit osteopetrosis (abnormally dense bone) of the long bones and vertebrae and abnormal joint morphology,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> indicating the potential role of this enzyme in key bone pathologies associated with abnormal bone turnover such as osteoporosis (OP), osteoarthritis (OA), and metastatic bone disease (MBD).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a>As well as a role in bone disorders and OA, more recent findings have shown potential for the treatment of diabetes and obesity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Several pharmaceutical companies have trialed Cat K inhibitors in these disease areas; Novartis has completed phase II studies in OP and OA with balicatib (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The phase II OP trial reported positive outcomes on bone mineral density measures. Merck is studying odanacatib (MK0822) in a phase III trial for OP and has abandoned plans for a phase II in OA.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> GSK (relacatib)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> conducted phase I trials for both OP and OA several years ago but switched to MBD for phase II during 2006.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature nitrile cathepsin K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Drug-Hunting Approach</h3><div class="NLM_p">A directed screen of nitrile-containing compounds, from the corporate collection, identified <b>3</b> and <b>4</b>, which were originally designed as inhibitiors of cathepsin S (Cat S), as starting points for this work (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Both <b>3</b> (Cat K IC<sub>50</sub> 0.002 Î¼M; Cat S IC<sub>50</sub> 0.076 Î¼M) and <b>4</b> (Cat K IC<sub>50</sub> 0.003 Î¼M; Cat S IC<sub>50</sub> 0.258 Î¼M) were attractive, potent neutral inhibitors of Cat K with some selectivity over Cat S. Cathepsins are present in the lysosome, an acidic compartment in cells, and as such basic compounds have been shown to accumulate to high concentration (lysosotropism), resulting in pan cathepsin inhibition; hence, these neutral cyclohexyls are attractive from this point of view.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> However, <b>3</b> and <b>4</b> both had poor metabolic stability in rodent pharmacokinetic (PK) studies, with clearances exceeding liver blood flow. The objective of the current study was to optimize these nitrile inhibitors by increasing Cat K selectivity and reduce metabolism to produce a PK profile compatible with oral dosing and an acceptable half-life.</div><div class="NLM_p">We elected to start with an unsubstituted nitrile-amide covalent binder and selected simple tertiary amides with low molecular complexity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> There were two reasons for adopting this approach to library design. First, it was desirable to quantify the contribution that the core portion of the molecule makes to affinity. Second, it was desirable to provide multiple scaffolds with hopefully high ligand efficiency (LE) that could readily be elaborated synthetically. The number of compounds in the design was further reduced, selecting those tertiary amides that would be rigid in structure and thereby most likely to make good surface contact with the protein surface, which is known to be fairly open in nature.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> With this initial understanding of the SAR, these hopefully efficient scaffolds would allow exploration of the nitrile end of the molecules and then finally optimization to quality candidates.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening hits from cathepsin S program.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The resolution of (Â±)-<i>trans</i>-cyclohexyl-1,2-dicarboxylic acid to yield (<i>R</i>,<i>R</i>)-<b>5</b> was initially carried out using (<i>R</i>)-1-phenethylamine by the method of Berkessel,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and subsequent recrystallizations gave a high enantiomeric excess (>99%). We found heating in neat acetic anhydride was a better method of dehydrating <b>5</b> into anhydride <b>6</b>, as this only required concentration to dryness to provide material used directly in the next step. Ring-opening of the anhydride at ambient temperature with a series of secondary amines (<b>7a</b>â<b>13a</b>,<b> 18a</b>â<b>39a</b>) yielded in situ the acids <b>7b</b>â<b>13b</b>, <b>18b</b>â <b>39b</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Final compounds (<b>7</b>â<b>39</b>) were synthesized by a general procedure of amide formation with the hydrochloride salt of aminoacetonitrile either with <i>O</i>-(7-azabenzotriazol-1-yl)- <i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium hexafluorophosphate (HATU) or benzotriazolyloxy-tris(pyrrolidino)phosphonium hexafluorophosphate (PYBOP) coupling reagents and diisopropylethylamine (DIPEA) at ambient temperature in overall yields of 7â78%. The carbolines used to  synthesize final compounds were made by Fischer indole synthesis<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> from a suitable hydrazine <b>40</b> and 4-piperidone hydrochloride <b>41</b>. Simple heating of the two together in  ethanol/concentrated HCl, in general, yielded the carboline in good yield (for example <b>34a</b>, R<sup>6</sup> = OCH<sub>3</sub> in 55%, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). With electron-poor hydrazines, more forcing conditions from trifluoroboron etherate complex (BF<sub>3</sub>Â·OEt<sub>2</sub>) in acetic acid at 150 Â°C were used. The exception to this was the synthesis of 2,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]-7-azaindole <b>35a</b> where an <i>N</i>-benzyl-protected 4-piperidone <b>39</b> with pyridine-1-hydrazine <b>38</b> and prolonged heating in polyphosphoric acid was required. Transfer hydrogenation using homogeneous conditions with palladium acetate, formic acid, and ammonium formate at reflux yielded <b>39a</b> in 40% overall yield on small scale only.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> With these tricycles in hand, a similar procedure was followed to yield final SAR compounds by the same ring-opening method and coupling to the acid.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cyclohexyl-1,2-diamides <b>7</b>â<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, 80 Â°C, 1 h, concentrate. (b) CH<sub>2</sub>Cl<sub>2</sub>, RT, 1 h, concentrate. (c) DMF or CH<sub>2</sub>Cl<sub>2</sub>, DIPEA (5 equiv), HATU (1.1 equiv), <b>13câ17c</b> HCl salts (1.0 equiv), RT, 12 h, 12â78% yield.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Carbolines via Fischer Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EtOH, concd HCl(aq), 80 Â°C, 3 h, 29â71% yield; or (ii) AcOH, BF<sub>3</sub>.OEt<sub>2</sub>, 80 Â°C, 3 h, 44â68% yield. (b) (i) PPA, 80 Â°C; (ii) HCO<sub>2</sub>H, NH<sub>4</sub>(HCO<sub>2</sub>), Pd(OAc)<sub>2</sub>, 40%.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Enzyme inhibitory activity for seven compounds from this first library is reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> with measured physicochemical properties and in vitro microsomal stability. The IC<sub>50</sub> value of 0.257 Î¼M measured for the prototypical <i>N</i>,<i>N</i>-dimethyl amide <b>7</b> shows that the core substructure does indeed make a significant contribution to affinity and thus provides a useful reference point. The LE of 0.53 and ligand lipophilicity efficiency (LLE = âlog<sub>10</sub>(IC<sub>50</sub>) â log <i>D</i><sub>7.4</sub>) > 6 for <b>7</b> are both high, and the compound shows some good selectivity with respect to other cathepsins (Cat S, 14-fold). Compound <b>7</b> is polar (log <i>D</i><sub>7.4</sub> < 0.5) and, as such, has good aqueous solubility and high stability in both human (HLM) and rat liver microsomes (RLM), revealing the cyclohexyl diamide core as an excellent chemical starting point.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> Compared to <b>7</b>, partially and fully saturated rings with connecting aromatic rings yield positive gains in enzyme inhibition, which was in line with a concomitant rise in lipophicity, suggesting hydrophobic and favorable ligand van de Waals interactions were responsible, and these were efficient (only slight reduction in LE on going from <b>7</b> to <b>13</b>). The change from <b>8</b> to <b>9</b> is interesting, suggesting an improved fit into the P3 groove by the partially saturated cyclohexenyl ring. The aromatic ring of <b>10</b> adds 9-fold in Cat K potency, suggesting only partial contact with the protein surface, but gratifyingly selectivity is improved (Cat S, 250 fold). (<i>N</i>,<i>N</i>)-Piperazines inspired by the original hits (<b>3</b>, <b>4</b>) were included in the library. Compound <b>11</b> is sufficiently basic to protonate at normal physiological pH, and the observation that it is essentially equipotent with <b>8</b> suggests that solvation of the cation is not compromised by binding to these proteins. Compound <b>9</b> again indicates that addition of a phenyl group increases potency to yield a lead similar to <b>10</b> but with lower selectivity (Cat S, 147 fold). The tricyclic carboline <b>13</b> stood out from this first library by having high enzyme inhibition (close to the tight binding limit for the assay<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>) and higher selectivity (Cat S, >3300; Cat B, >1400) despite compromised aqueous solubility and in vitro rat clearance.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR for Tertiary Amide Variations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Binding affinity for cathepsin versus FRET substrate; mean of greater than <i>n</i> = 4 tests, unless where stated.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Mean of <i>n</i> = 2 tests.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">kJ mol<sup>â1</sup> Da<sup>1â</sup>.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">In vitro human liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">In vitro rat liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg); values in parentheses denote rat liver hepatocyte Cl<sub>int</sub> mean <i>n</i> = 2 (Î¼L/min/10<sup>6</sup> cells).</p></div></div><div></div></div><div class="NLM_p">The effects of substitution on the acetonitrile portion of the molecule were explored with compounds <b>14</b> through <b>17</b> to further develop the series from <b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>14</b> is as potent as <b>13</b>, about 2-fold less stable in the in vitro HLM but 45-fold more soluble in water. This solubility difference is especially noteworthy because the latter is more lipophilic than the former. Enantiomers <b>15</b> and <b>16</b> are equipotent but over 10-fold less potent against Cat K than either <b>13</b> or <b>14.</b> One interpretation of this observation is that <b>15</b> and <b>16</b> incur greater energy costs in adopting their bound positions in the protein. Similarly, the extra substitution of a methyl group on <b>15</b> had increased solubility. Increasing the bulk of the alkyl substituent appears to have an adverse effect on potency as shown by <b>17</b> Cat K IC<sub>50</sub> is â¼800 fold less active.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR for Acetonitrile Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Binding affinity Cat K versus FRET substrate; mean of greater than <i>n</i> = 4 tests, unless where stated.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Mean of <i>n</i> = 2 tests.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">In vitro human liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">In vitro rat liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg).</p></div></div><div></div></div><div class="NLM_p">Further testing of compound <b>14</b> found that high in vitro rat liver microsome turnover translated into high hepatocyte clearance and so explained the near liver blood flow clearance and low bioavailability; however, we did not rule out absorption as an additional contributing factor (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Thus, we examined <b>14</b> in iv and po dog pharmacokinetics and were encouraged to find that low in vitro translated into low in vivo clearance and pleasingly the bioavailability was high at 82%. While <b>14</b> is a good compound for further consideration the low bioavailability in rodents left uncertainties about the human fraction absorbed so we sought to optimize clearance in rodents while maintaining a good dog PK. Metabolite identification from in vitro rat hepatocyte incubation of <b>14</b> highlighted that an oxidation event occurred on the cyclohexyl ring (<b>14-met-2</b>), as has been reported for structurally related compounds (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, major metabolites were found from oxidation on the carboline ring and subsequent conjugation (<b>14-met-1</b>, <b>-4</b>, <b>-5</b>, <b>-6</b>, <b>-7</b>), suggesting that substitution on this ring may lead to reduced metabolism.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Metabolites Found after in Vitro Incubation of <b>14</b> with Rat Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>34</b> bound to cathepsin K (PDB 4DMY). (A) Identification of key H-bonding residues. (B) Surface of protein to illustrate the fit of the cyclohexyl and carboline moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structure of a cocrystal of <b>14</b> with Cat K revealed a covalent bond between the nitrile of <b>14</b> and the active site C25 as the primary interaction, with the primary amide group forming hydrogen bonds to N161 and G66, as has been observed in related inhibitor complexes (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The cyclohexane ring of a related inhibitor has been shown to occupy the relatively shallow S2 pocket of the enzyme as does <b>14</b> (seen more clearly in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The tricyclic carboline fits into a relatively flat open S3 groove, bound on one side by a glycine-rich loop and Y67 on the other side, such that an aromatic CâH (R9) is placed against it. The solvent-exposed acid moeity of D61 was measured in this static structure at 3.95 Ã from the carboline NâH (R5), suggesting a possible hydrogen bond; however, both groups are exposed to solvent so this is unlikely to contribute significantly to binding free energy. The fluoro atom at R8 does not appear to make much surface contact, and the structure suggests space to expand along the protein surface. From these findings we decided to explore SAR at R5, R6, R7, and R8, of the carboline, leaving R9 unsubstituted to maintain the interaction with Y67, monitoring the effects on potency and aiming to reduce metabolism using the in vitro RLM assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). With LE and LLE already high for <b>14</b>, we focused on small substituents or heteroatom substitution to combine SAR exploration and potential metabolic blocks, while keeping lipophilicity under control to retain aqueous solubility. The structural prototype <b>18</b> was synthesized first and was nearly equipotent to <b>14</b>, with almost millimolar aqueous solubility. A fluorine scan (<b>19</b> to <b>21</b> and including <b>14</b>) revealed that binding to Cat K compromised fluorination at positions R7 and R9 although this substituent can be accommodated without loss of potency at positions R6 and R8. Of these four compounds, <b>20</b>, the least potent, was the only compound with a significant increase in RLM stability. Addition of a methyl at <b>22</b> (or NâH of carboline) resulted in a small drop in activity consistent with the hypothesis that the NâH did not form a H-bond to D61. Despite the initial hypothesis, increasing the size of the group at R8 resulted in a decrease in Cat K inhibition (<b>23</b> to <b>27</b>); we speculate that the bulky groups have moved the tricycle out of the groove such that the R9 is further from Y67. The target protein is more tolerant of larger substituents at R6 (<b>29</b>â<b>38</b>), although none of these led to a significant increase in potency relative to <b>18</b>. From the structure of <b>14</b> bound in Cat K, these groups would point out to solvent and should make an impact on inhibition: chloro <b>29</b>, methyl <b>30</b>, bromo <b>31</b>, and CF<sub>3</sub><b>33</b> are all less active, despite being more lipophilic, and did not alter RLM clearence. Lipophilicity is generally associated with poor ADMET characteristics so we included polar substituents into our compound design.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The CH<sub>3</sub>SO<sub>2</sub> substituent, which often improves the physicochemical properties of compounds<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and HLM stability,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> was introduced at three positions (<b>27</b>, <b>28</b>, and <b>38</b>). Although this led to significantly increased stability in both HLM and RLM assays, the accompanying loss of potency was unacceptably large. Similarly, the 6-CN compound <b>32</b> was predicted to increase stability and yielded a significant reduction in RLM (80 Î¼L/min/mg) and a small reduction in measured log <i>D</i><sub>7.4</sub> and was similar in Cat K potency. However, the 6-OCH<sub>3</sub> (<b>34</b>, IC<sub>50</sub> < 0.001 Î¼M) and 6-OCF<sub>3</sub> (<b>36</b>, IC<sub>50</sub> 0.002 Î¼M) were more stable in HLM and RLM assays despite the increase in lipophilicity, and comparing to 6-SCH<sub>3</sub><b>35</b>, which showed a small reduction in activity, and 6-OCH<sub>2</sub>CH<sub>3</sub>, we observed that the alkoxy substituent had an electronic effect that maintained high Cat K activity and increased stability. Finally, we synthesized 6-aza-carboline <b>39</b> following the SAR that the 6 position tolerated substitution and allowed reduction in lipophilicity. As hypothesized, the compound has improved stability in both RLM and HLM stability but without any reduction of Cat K potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR for Carboline Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0015.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R5</th><th class="colsep0 rowsep0" align="center">R6</th><th class="colsep0 rowsep0" align="center">R7</th><th class="colsep0 rowsep0" align="center">R8</th><th class="colsep0 rowsep0" align="center" char=".">Cat K IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">aqueous solubility, pH 7.4 (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">HLM Î¼L/min/mg<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM Î¼L/min/mg<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">910</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">470</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">311</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">540</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">580</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">322</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="char" char=".">>350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">>350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">822</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">(20)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.042<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>3</sub>)<sub>2</sub>CH</td><td class="colsep0 rowsep0" align="char" char=".">0.050<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">â</td><td class="colsep0 rowsep0" align="char" char=".">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.078<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">â</td><td class="colsep0 rowsep0" align="char" char=".">193</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">(3.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.034<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">902</td><td class="colsep0 rowsep0" align="char" char="."><2.0</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">226</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">510</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">179</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">164</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Nâ¡C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.002<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.005<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">116</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">620</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>S</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">â</td><td class="colsep0 rowsep0" align="char" char=".">â</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">303</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1500</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Binding affinity Cat K versus FRET substrate; mean of greater than <i>n</i> = 4 tests, unless where stated. Compounds tested at least >4 Î¼M for Cat S, >2.9 Î¼M for Cat B and as inactive for Cat L.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Mean of <i>n</i> = 2 tests.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">In vitro human liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">In vitro rat liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg); values in parentheses for rat liver hepatocyte Cl<sub>int</sub> mean <i>n</i> = 2 (Î¼L/min/10<sup>6</sup> cells).</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>has comparison data for <b>14</b>, <b>34</b>, and <b>39</b> obtained from in vitro assay and in vivo rat and dog PK experiments, including scaling to human predicted data.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Plasma protein binding was not an issue because the fraction unbound exceeded 10% in rat, dog, and human plasma. The increase in the in vitro stability for <b>34</b> translated into improved bioavailability in rat (28%), which was maintained in dogs (65%). The in vitro human hepatic clearance of <b>39</b> was consistently below the limit of detection, rat hepatic clearance was low at 9.9 Î¼L/min/10<sup>6</sup> cells, and this led to a prediction of low clearance in vivo; however, we observed a CL of 32 mL/min/kg. Metabolite identification of rat urine after oral dosing found a significant number of metabolites and parent compound (ca. 50% of total clearance).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> When scaled to human, this extra component is likely to cause an approximate 30% increase in the human clearance.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The consequent decrease in human half-life made it unlikely that the compound would be a suitable clinical candidate. For compound <b>34</b>, neither in vitro human hepatic Cl<sub>int</sub> (predicted low clearance) nor rodent renal elimination data (not detectable) suggested that human clearance would be a risk; this plus the consistency in oral absorption observed across species for the compound confirmed it as a more likely clinical candidate.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Serum Protein Binding and Pharmacokinetic Data</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">protein binding (% free)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">in vitro hepatocyte Cl<sub>int</sub> (Î¼L/min/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center">Cl<sub>p</sub>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center">iv half-life (h)</th><th class="colsep0 rowsep0" align="center">bioavailability (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">126Â Â±Â 28</td><td class="colsep0 rowsep0" align="left">63Â Â±Â 7.8<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.3Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="left">0.6Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">3.8Â Â±Â 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">6.7 (<i>n</i>Â =Â 1)</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 4.9<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.2Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="left">1.8Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">82Â Â±Â 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><2.5 (<i>n</i>Â =Â 2)</td><td class="colsep0 rowsep0" align="left">[<5.3]<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">[1.7]</td><td class="colsep0 rowsep0" align="left">[3.7]</td><td class="colsep0 rowsep0" align="left">[40]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">23Â Â±Â 16</td><td class="colsep0 rowsep0" align="left">53Â Â±Â 3.4<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.3Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="left">1.0Â Â±Â 0.08</td><td class="colsep0 rowsep0" align="left">28Â Â±Â 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">2.5Â Â±Â 2.3</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 2.4<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.7Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="left">1.5Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="left">65Â Â±Â 5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">5.3Â Â±Â 4.6</td><td class="colsep0 rowsep0" align="left">[8.7]<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">[2.0]</td><td class="colsep0 rowsep0" align="left">[2.2]</td><td class="colsep0 rowsep0" align="left">[53]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">9.9Â Â±Â 7.9</td><td class="colsep0 rowsep0" align="left">32Â Â±Â 9.7<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.6Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">1.8Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">3.1Â Â±Â 1.0</td><td class="colsep0 rowsep0" align="left">7.2Â Â±Â 4.8<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.9Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="left">1.4Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="left">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left"><2.0 (<i>n</i>Â =Â 6)</td><td class="colsep0 rowsep0" align="left">[<5.4]<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">[1.0]</td><td class="colsep0 rowsep0" align="left">[2.1]</td><td class="colsep0 rowsep0" align="left">[42]</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">All results are a mean at least <i>n</i> = 2 experiments. All pharmacokinetic experiments reported as single dosed compounds in at least two experiments involving two animals in each.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Alderley Park Han Wistar male rats, dosed to fed animals, po 2.0 mg/kg as a suspension in 5% DMSO/95% HPMC/TWEEN, iv dosed as solution in 40% DMA/water at 2.0 mg/kg.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Beagle dog, dosed to fasted animals, po 1.0 mg/kg as a suspension in 5% DMSO/95% HPMC/TWEEN, iv dosed as solution in 10% DMSO/90% Sorensons at 1.0 mg/kg.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Numbers inside brackets are predicted values from scaling to human from rat and dog results; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div></div><div class="NLM_p">To understand the effect of the OCH<sub>3</sub> group at R6 on pharmacokinetic properties, metabolites of <b>34</b> post in vitro incubation with rat haptocytes were examined. This showed a switch of major metabolite to oxidation of the cyclohexyl ring (<b>34-met-3</b>) and reduced oxidation of the carboline aromatic (<b>34-met-4</b>) (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) when compared to <b>14</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). A new metabolic route by oxidative demethylation and conjugation was found (<b>34-met-1</b> and <b>-2</b>) although they were minor metabolites. This change in profile resulted in an overall reduction in rate of turnover, perhaps by a change in recognition by the Cyp450s involved. We also considered that the effect of the OCH<sub>3</sub> was to partially mask the NâH donor of the carboline group. Reduction of the number of hydrogen bond donors is an adopted approach for improving pharmacokinetics and, in particular, absorption.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41-44)</a> As such, compound <b>44</b> would test this hypothesis by complete removal of the donor and could be compared with the unfunctionalized carboline <b>18</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Surprisingly, <b>44</b> had high in vitro rat microsomal turnover and no bioavailability; in comparison, <b>18</b> had low bioavailability and high clearance, marking it hard to establish the role of the H-bond donor of the carbolines from a pharmokinetic point of view.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR for Carboline Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0017.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Cat K IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub></th><th class="colsep0 rowsep0" align="center" char=".">aqueous solubility, pH 7.4 (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">protein binding (% free)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM (Î¼L/min/mg)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>p</sub>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center">bioavailability (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">910</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">143</td><td class="colsep0 rowsep0" align="left">46Â Â±Â 7.9<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">8.2Â Â±Â 5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">580</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">>350</td><td class="colsep0 rowsep0" align="left">52 (<i>n</i>Â =Â 1)</td><td class="colsep0 rowsep0" align="left">0.0 (<i>n</i>Â =Â 1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">All results are a mean of at least <i>n</i> = 2 experiments.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">In vitro rat liver microsomal turnover mean of at least <i>n</i> = 2 tests (Î¼L/min/mg).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">All pharmacokinetic experiments reported as single dosed compounds in at least two experiments involving two animals in each. Alderley Park Han Wistar male rats, dosed to fed animals, po 2.0 mg/kg as a suspension in 5% DMSO/95% HPMC/TWEEN, iv dosed as solution in 40% DMA/water at 2.0 mg/kg.</p></div></div></div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Metabolites Found after in Vitro Incubation of <b>34</b> with Rat Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Pharmacology</h3><div class="NLM_p">The in vivo effects of <b>34</b> were studied in dogs using levels of C-telopeptide (CTX-1), a protein fragment of type 1 collagen, as a measure of Cat K inhibition.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> Compound <b>34</b> tested in a dog Cat K enzyme FRET assay had a mean inhibition IC<sub>50</sub> of 0.8 nM (<i>n</i> = 7), the same as human enzyme inhibition. Blood level concentrations of <b>34</b> and CTX-1 were measured as a function of time in this PK/PD study at three doses (0.1, 0.3, and 2.0 mg/kg), the results of which are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. A dose-dependent increase in the area under the curve was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a) and concomitant reduction in [CTX-1] which appeared very similar at the three doses studied (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). This clearly demonstrated target engagement, rapid onset of action, and the in vivo potency of <b>34</b>; a maximum effect level has been reached with all three doses. These data suggest that inhibition of Cat K need only occur for a short period of time to achieve maximum inhibition.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dog PK/PD experiment for compound <b>34</b>. Each point was mean <i>n</i> = 2 with the same blood sample taken at a given time after compound dosing split to measure [<b>34</b>] and [CTX-1]. (a) Total plasma [<b>34</b>] from the dog PK experiment: â, PK[<b>34</b>]/nM at 0.1 mg/kg uid; +, PK[<b>34</b>]/nM at 0.3 mg/kg uid/nM; â, PK[<b>34</b>]/nM at 2.0 mg/kg uid. (b) ELISA-measured reduction [CTX-1] from baseline: â, [CTX-1] as % baseline 0.1 mg/kg uid; +, [CTX-1] as % baseline 0.3 mg/kg uid; â, [CTX-1] as % baseline 2.0 mg/kg uid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Directed screening of nitrile compounds revealed <b>3</b> and <b>4</b> as highly potent cathepsin K (Cat K) inhibitors but with Cat S activity and very poor stability to microsomes. Reducing molecular complexity led to compounds such as <b>7</b> that revealed key SAR and demonstrated that baseline physical properties and in vitro stability were in fact excellent for this series. The tricycle carboline P3 unit was discovered by hypothesis-based design using existing structural information. Optimization using small substituents, knowledge from matched molecular pairs, and control of lipophilicity yielded compounds very close to the desired profile, such as <b>39</b>. We were surprised to find an OCH<sub>3</sub> at R6 (<b>34</b>) had reduced metabolic turnover and thus improved pharmacokinetics in rodents, as well as the benefit of a simple high-yielding synthesis. The OCH<sub>3</sub> group also retained Cat K inhibition, although the mechanism for this and the increased stability are not understood. Selectivity was also maximized with only Cat B inhibition observed at 2.97 Î¼M (>3000 fold) and hERG ionworks screening inactive (>100 Î¼M). Comparing to balicatib, synthesized and tested in our hands (Cat K 0.005 Î¼M, Cat B 4.75 Î¼M), and bdanacatib (Cat K <0.001 Î¼M, Cat S 0.183 Î¼M), we found our compounds as potent but with higher selectivity. Our in vivo pharmacology experiment in dogs demonstrated target engagement and a maximum inhibition of activity at 0.1 mg/kg, showing the potential of this compound as a clinical candidate. Considering all of these factors and the short convergent route, compound <b>34</b> (AZD4996) was selected as a clinical candidate.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All solvents and chemicals used were reagent grade. Anhydrous solvents tetrahydrofuran (THF) and dimethoxyethane (DME) were purchased from Aldrich. Purity and characterization of compounds were established by a combination of low resolution mass spectra (LC-MS), obtained using a Waters liquid chromatography mass spectrometry system, where purity was determined by UV absorption at a wavelength of 254 nm and the mass ion determined by electrospray ionization (Micromass instrument), and NMR analytical techniques. All test compounds were >95% pure. <sup>1</sup>H NMR spectra were recorded using a AVIAN AV400 FT spectrometer or via a Flow NMR process using an AVANCE 500 FT spectrometer. DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> solvent was used, with the data expressed as chemical shifts in ppm from internal standard TMS on the Î´ scale. Coupling constants (<i>J</i>) values are reported in hertz (Hz). Splitting patterns are indicated as follows: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad peak. Compounds <b>7</b>, <b>11</b>, <b>12</b>, and <b>14</b>â <b>27</b>  when measured by <sup>1</sup>H NMR at ambient temperature showed differential rotameric peaks around the tertiary amide group. In these cases, assignments for protons which were measured distinctly have been expressed as fractions  (e.g., 0.5H). Higher temperature <sup>1</sup>H NMR spectra have been recorded on compounds <b>13</b>, <b>14</b>, and <b>39</b> for comparison and clear assignment. The reverse phase column used was a 4.6 mm  Ã 50 mm Phenomenex Synergi Max-RP  80 Ã, and the solvent system was water containing 0.1% formic acid and acetonitrile unless otherwise stated. A typical run was 5.5 min with a 4.0 min gradient from 0% to 95% acetonitrile. Purification by column chromatography was typically performed using silica gel (Merck 7734 grade) and solvent mixtures, and gradients are described herein. Purification by reverse phase high performance chromatography was typically performed using a  Perkin-Elmer instrument using UV detection at 254 nm and a C18 1500 Ã 21.2 mm Phenomenex column 100  Ã. Acidic conditions (0.1% to 0.5% formic acid) or basic conditions (ammonia to pH 10) were used with gradiant solvent mixtures of acetonitrile and water. SCX columns were supplied from International Sorbent Technology and used as directed in this specific case .</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Preparation of <b>7</b>, <b>12</b>â<b>14</b>, <b>34</b>, and <b>39</b></h3><div class="NLM_p last">An appropriate amine (1.0 equiv) was added to (3a<i>R</i>,7a<i>R</i>)-hexahydroisobenzofuran-1,3-dione (<b>6</b>) (1.0 equiv) and DIPEA (3.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> to a concentration of 0.1 M. The resulting solution was stirred at 20 Â°C for 18 h and then either aminoacetonitrile hydrochloride (<b>13c</b>) or <b>14c</b> (3.0 equiv) was added followed by HATU (1.1 equiv) and further DIPEA (5.0 equiv). The resulting suspension was stirred at 20 Â°C for 72 h. The solution was diluted with CH<sub>2</sub>Cl<sub>2</sub> (equal volume), partitioned with 50% brine (equal volume), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and adsorbed onto silica. Flash chromatography (silica, 0â100% EtOAc in isohexane) yielded the desired compound, usually as a solid, or alternatively preparative HPLC was used where stated.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(Cyanomethyl)-<i>N</i>,<i>N</i>-dimethylcyclohexane-1,2-dicarboxamide (<b>7</b>)</h3><div class="NLM_p last">Dimethylamine (2 M in THF, 0.65 mL, 1.30 mmol) was utilized with 1-aminoacetonitrile hydrochloride (192 mg, 2.08 mmol) (<b>13c</b>) to yield <b>7</b>, after purification via prep HPLC, as a white powder (192 mg, 61%). HRMS (ES+) for C<sub>12</sub>H<sub>20</sub>O<sub>2</sub>N<sub>3</sub> (M<sup>+</sup> + H): calcd 238.1550; found, 238.1551. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 1.21â1.48 (m, 4H), 1.48â1.67 (m, 1H), 1.67â2.00 (m, 4H), 2.70 (ddd, <i>J</i> = 12.5, 10.6, 3.6 Hz, 1H), 2.82â2.96 (m, 4H), 3.08 (s, 3H), 3.99 (dd, <i>J</i> = 17.4, 5.9 Hz, 1H), 4.10 (dd, <i>J</i> = 17.4, 5.9 Hz, 1H), 7.09 (s, 1H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(Cyanomethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide (<b>12</b>)</h3><div class="NLM_p last"><i>N</i>-(4-Phenyl)piperazine (162 mL, â¼1.0 mmol) was utilized with 1-aminoacetonitrile hydrochloride (29.0 mg, 0.52 mmol) (<b>13c</b>) to yield <b>12</b>, after purification via prep HPLC, as a solid gum (80.3 mg, 52%). HRMS (ES+) for C<sub>20</sub>H<sub>27</sub>O<sub>2</sub>N<sub>4</sub> (M<sup>+</sup> + H): calcd 355.2129; found, 355.2130. <sup>1</sup>H NMR (500 MHz, DMSO) Î´ 1.11â1.50 (m, 4H), 1.62â1.92 (m, 4H), 2.58 (t, <i>J</i> = 16.0 Hz, 1H), 2.94 (t, <i>J</i> = 16.0 Hz, 1H), 3.01â3.27 (m, 4H), 3.59â3.70 (m, 4H), 4.05 (d, <i>J</i> = 5.6 Hz, 2H), 6.81 (t, <i>J</i> = 7.2 Hz, 1H), 6.94 (d, <i>J</i> = 7.2 Hz, 2H), 7.23 (t, <i>J</i> = 7.2 Hz, 2H), 8.49 (t, <i>J</i> = 5.6 Hz, 1H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(Cyanomethyl)-2-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-<i>b</i>]indole-2-carbonyl)cyclohexanecarboxamide (<b>13</b>)</h3><div class="NLM_p last">8-Fluoro-1,3,4,5-tetrahydropyrido[4,3-<i>b</i>]indole <b>13a</b> (162 mg, 0.87 mmol) was utilized with 1-aminoacetonitrile hydrochloride (69.0 mg, 0.75 mmol) (<b>13c</b>) to yield <b>13</b>, after purification via prep HPLC, as a solid gum (134 mg, 57%). HRMS (ES+) for C<sub>21</sub>H<sub>24</sub>O<sub>2</sub>N<sub>4</sub>F (M<sup>+</sup> + H): calcd 383.1878; found, 383.1880. <sup>1</sup>H NMR (500 MHz, DMSO) Î´ 1.13â1.50 (m, 4H), 1.62â1.92 (m, 4H), 2.58 (t, <i>J</i> = 10.4 Hz, 1H), 2.75â3.09 (m, 4H), 3.48â3.75 (m, 3H), 4.00â4.16 (m, 2H), 6.88 (d, <i>J</i> = 3.8 Hz, 2H), 6.97 (dt, <i>J</i> = 13.7, 5.9 Hz, 2H), 8.48 (t, <i>J</i> = 5.5 Hz, 1H). <sup>1</sup>H NMR (500 MHz, DMSO) Î´ 1.18â1.48 (m, 4H), 1.62â1.91 (m, 4H), 2.79 (t, <i>J</i> = 11.7 Hz, 1H), 2.75â2.93 (m, 2H), 3.03(t, <i>J</i> = 11.7 Hz, 1H), 3.80 (s, 1H), 3.87â4.06 (m, 2H), 4.64 (t, <i>J</i> = 16.6 Hz, 2H), 6.83 (td, <i>J</i> = 9.2, 2.4 Hz, 1H), 7.20 (d, <i>J</i> = 7.0 Hz, 1H), 7.25 (dd, <i>J</i> = 8.7, 4.5 Hz, 1H), 8.08 (s, 1H), 10.64 (s, 1H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(1-Cyanocyclopropyl)-2-[(8-fluoro-1,3,4,5-tetrahydro-2<i>H</i>-pyrido[4,3-<i>b</i>]indol-2-yl)carbonyl]cyclohexanecarboxamide (<b>14</b>)</h3><div class="NLM_p last"><b>13a</b> (798 mg, 4.20 mmol) was utilized with <b>14c</b> (585 mg, 5.04 mmol) to yield <b>14</b>, after purification silica chromatography, as a solid gum (212 mg, 12%). HRMS (ES+) for C<sub>23</sub>H<sub>26</sub>O<sub>2</sub>N<sub>4</sub>F (M<sup>+</sup> + H): calcd 409.2034; found, 409.2036. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 0.77â0.94 (m, 1H), 0.95â1.54 (m, 7H), 1.75â1.91 (m, 4H), 2.61 (âtâ, <i>J</i> = 11.4 Hz, 1H), 2.68â2.94 (m, 3H), 3.64â3.80 (m, 1H), 3.88â4.03 (m, 0.5H), 4.20â4.33 (m, 0.5H), 4.60 (d, <i>J</i> = 15.7 Hz, 0.5H), 4.69 (s, 1H), 4.89 (d, <i>J</i> = 15.8 Hz, 0.5H), 6.53 (s, 0.5H), 6.61 (s, 0.5H), 6.89 (td, <i>J</i> = 11.3, 2.4 Hz, 1H), 7.08 (td, <i>J</i> = 9.4, 2.3 Hz, 1H), 7.20 (td, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.93 (s, 1H). <sup>1</sup>H NMR (500 MHz, DMSO) Î´ 0.88 (s, 1H), 1.01 (s, 1H), 1.19â1.45 (m, 6H), 1.70â1.85 (m, 4H), 2.79â2.90 (m, 2H), 3.01 (td, <i>J</i> = 11.9, 3.6 Hz, 1H), 3.81 (s, 1H), 3.88 (dt, <i>J</i> = 11.3, 5.7 Hz, 1H), 4.63 (s, 2H), 6.82 (dt, <i>J</i> = 9.2, 2.6 Hz, 1H), 7.22 (d, <i>J</i> = 9.2 Hz, 1H), 7.26 (dd, <i>J</i> = 8.8, 4.6 Hz, 1H), 8.26 (s, 1H), 10.65 (s, 1H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-Methoxy-2,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>34a</b>)</h3><div class="NLM_p last">Piperidin-4-one hydrochloride (<b>41</b>) (4.66 g, 34.5 mmol) was added to a suspension of (2-methoxyphenyl)hydrazine hydrochloride (6.00 g, 34.4 mmol) in ethanol (80 mL) and concd HCl (6.0 mL), and the resulting solution was heated at 80 Â°C for 3 h. The reaction was allowed to cool to room temperature overnight, and the resulting precipitated solid was filtered, washed with chilled ethanol (20 mL), and dried under vacuum to give a salt. This was stirred in water (100 mL) and made basic with 2 M NaOH(aq) (â¼5 mL), and the resulting solid was filtered, azeotroped with toluene (30 mL, rotary evaporator), and dried under vacuum to yield <b>34a</b> (3.84 g, 55%) as an off-white solid. LCMS (+ve ESI): <i>t</i><sub>R</sub> = 0.85 min, 203.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO) 2.63â2.66 (m, 2H), 2.99â303 (m, <i>2</i>H), 3.83 (âsâ, 2H), 3.89 (s, 3H), 6.59 (d, <i>J</i> = 7.5 Hz, 1H), 6.83 (âtâ, <i>J</i> = 7.8 Hz, 1H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 10.72 (s, 1H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(1-Cyanocyclopropyl)-2-[(6-methoxy-1,3,4,5-tetrahydro-2<i>H</i>-pyrido[4,3-<i>b</i>]indol-2-yl)carbonyl]cyclohexanecarboxamide (<b>34</b>)</h3><div class="NLM_p last"><b>34a</b> (3.84 g, 19.0 mmol) was utilized with 1-aminocyclopropanecarbonitrile hydrochloride <b>14c</b> (6.76 g, 57.0 mmol) to yield <b>34</b> after purification via flash silica chromatography and crystallization slurry stirring over 48 h (6.27 g, 78%) as a white powder. HRMS (ES+) for C<sub>24</sub>H<sub>29</sub>O<sub>3</sub>N<sub>4</sub> (M<sup>+</sup> + H): calcd 421.2234; found, 421.2233. <sup>1</sup>H NMR (400 MHz, DMSO) Î´ 0.73â0.83 (m, 1H), 0.87â0.91 (m, 0.5H), 0.87â1.03 (m, 1H), 1.17â1.40 (m, 6H), 1.61â1.82 (m, 5H), 2.63â2.70 (m, 1H), 2.75â2.82 (m, 0.5H), 2.84â3.05 (m, 1.5H), 3.64â3.72 (m, 0.5H), 3.94â3.73 (m, 5H), 4.71 (s, 1H), 6.64 ("t", <i>J</i> = 8.2 Hz, 1H), 6.90 (qn, <i>J</i> = 7.8 Hz, 1H), 6.97 (d, <i>J</i> = 7.8 Hz, 0.5H), 7.10 (d, <i>J</i> = 7.8 Hz, 0.5H), 8.64 (s, 1H), 10.91 (s, 1H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Benzylpiperidin-4-one Pyridin-2-yl Hydrazone (<b>45</b>)</h3><div class="NLM_p last">2-Hydrazinopyridine dihydrochloride (5.00 g, 27.5 mmol) and 1-benzylpiperidin-4-one (6.18 g, 27.5 mmol) were suspended in EtOH (70 mL). AcOH (2 mL) was added and the mixture stirred at reflux for 2 h, cooled to RT, and concentrated in vacuo. The residue was partitioned between 2 N NaOH (aq) (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 30 mL), and the combined organic fractions were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and adsorbed onto silica for purification by flash column chromatography (0â10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>). This gave <b>45</b> as a pale yellow gum which was used crude in the next reaction (7.70 g, 100% yield). <sup>1</sup>H NMR (400 MHz, DMSO) Î´ 2.34 (d, <i>J</i> = 5.6 Hz, 2H), 2.62â2.36 (m, 6H), 3.52 (s, 2H), 6.68 (ddd, <i>J</i> = 7.1, 4.9, 0.8 Hz, 1H), 7.04 (s, 1H), 7.51â7.06 (m, 5H), 7.59â7.51 (m, 1H), 8.05 (dd, <i>J</i> = 4.9, 1.1 Hz, 1H), 9.47 (s, 1H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Benzyl-2,3,4,5-tetrahydro-1-benzylpyrido[4,3-<i>b</i>]-7-azaindole (<b>46</b>)</h3><div class="NLM_p last">Polyphosphoric acid (60 g) was added to <b>45</b> (7.69 g, 27.5 mmol) and the mixture stirred gently at 150 Â°C for 24 h. The mixture was cooled to RT, and ice (50 g) was added to break up the gum. The reaction mixture was made basified with 2 M NaOH (aq) and extracted with EtOAc (3 Ã 300 mL). The combined organic extracts were treated with brine (90 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and adsorbed onto silica for purification by flash column chromatography (0â10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>). The mustard colored solid obtained (3.80 g) was triturated with a small volume of CH<sub>2</sub>Cl<sub>2</sub>, filtered, and dried to furnish the desired compound as a sand colored solid <b>57</b> (3.00 g, 42% yield). LCMS (+ve ESI): <i>t</i><sub>R</sub> = 0.97 min, 264 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO) Î´ 2.80 (m, 4H), 3.57 (s, 2H), 3.73 (s, 2H), 6.94 (dd, <i>J</i> = 7.8, 4.7 Hz, 1H), 7.21â7.42 (m, 5H), 7.67 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 8.07 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 11.32 (s, 1H).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2,3,4,5-Tetrahydro-1-benzylpyrido[4,3-<i>b</i>]-7-azaindole (<b>39a</b>)</h3><div class="NLM_p last"><b>46</b> (2.90 g, 11.0 mmol), NH<sub>4</sub>CO<sub>2</sub>H(s) (2.78 g, 44.0 mmol), and 20% PdOH on carbon (290 mg) were suspended in EtOH (200 mL) and stirred under reflux. After 1 h, more NH<sub>4</sub>CO<sub>2</sub>H(s) (695 mg, 11.0 mmol) was added and refluxing continued for 1 h. The catalyst was filtered off through Celite and washed with a small volume of CH<sub>2</sub>Cl<sub>2</sub>, and the combined filtrate was concentrated in vacuo and dried under vacuum to furnish the desired compound as off-white solid <b>39a</b> (1.90 g, 100% yield). <sup>1</sup>H NMR (400 MHz, DMSO) Î´ 2.46â2.55 (m, 2H), 2.67 (t, <i>J</i> = 5.6 Hz, 2H), 3.02 (t, <i>J</i> = 5.6 Hz, 2H), 3.83 (s, 2H), 6.95 (dd, <i>J</i> = 7.7, 4.7 Hz, 1H), 7.70 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 8.07 (dd, <i>J</i> = 4.7, 1.4 Hz, 1H), 11.25 (s, 1H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (1<i>R</i>,2<i>R</i>)-<i>N</i>-(1-Cyanocyclopropyl)-2-[1,3,4,5-tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]-7-azaindol-2-yl)carbonyl]cyclohexanecarboxamide (<b>39</b>)</h3><div class="NLM_p last"><b>39a</b> (200 mg, 1.15 mmol) was utilized with <b>14c</b> (177 mg, 1.20 mmol) to furnish <b>39</b>, after purification, as an off-white solid (40.0 mg, 9% yield). HRMS (ES+) for C<sub>22</sub>H<sub>26</sub>O<sub>2</sub>N<sub>5</sub> (M<sup>+</sup> + H): calcd 392.2081; found, 392.2084. <sup>1</sup>H NMR (400 MHz, DMSO, 303 K) Î´ 0.72 (s, 1H), 0.69â0.80 (dd, <i>J</i> = 41.8, 7.8 Hz, 0.5H), 0.93â1.30 (m, 1H), 1.15â1.45 (m, 6H), 1.62â1.85 (m, 4H), 2.67â2.75 (m, 0.5H), 2.78â2.84 (m, 0.5H), 2.95â3.05 (m, 1H), 3.69â3.82 (m, 0.5H), 3.84â3.94 (m, 1.5H), 4.52 (d, <i>J</i> = 15.8 Hz, 0.5H), 4.65 (d, <i>J</i> = 15.8 Hz, 0.5H), 4.75 (s, 1H), 7.02 (âdddâ, <i>J</i> = 16.6, 7.7, 4.8 Hz, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 0.5H), 7.93 (d, <i>J</i> = 7.6 Hz, 0.5H), 8.13 (dd, <i>J</i> = 8.5, 4.4 Hz, 1H), 8.71 (d, <i>J</i> = 3.7 Hz, 1H), 11.44 (s, 1H). <sup>1</sup>H NMR (500 MHz, DMSO, 373 K) Î´ 0.84â0.86 (m, 1H), 0.94 (d, <i>J</i> = 62.4 Hz, 1H), 1.16â1.53 (m, 6H), 1.70â1.92 (m, 4H), 2.81 (m, 1H), 3.02 (td, <i>J</i> = 11.8, 3.5 Hz, 1H), 3.83 (b, 1H), 3.89 (dt, <i>J</i> = 13.3, 5.6 Hz, 1H), 4.66 (s, 2H), 6.98 (dd, <i>J</i> = 7.2, 4.7 Hz, 1H), 7.80 (d, <i>J</i> = 7.2 Hz, 1H), 8.12 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 8.27 (s, 1H), 11.04 (s, 1H).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Assay for the Identification of Cat K Inhibitors</h3><div class="NLM_p">QFRET Technology (quenched fluorescent resonance energy transfer) was used to measure the inhibition by test compounds of Cat K-mediated cleavage of the synthetic peptide Z-Phe-Arg-AMC. Compounds were screened at twelve concentrations (0.0003â10 Î¼M), on two separate occasions, and the mean IC<sub>50</sub> values reported.</div><div class="NLM_p">A concentration of 0.5 nM [final] rhuman Cat K (prepared in-house) in phosphate buffer was added to a 384-well black microtiter plate containing investigative compounds. The enzyme and compound were preincubated at room temperature for 30 min before the addition of 50 Î¼M [final] Z-Phe-Arg-AMC synthetic substrate in sodium acetate/EDTA buffer at pH 5.5. The plates were covered and incubated for 1 h at room temperature and protected from light. Following the incubation, the reaction was stopped with 7.5% [final] acetic acid. Relative fluorescence was measured using the Ultra plate reader at a wavelength of 360 nm excitation and 425 nm emission.</div><div class="NLM_p last">Data was corrected for background fluorescence (minimum controls without enzyme). This data was used to plot inhibition curves and calculate IC<sub>50</sub> values by nonlinear regression using a variable slope, offset=zero model in Origin 7.5 analysis package. Reproducibility of data was assessed using a quality control statistical analysis package whereby internal variability of the assayed indicated a repeat testing (<i>n</i> = 3) if pIC<sub>50</sub> SD was >0.345.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Assay for the Identification of Cat L Inhibitors</h3><div class="NLM_p last">In a similar manner using the same QFRET technology compounds were tested for inhibition of cathepsin L-mediated cleavage of a synthetic peptide Z-Phe-Arg-AMC (10 Î¼M final concentration) using 0.1 nM [final] r-human Cat L (prepared in-house). A potassium phosphate buffer was used to maintain pH at 6.4.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Assay for the Identification of Cat S Inhibitors</h3><div class="NLM_p last">In a similar manner using the same QFRET technology, compounds were tested for inhibition of cathepsin S-mediated cleavage of a synthetic peptide Z-Val-Val-Arg-AMC (100 Î¼M final concentration) using 0.5 nM [final] r-human Cat S (prepared in-house). A potassium phosphate buffer was used to maintain pH at 6.4.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Assay for the Identification of Cat B Inhibitors</h3><div class="NLM_p last">In a similar manner using the same QFRET technology, compounds were tested for inhibition of cathepsin B-mediated cleavage of a synthetic peptide Z-Arg-Arg-AMC (100 Î¼M final concentration) using 0.5 nM [final] r-human Cat B (prepared in-house). A potassium phosphate buffer was used to maintain pH at 6.4.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Assay for the Identification of Cat K inhibitors in Dog</h3><div class="NLM_p last">In a similar manner using the same QFRET technology, compounds were tested for inhibition of cathepsin K-mediated cleavage of a synthetic peptide Z-Phe-Arg-AMC (15 Î¼M final concentration) using 0.5 nM [final] r-dog Cat K (prepared in-house). A sodium acetate buffer was used to maintain pH at 5.5.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Dog Beagle Blood Bone Remodeling via ELISA Detection of CTK-1</h3><div class="NLM_p last">All pharmacodynamic work was carried out on a small colony of 6 male dogs (Alderley Park Beagle), at the age of 12â14 months, weighing 14â17 kg. All studies were started at the same time of day to standardize results against the normal 24 h circadian rhythm. Dogs were typically dosed with test compound by gavage (po), and blood samples for both PK and PD analysis were taken at predetermined time points via the jugular vein. Formulation of test compounds was in 5% DMSO + 95% HPMC/Tween, in a typical dosing volume of 5 mL/kg. PD sampling (serum): blood samples were allowed to clot for a minimum of 1 h, at room temperature, prior to being spun at 2000 rpm for 15 min. The serum was then removed and placed into appropriate tubing and stored at â20 Â°C until analysis, after which the samples were stored at â80 Â°C. Bone resorption: samples were analyzed for CTX-1 using a Nordic Bioscience Serum CrossLaps ELISA kit (4CRL4000). ELISA was carried out according to protocol, while data were analyzed using Molecular Devices Softmax Pro software installed on a Molecular Devices Versamax tunable plate reader. PK sampling (whole blood): 200 Î¼L of whole blood was placed into the appropriate well of a 96-well plate, containing 200 Î¼L of distilled water. Analysis was by LC-MS against standard concentration curves for compound <b>1</b>, after protein precipitation with cold CH<sub>3</sub>CN and centrifugation.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Crystallography</h3><div class="NLM_p last">Diffraction data for compound <b>14</b> were collected at 100 K on a beamline PX at the Swiss Light Source (SLS, Villigen, Switzerland). The structure was solved by molecular replacement and refined to a final resolution of 2.33 Ã and an <i>R</i>-factor of 25.0% using the Collaborative Computational Project, Number 4 CCP4 (<a href="http://www.ccp4.ac.uk" class="extLink">http://www.ccp4.ac.uk</a>) CCP4 and Coot (<a href="http://www.ysbl.york.ac.uk/â¼emsley/coot" class="extLink">http://www.ysbl.york.ac.uk/â¼emsley/coot</a>) software packages. This structure has been deposited in the RSB (home.rcsb.org) Protein Data Bank (<a href="http://www.rcsb.org/pdb/home/home.do" class="extLink">www.rcsb.org/pdb/home/home.do</a>) with reference code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMY">4DMY</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/jm3007257">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of synthesis of final compounds and intermediates; <sup>1</sup>H NMR for compounds <b>13</b>, <b>14</b>, and <b>39</b> at 373 K; rat and human hepatic metabolite identification for <b>14</b> and <b>34</b>, and rat in vivo urinalysis metabolite identification for <b>39</b>. Table of data: dog PK/PD [CTX-1] for <b>34</b>; baseline [CTX-1] levels over 48 h for comparison of the magnitude of effect; dose to man prediction calculations; crystallization coordinates for Cat K/<b>34</b> cocomplex. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3007257/suppl_file/jm3007257_si_001.pdf">jm3007257_si_001.pdf (1.67 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3007257" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander G. Dossetter</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d1c115319120e0e180909180f3d1c0e090f1c071813181e1c531e1210"><span class="__cf_email__" data-cfemail="87e6eba9e3e8f4f4e2f3f3e2f5c7e6f4f3f5e6fde2e9e2e4e6a9e4e8ea">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Howard Beeley</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Bowyer</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Calum R. Cook</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. Crawford</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan E. Finlayson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola M. Heron</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Heyes</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Highton</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julian A. Hudson</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anja Jestel</span> - <span class="hlFld-Affiliation affiliation">Proteros Biostructures, Am Klopferspitz 19, D-82152 Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter W. Kenny</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan Krapp</span> - <span class="hlFld-Affiliation affiliation">Proteros Biostructures, Am Klopferspitz 19, D-82152 Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Martin</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip A. MacFaul</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas M. McGuire</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo Morentin Gutierrez</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew D. Morley</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey J. Morris</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken M. Page</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lyn Rosenbrier Ribeiro</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen Sawney</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Steinbacher</span> - <span class="hlFld-Affiliation affiliation">Proteros Biostructures, Am Klopferspitz 19, D-82152 Martinsried, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Smith</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Madeleine Vickers</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca R&D, Mereside, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> Abbreviations Used</h2><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">osteoarthritis</p></td></tr><tr><td class="NLM_term">OP</td><td class="NLM_def"><p class="first last">osteoporosis</p></td></tr><tr><td class="NLM_term">MBD</td><td class="NLM_def"><p class="first last">metastatic bone disease</p></td></tr><tr><td class="NLM_term">Cat K</td><td class="NLM_def"><p class="first last">cathepsin K</p></td></tr><tr><td class="NLM_term">Cat S</td><td class="NLM_def"><p class="first last">cathepsin S</p></td></tr><tr><td class="NLM_term">cat B</td><td class="NLM_def"><p class="first last">cathepsin B</p></td></tr><tr><td class="NLM_term">Cat L</td><td class="NLM_def"><p class="first last">cathepsin L</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">PYBOP</td><td class="NLM_def"><p class="first last">benzotriazolyloxy-tris(pyrrolidino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand lipophilicity efficiency</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">CTX-1</td><td class="NLM_def"><p class="first last">C-telopeptide fragment of type 1 collagen</p></td></tr><tr><td class="NLM_term">QFRET</td><td class="NLM_def"><p class="first last">quenched fluorescent resonance energy transfer technology</p></td></tr><tr><td class="NLM_term">CCP4</td><td class="NLM_def"><p class="first last">collaborative computational project, number 4</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hunter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span> </span><span class="NLM_article-title">Osteoarthritis</span> <span class="citation_source-journal">BMJ [Br. Med. J.]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">â</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1136%2Fbmj.332.7542.639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=16543327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD287ltlSjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2006&pages=639-642&author=D.+J.+Hunterauthor=D.+T.+Felson&title=Osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis</span></div><div class="casAuthors">Hunter David J; Felson David T</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">7542</span>),
    <span class="NLM_cas:pages">639-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK97-ragm9Wu_Q9URG6Dx8fW6udTcc2ebaRyjc4x78q7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ltlSjtA%253D%253D&md5=5b419e3aba5f05175f6d81bebbf666a6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fbmj.332.7542.639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.332.7542.639%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26atitle%3DOsteoarthritis%26jtitle%3DBMJ%2520%255BBr.%2520Med.%2520J.%255D%26date%3D2006%26volume%3D332%26spage%3D639%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lawrence, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmick, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunder, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, F.</span><span> </span><span class="NLM_article-title">National Arthritis Data Workgroup Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2Fart.23176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18163497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252Flt1Ghsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=26-35&author=R.+C.+Lawrenceauthor=D.+T.+Felsonauthor=C.+G.+Helmickauthor=L.+M.+Arnoldauthor=H.+Choiauthor=R.+A.+Deyoauthor=S.+Gabrielauthor=R.+Hirschauthor=M.+C.+Hochbergauthor=G.+G.+Hunderauthor=J.+M.+Jordanauthor=J.+N.+Katzauthor=H.+M.+Kremersauthor=F.+Wolfe&title=National+Arthritis+Data+Workgroup+Estimates+of+the+prevalence+of+arthritis+and+other+rheumatic+conditions+in+the+United+States.+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II</span></div><div class="casAuthors">Lawrence Reva C; Felson David T; Helmick Charles G; Arnold Lesley M; Choi Hyon; Deyo Richard A; Gabriel Sherine; Hirsch Rosemarie; Hochberg Marc C; Hunder Gene G; Jordan Joanne M; Katz Jeffrey N; Kremers Hilal Maradit; Wolfe Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To provide a single source for the best available estimates of the US prevalence of and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell arteritis, gout, fibromyalgia, and carpal tunnel syndrome, as well as the symptoms of neck and back pain.  A companion article (part I) addresses additional conditions.  METHODS:  The National Arthritis Data Workgroup reviewed published analyses from available national surveys, such as the National Health and Nutrition Examination Survey and the National Health Interview Survey.  Because data based on national population samples are unavailable for most specific rheumatic conditions, we derived estimates from published studies of smaller, defined populations.  For specific conditions, the best available prevalence estimates were applied to the corresponding 2005 US population estimates from the Census Bureau, to estimate the number affected with each condition.  RESULTS:  We estimated that among US adults, nearly 27 million have clinical osteoarthritis (up from the estimate of 21 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteritis, up to 3.0 million have had self-reported gout in the past year (up from the estimate of 2.1 million for 1995), 5.0 million have fibromyalgia, 4-10 million have carpal tunnel syndrome, 59 million have had low back pain in the past 3 months, and 30.1 million have had neck pain in the past 3 months.  CONCLUSION:  Estimates for many specific rheumatic conditions rely on a few, small studies of uncertain generalizability to the US population.  This report provides the best available prevalence estimates for the US, but for most specific conditions more studies generalizable to the US or addressing understudied populations are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRoGBggfl_DDdblLE_E9PWfW6udTcc2ebaRyjc4x78q7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252Flt1Ghsw%253D%253D&md5=8fb852bfb01285c89db9c7d87369e167</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fart.23176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23176%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DR.%2BC.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DHelmick%26aufirst%3DC.%2BG.%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DDeyo%26aufirst%3DR.%2BA.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DR.%26aulast%3DHochberg%26aufirst%3DM.%2BC.%26aulast%3DHunder%26aufirst%3DG.%2BG.%26aulast%3DJordan%26aufirst%3DJ.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%2BN.%26aulast%3DKremers%26aufirst%3DH.%2BM.%26aulast%3DWolfe%26aufirst%3DF.%26atitle%3DNational%2520Arthritis%2520Data%2520Workgroup%2520Estimates%2520of%2520the%2520prevalence%2520of%2520arthritis%2520and%2520other%2520rheumatic%2520conditions%2520in%2520the%2520United%2520States.%2520Part%2520II%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x"> Disease and Injury country estimates </span><a href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html" class="extLink">http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Disease+and+Injury+country+estimates+http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Felson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totterman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, D. R.</span><span> </span><span class="NLM_article-title">The association of bone marrow lesions with pain in knee osteoarthritis</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">â</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.7326%2F0003-4819-134-7-200104030-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=11281736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gslOqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=541-549&author=D.+T.+Felsonauthor=C.+E.+Chaissonauthor=C.+L.+Hillauthor=S.+M.+Tottermanauthor=M.+E.+Galeauthor=K.+M.+Skinnerauthor=L.+Kazisauthor=D.+R.+Gale&title=The+association+of+bone+marrow+lesions+with+pain+in+knee+osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The association of bone marrow lesions with pain in knee osteoarthritis</span></div><div class="casAuthors">Felson D T; Chaisson C E; Hill C L; Totterman S M; Gale M E; Skinner K M; Kazis L; Gale D R</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">541-9</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">BACKGROUND:  The cause of pain in osteoarthritis is unknown.  Bone has pain fibers, and marrow lesions, which are thought to represent edema, have been noted in osteoarthritis.  OBJECTIVE:  To determine whether bone marrow lesions on magnetic resonance imaging (MRI) are associated with pain in knee osteoarthritis.  DESIGN:  Cross-sectional observational study.  SETTING:  Veterans Affairs Medical Center.  PATIENTS:  401 persons (mean age, 66.8 years) with knee osteoarthritis on radiography who were drawn from clinics in the Veterans Administration health care system and from the community.  Of these persons, 351 had knee pain and 50 had no knee pain.  MEASUREMENTS:  Knee radiography and MRI of one knee were performed in all participants.  Those with knee pain quantified the severity of their pain.  On MRI, coronal T(2)-weighted fat-saturated images were used to score the size of bone marrow lesions, and each knee was characterized as having any lesion or any large lesion.  The prevalence of lesions and large lesions in persons with and without knee pain was compared; in participants with knee pain, the presence of lesions was correlated with severity of pain.  RESULTS:  Bone marrow lesions were found in 272 of 351 (77.5%) persons with painful knees compared with 15 of 50 (30%) persons with no knee pain (P < 0.001).  Large lesions were present almost exclusively in persons with knee pain (35.9% vs. 2%; P < 0.001).  After adjustment for severity of radiographic disease, effusion, age, and sex, lesions and large lesions remained associated with the occurrence of knee pain.  Among persons with knee pain, bone marrow lesions were not associated with pain severity.  CONCLUSIONS:  Bone marrow lesions on MRI are strongly associated with the presence of pain in knee osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeVmLO2JfoRO-MdeMhXAHkfW6udTcc2ebaRyjc4x78q7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gslOqtg%253D%253D&md5=b7f66455dfc4ffa17405f4eafcff1b8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-134-7-200104030-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-134-7-200104030-00007%26sid%3Dliteratum%253Aachs%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DChaisson%26aufirst%3DC.%2BE.%26aulast%3DHill%26aufirst%3DC.%2BL.%26aulast%3DTotterman%26aufirst%3DS.%2BM.%26aulast%3DGale%26aufirst%3DM.%2BE.%26aulast%3DSkinner%26aufirst%3DK.%2BM.%26aulast%3DKazis%26aufirst%3DL.%26aulast%3DGale%26aufirst%3DD.%2BR.%26atitle%3DThe%2520association%2520of%2520bone%2520marrow%2520lesions%2520with%2520pain%2520in%2520knee%2520osteoarthritis%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2001%26volume%3D134%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Alzahrani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruccelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahomed, N.</span><span> </span><span class="NLM_article-title">Prevalence of clinically significant improvement following total knee replacement</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">â</span> <span class="NLM_lpage">759</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.3899%2Fjrheum.100233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=21239743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvgt1Cjsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=753-759&author=K.+Alzahraniauthor=R.+Gandhiauthor=J.+Debeerauthor=D.+Petruccelliauthor=N.+Mahomed&title=Prevalence+of+clinically+significant+improvement+following+total+knee+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of clinically significant improvement following total knee replacement</span></div><div class="casAuthors">Alzahrani Khalid; Gandhi Rajiv; Debeer Justin; Petruccelli Danielle; Mahomed Nizar</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-9</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Although total knee replacement (TKR) has a high reported success rate, the pain relief and functional improvement after surgery vary.  The purpose of our retrospective cohort study was to determine the prevalence of patients showing no clinically important improvement 1 year after TKR, and patient factors that may predict this outcome.  METHODS:  We reviewed primary TKR registry data that were collected from 2 academic hospitals: the Toronto Western Hospital and the Hamilton Health Sciences Henderson Hospital in Ontario, Canada.  Relevant covariates including demographic data, body mass index, and comorbidity were recorded.  Knee joint pain and functional status were assessed at baseline and at 1-year followup with the Western Ontario McMaster University Osteoarthritis Index (WOMAC) and Oxford Knee Score (OKS) to measure the change using the minimal clinically important difference (MCID).  Logistic regression modeling was used to identify the predictors of interest.  RESULTS:  Overall, 11.7% (373/3177) of patients reported no clinically important improvement 1 year after surgery.  Logistic regression modeling showed that a greater patient age independently predicted no clinically important improvement on the WOMAC scale 1 year after surgery (p = 0.0003), while being male independently predicted no clinically important improvement on the OKS 1 year after surgery (p = 0.008).  CONCLUSION:  Awareness of the prevalence of patients who may show no clinically important improvement and factors that predict this outcome will help patients and surgeons set realistic expectations of surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPBTsv0kk_AMERNNga7KD-fW6udTcc2ebbdDSF3Z5uc7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvgt1Cjsw%253D%253D&md5=278477c306b846ce3720a7ed49764f99</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.100233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.100233%26sid%3Dliteratum%253Aachs%26aulast%3DAlzahrani%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DR.%26aulast%3DDebeer%26aufirst%3DJ.%26aulast%3DPetruccelli%26aufirst%3DD.%26aulast%3DMahomed%26aufirst%3DN.%26atitle%3DPrevalence%2520of%2520clinically%2520significant%2520improvement%2520following%2520total%2520knee%2520replacement%26jtitle%3DJ.%2520Rheumatol.%26date%3D2011%26volume%3D38%26spage%3D753%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Bone resorption by osteoclasts</span> <span class="citation_source-journal">Science (Washington, D. C.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">â</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1126%2Fscience.289.5484.1504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=10968780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1KgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1504-1508&author=S.+L.+Teitelbaum&title=Bone+resorption+by+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Bone resorption by osteoclasts</span></div><div class="casAuthors">Teitelbaum, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5484</span>),
    <span class="NLM_cas:pages">1504-1508</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 57 refs.  Osteoporosis, a disease endemic in Western society, typically reflects an imbalance in skeletal turnover so that bone resorption exceeds bone formation.  Bone resorption is the unique function of the osteoclast, and anti-osteoporosis therapy to date has targeted this cell.  The osteoclast is a specialized macrophage polykaryon whose differentiation is principally regulated by macrophage colony-stimulating factor, RANK ligand, and osteoprotegerin.  Reflecting integrin-mediated signals, the osteoclast develops a specialized cytoskeleton that permits it to establish an isolated microenvironment between itself and bone, wherein matrix degrdn. occurs by a process involving proton transport.  Osteopetrotic mutants have provided a wealth of information about.the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqtaM613uBLVg90H21EOLACvtfcHk0lj8DE0DK1JB0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1KgsLk%253D&md5=ac72d05b78ad3ae84b3fcd1a4a3e8e1f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5484.1504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5484.1504%26sid%3Dliteratum%253Aachs%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DBone%2520resorption%2520by%2520osteoclasts%26jtitle%3DScience%2520%2528Washington%252C%2520D.%2520C.%2529%26date%3D2000%26volume%3D289%26spage%3D1504%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feild, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavaria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoncello, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavarselk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzog, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span> </span><span class="NLM_article-title">Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1654</span><span class="NLM_x">â</span> <span class="NLM_lpage">1663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1359%2Fjbmr.1999.14.10.1654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=10491212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOis7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=1654-1663&author=M.+Gowenauthor=F.+Laznerauthor=R.+Doddsauthor=R.+Kapadiaauthor=J.+Feildauthor=M.+Tavariaauthor=I.+Bertoncelloauthor=F.+Drakeauthor=S.+Zavarselkauthor=I.+Tellisauthor=P.+Hertzogauthor=C.+Debouckauthor=I.+Kola&title=Cathepsin+K+knockout+mice+develop+osteopetrosis+due+to+a+deficit+in+matrix+degradation+but+not+demineralization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization</span></div><div class="casAuthors">Gowen, Maxine; Lazner, Francesca; Dodds, Robert; Kapadia, Rasesh; Feild, John; Tavaria, Michael; Bertoncello, Ivan; Drake, Fred; Zavarselk, Silva; Tellis, Irene; Hertzog, Paul; Debouck, Christine; Kola, Ismail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1654-1663</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">Cathepsin K is a cysteine protease expressed predominantly in osteoclasts.  Activated cathepsin K cleaves key bone matrix proteins and is believed to play an important role in degrading the org. phase of bone during bone resorption.  Mutations in the human cathepsin K gene have been demonstrated to be assocd. with a rare skeletal dysplasia, pycnodysostosis.  The degree of functional activity of the mutated forms of cathepsin K in these individuals has not been elucidated, but is predicted to be low or absent.  To study the role of cathepsin K in bone resorption, we have generated mice deficient in the cathepsin K gene.  Histol. and radiog. anal. of the mice revealed osteopetrosis of the long bones and vertebrae, and abnormal joint morphol.  X-ray microcomputerized tomog. images allowed quantitation of the increase in bone vol., trabecular thickness, and trabecular no. in both the primary spongiosa and the metaphysis of the proximal tibia.  Not all bones were similarly affected.  Chondrocyte differentiation was normal.  The mice also had abnormalities in hematopoietic compartments, particularly decreased bone marrow cellularity and splenomegaly.  The heterozygous animals appeared normal.  Close histol. examn. of bone histol. revealed fully differentiated osteoclasts apposed to small regions of demineralized bone.  This strongly suggests that cathepsin K-deficient osteoclasts are capable of demineralizing the extracellular matrix but are unable to adequately remove the demineralized bone.  This is entirely consistent with the proposed function of cathepsin K as a matrix-degrading proteinase in bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71C1bZXpqO7Vg90H21EOLACvtfcHk0lj8DE0DK1JB0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOis7c%253D&md5=a549ea562d98908719cb52c6a7e66366</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.1999.14.10.1654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.1999.14.10.1654%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLazner%26aufirst%3DF.%26aulast%3DDodds%26aufirst%3DR.%26aulast%3DKapadia%26aufirst%3DR.%26aulast%3DFeild%26aufirst%3DJ.%26aulast%3DTavaria%26aufirst%3DM.%26aulast%3DBertoncello%26aufirst%3DI.%26aulast%3DDrake%26aufirst%3DF.%26aulast%3DZavarselk%26aufirst%3DS.%26aulast%3DTellis%26aufirst%3DI.%26aulast%3DHertzog%26aufirst%3DP.%26aulast%3DDebouck%26aufirst%3DC.%26aulast%3DKola%26aufirst%3DI.%26atitle%3DCathepsin%2520K%2520knockout%2520mice%2520develop%2520osteopetrosis%2520due%2520to%2520a%2520deficit%2520in%2520matrix%2520degradation%2520but%2520not%2520demineralization%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1999%26volume%3D14%26spage%3D1654%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Cysteine cathepsin S as an immunomodulatory target: present and future trends</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1517%2F14728222.12.3.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18269339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslKqur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=291-299&author=S.+Guptaauthor=R.+K.+Singhauthor=S.+Dastidarauthor=A.+Ray&title=Cysteine+cathepsin+S+as+an+immunomodulatory+target%3A+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsin S as an immunomodulatory target: present and future trends</span></div><div class="casAuthors">Gupta, Suman; Singh, Rakesh Kumar; Dastidar, Sunanda; Ray, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-299</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Objective: Antigen presentation is the key to immune response.  Cathepsin S plays a major role in the degrdn. of the invariant peptide chain assocd. with the major histocompatibility complex and thus affects antigen presentation.  This review will focus on the recent developments made in field of cysteine cathepsins esp. cathepsin S and their future prospects as a therapeutic target.  Methods: Selective cathepsin inhibitors for targeting autoimmune disorders, atherosclerosis, osteoporosis, osteoarthritis and cancer are being pursued by many pharmaceutical companies.  Recent publications in this field have been used as refs. to evaluate the current and future trends in cathepsin S inhibitors as an immunomodulatory target.  Conclusions: The temporal and spatial position occupied by cathepsin S in immune presentation, gives rise to the hope that an inhibitor would impart selectivity with a lesser propensity for side effects than other immunosuppressive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiiKL4FULMbVg90H21EOLACvtfcHk0lgA_BGaa3Cqrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslKqur0%253D&md5=78ff33141475b8f6239ea76a6b342f1b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.3.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.3.291%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26aulast%3DDastidar%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DCysteine%2520cathepsin%2520S%2520as%2520an%2520immunomodulatory%2520target%253A%2520present%2520and%2520future%2520trends%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D291%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors: a novel target for osteoporosis therapy</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1038%2Fsj.clpt.6100450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18073778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVylt7bM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=172-176&author=S.+A.+Stochauthor=J.+A.+Wagner&title=Cathepsin+K+inhibitors%3A+a+novel+target+for+osteoporosis+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy</span></div><div class="casAuthors">Stoch, Sa; Wagner, Ja</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-176</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is characterized by low bone mass with skeletal fragility and an increased risk of fracture.  This bone loss is brought about by an imbalance between bone resorption and formation.  Cathepsin K is the most abundant cysteine protease expressed in the osteoclast and is believed to be instrumental in bone matrix degrdn. necessary for bone resorption.  Cathepsin K inhibitors represent a novel target for developing agents to treat osteoporosis and other disorders characterized by increased bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr489JhmTXx8LVg90H21EOLACvtfcHk0lgA_BGaa3Cqrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVylt7bM&md5=4c77fe3842044d99fbef8cf78f054bac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.clpt.6100450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.clpt.6100450%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DCathepsin%2520K%2520inhibitors%253A%2520a%2520novel%2520target%2520for%2520osteoporosis%2520therapy%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D83%26spage%3D172%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaleta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broemme, D.</span><span> </span><span class="NLM_article-title">The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">â</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=973-993&author=Y.+Yasudaauthor=J.+Kaletaauthor=D.+Broemme&title=The+role+of+cathepsins+in+osteoporosis+and+arthritis%3A+rationale+for+the+design+of+new+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DKaleta%26aufirst%3DJ.%26aulast%3DBroemme%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520osteoporosis%2520and%2520arthritis%253A%2520rationale%2520for%2520the%2520design%2520of%2520new%2520therapeutics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D973%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darakhshan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerre-Millo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgnov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.</span><span> </span><span class="NLM_article-title">Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2202</span><span class="NLM_x">â</span> <span class="NLM_lpage">2208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1161%2FATVBAHA.108.172320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18818416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKrtrzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=2202-2208&author=M.+Yangauthor=J.+Sunauthor=T.+Zhangauthor=J.+Liuauthor=J.+Zhangauthor=M.+A.+Shiauthor=F.+Darakhshanauthor=M.+Guerre-Milloauthor=K.+Clementauthor=B.+D.+Gelbauthor=G.+Dolgnovauthor=G.+Shi&title=Deficiency+and+Inhibition+of+Cathepsin+K+Reduce+Body+Weight+Gain+and+Increase+Glucose+Metabolism+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice</span></div><div class="casAuthors">Yang, Min; Sun, Jiusong; Zhang, Tinghu; Liu, Jian; Zhang, Jie; Shi, Michael A.; Darakhshan, Froogh; Guerre-Millo, Michele; Clement, Karine; Gelb, Bruce D.; Dolgnov, Gregory; Shi, Guo-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2202-2208</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Previous studies demonstrated increased levels of cysteine proteases cathepsins in serum and adipose tissues from obese patients.  We now provide evidence from a mouse model of obesity to suggest a direct participation of cathepsin K (CatK) in mouse body wt. gain and glucose metab.  Using real-time polymerase chain reaction, we detected 12-fold increase in CatK transcripts after adipogenesis of human preadipocytes.  Using an immunohistol. anal., we consistently obsd. high levels of CatK expression in adipose tissues from obese humans and mice.  Selective inhibition of CatK activity blocked the lipid accumulation in human and mouse preadipocytes.  In mice, CatK deficiency reduced significantly diet-induced body wt. gain and serum glucose and insulin levels.  Similar results were obtained in diet-induced and genetically created (ob/ob) obese mice after animals were treated with a CatK-selective inhibitor.  Mechanistic study demonstrated a role for CatK in degrading fibronectin, a matrix protein that controls adipogenesis.  Deficiency or inhibition of CatK leads to fibronectin accumulation in muscle and adipose tissues.  This study demonstrates an essential role of CatK in adipogenesis and mouse body wt. gain, possibly via degrdn. of fibronectin, thus suggesting a novel therapeutic strategy for the control of obesity by regulating CatK activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KxuB1AW1J7Vg90H21EOLACvtfcHk0lgA_BGaa3Cqrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKrtrzM&md5=89f5b4a58bd4af9992ff235305e61b4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.108.172320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.108.172320%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DM.%2BA.%26aulast%3DDarakhshan%26aufirst%3DF.%26aulast%3DGuerre-Millo%26aufirst%3DM.%26aulast%3DClement%26aufirst%3DK.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DDolgnov%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DG.%26atitle%3DDeficiency%2520and%2520Inhibition%2520of%2520Cathepsin%2520K%2520Reduce%2520Body%2520Weight%2520Gain%2520and%2520Increase%2520Glucose%2520Metabolism%2520in%2520Mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D2202%26epage%3D2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.2174%2F138161207780162962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=17311556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=387-403&author=O.+Vasiljevaauthor=T.+Reinheckelauthor=C.+Petersauthor=D.+Turkauthor=V.+Turkauthor=B.+Turk&title=Emerging+roles+of+cysteine+cathepsins+in+disease+and+their+potential+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span></div><div class="casAuthors">Vasiljeva, Olga; Reinheckel, Thomas; Peters, Christoph; Turk, Dusan; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The general view on Cys cathepsins, which were long believed to be primarily involved in intracellular protein turnover, has dramatically changed in last 10 to 15 years.  The discovery of new cathepsins, such as cathepsins K, V, X, F and O, and their tissue distribution suggested that at least some of them are involved in very specific cellular processes.  Moreover, gene ablation expts. revealed that cathepsins play a vital role in numerous physiol. processes, such as antigen processing and presentation, bone remodeling, prohormone processing and wound healing.  Their involvement in several pathologies, including osteoporosis, rheumatoid arthritis, osteoarthritis, bronchial asthma and cancer were also confirmed and today several of them were validated as relevant targets for therapies.  Compds. targeting cathepsins S and K are already in clin. evaluation, whereas others are in exptl. phases.  The cathepsin K inhibitor AAE-581 (balicatib) as the most advanced of them passed Phase II clin. trials in 2005.  In this review, we discuss the current view on cathepsins as an emerging group of targets for several diseases and the development of cathepsin K and S inhibitors for treatment of osteoporosis and various immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpl43svUGSDrVg90H21EOLACvtfcHk0ljS6qLm0Yn3kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D&md5=50a14bd3146b8c29e745f4bb3af85af7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161207780162962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780162962%26sid%3Dliteratum%253Aachs%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DEmerging%2520roles%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520and%2520their%2520potential%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0ljS6qLm0Yn3kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, D., K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, D., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panebianco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies</span> <span class="citation_source-journal">Clin. Pharmacol. Ther. (N. Y., NY, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">â</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1038%2Fclpt.2009.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=19421185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2009&pages=175-182&author=S.+A.+Stochauthor=S.+Zajicauthor=J.+Stoneauthor=D.+L.+Millerauthor=D.%2C+K.+Vanauthor=M.+J.+Gutierrezauthor=D.%2C+M.+Deauthor=L.+Liuauthor=Q.+Liuauthor=B.+B.+Scottauthor=D.+Panebiancoauthor=B.+Jinauthor=L.+T.+Duongauthor=K.+Gottesdienerauthor=J.+A.+Wagner&title=Effect+of+the+Cathepsin+K+Inhibitor+Odanacatib+on+Bone+Resorption+Biomarkers+in+Healthy+Postmenopausal+Women%3A+Two+Double-Blind%2C+Randomized%2C+Placebo-Controlled+Phase+I+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies</span></div><div class="casAuthors">Stoch, S. A.; Zajic, S.; Stone, J.; Miller, D. L.; Van Dyck, K.; Gutierrez, M. J.; De Decker, M.; Liu, L.; Liu, Q.; Scott, B. B.; Panebianco, D.; Jin, B.; Duong, L. T.; Gottesdiener, K.; Wagner, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of cathepsin K (CatK) is a potential new treatment for osteoporosis.  In two double-blind, randomized, placebo-controlled phase I studies, postmenopausal female subjects received odanacatib (ODN), an orally active, potent, and selective CatK inhibitor, once weekly for 3 wk or once daily for 21 days.  Bone turnover biomarkers, safety monitoring, and plasma ODN concns. were assessed.  These studies showed ODN to be well tolerated.  Pharmacokinetic (PK) anal. revealed a long half-life (t1/2; 66-93 h) consistent with once-weekly dosing.  Pronounced redns. in C-terminal telopeptide of type I collagen (62%) and N-terminal telopeptide of type I collagen normalized to creatinine (NTx/Cr) (62%) at trough (C168 h) were seen following weekly administration.  Robust redns. in CTx (up to 81%) and NTx/Cr (up to 81%) were seen following daily administration.  ODN exhibits robust and sustained suppression of bone resorption biomarkers (CTx and NTx/Cr) at weekly doses â¥25 mg and daily doses â¥2.5 mg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtXIERVbQBorVg90H21EOLACvtfcHk0ljS6qLm0Yn3kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFOrt7c%253D&md5=e3e5a79ea2704e208701b4dc95b1bbe4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2009.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2009.60%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DZajic%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DD.%2BL.%26aulast%3DVan%26aufirst%3DD.%252C%2BK.%26aulast%3DGutierrez%26aufirst%3DM.%2BJ.%26aulast%3DDe%26aufirst%3DD.%252C%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DPanebianco%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DB.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520the%2520Cathepsin%2520K%2520Inhibitor%2520Odanacatib%2520on%2520Bone%2520Resorption%2520Biomarkers%2520in%2520Healthy%2520Postmenopausal%2520Women%253A%2520Two%2520Double-Blind%252C%2520Randomized%252C%2520Placebo-Controlled%2520Phase%2520I%2520Studies%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D86%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Eisman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hustad, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santora, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ince, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, A.</span><span> </span><span class="NLM_article-title">Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">â</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2Fjbmr.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=20740685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wru7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=242-251&author=J.+A.+Eismanauthor=H.+G.+Boneauthor=D.+J.+Hoskingauthor=M.+R.+McClungauthor=I.+R.+Reidauthor=R.+Rizzoliauthor=H.+Reschauthor=N.+Verbruggenauthor=C.+M.+Hustadauthor=S.+C.+Daauthor=R.+Petrovicauthor=A.+C.+Santoraauthor=B.+A.+Inceauthor=A.+Lombardi&title=Odanacatib+in+the+treatment+of+postmenopausal+women+with+low+bone+mineral+density%3A+three-year+continued+therapy+and+resolution+of+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect</span></div><div class="casAuthors">Eisman, John A.; Bone, Henry G.; Hosking, David J.; McClung, Michael R.; Reid, Ian R.; Rizzoli, Rene; Resch, Heinrich; Verbruggen, Nadia; Hustad, Carolyn M.; Da Silva, Carolyn; Petrovic, Romana; Santora, Arthur C.; Ince, B. Avery; Lombardi, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-251</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral d. (BMD) and decreased bone resorption markers during 2 years of treatment in postmenopausal women with low BMD.  A 1-yr extension study further assessed ODN efficacy and safety and the effects of discontinuing therapy.  In the base study, postmenopausal women with BMD T-scores between -2.0 and -3.5 at the lumbar spine or femur received placebo or ODN 3, 10, 25, or 50 mg weekly.  After 2 years, patients were rerandomized to ODN 50 mg weekly or placebo for an addnl. year.  Endpoints included BMD at the lumbar spine (primary), total hip, and hip subregions; levels of bone turnover markers; and safety assessments.  Continued treatment with 50 mg of ODN for 3 years produced significant increases from baseline and from year 2 in BMD at the spine (7.9 and 2.3%) and total hip (5.8 and 2.4%).  Urine cross-linked N-telopeptide of type I collagen (NTx) remained suppressed at year 3 (-50.5%), but bone-specific alk. phosphatase (BSAP) was relatively unchanged from baseline.  Treatment discontinuation resulted in bone loss at all sites, but BMD remained at or above baseline.  After ODN discontinuation at month 24, bone turnover markers increased transiently above baseline, but this increase largely resolved by month 36.  There were similar overall adverse-event rates in both treatment groups.  Thus, 3 years of ODN treatment resulted in progressive increases in BMD and was generally well tolerated.  Bone-resorption markers remained suppressed, whereas bone-formation markers returned to near baseline.  ODN effects were reversible: bone resorption increased transiently and BMD decreased following treatment discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMafU1lcX2E7Vg90H21EOLACvtfcHk0lhC_HLcQ23IWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wru7g%253D&md5=991c9a3ecb048737459c327c344d28bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.212%26sid%3Dliteratum%253Aachs%26aulast%3DEisman%26aufirst%3DJ.%2BA.%26aulast%3DBone%26aufirst%3DH.%2BG.%26aulast%3DHosking%26aufirst%3DD.%2BJ.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DResch%26aufirst%3DH.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DHustad%26aufirst%3DC.%2BM.%26aulast%3DDa%26aufirst%3DS.%2BC.%26aulast%3DPetrovic%26aufirst%3DR.%26aulast%3DSantora%26aufirst%3DA.%2BC.%26aulast%3DInce%26aufirst%3DB.%2BA.%26aulast%3DLombardi%26aufirst%3DA.%26atitle%3DOdanacatib%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%2520three-year%2520continued%2520therapy%2520and%2520resolution%2520of%2520effect%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2011%26volume%3D26%26spage%3D242%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nidamarthy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liable-Sands, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembryki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">StructureâActivity Relationships of 5-, 6-, and 7-Methyl-Substituted Azepan-3-one Cathepsin K Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1597</span><span class="NLM_x">â</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050915u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1597-1612&author=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=R.+Xieauthor=S.+D.+Nidamarthyauthor=H.+Ohauthor=J.+U.+Jeongauthor=K.+F.+Erhardauthor=K.+W.+Wardauthor=T.+J.+Roethkeauthor=B.+R.+Smithauthor=H.+Chengauthor=X.+Gengauthor=F.+Linauthor=P.+H.+Offenauthor=B.+Wangauthor=N.+Nevinsauthor=M.+S.+Headauthor=R.+C.+Haltiwangerauthor=S.+Narducciauthor=A.+Amyauthor=L.+M.+Liable-Sandsauthor=B.+Zhaoauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=E.+Gaoauthor=T.+Tomaszekauthor=M.+McQueneyauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=D.+L.+Zembrykiauthor=M.+W.+Larkauthor=D.+F.+Veber&title=Structure%E2%80%93Activity+Relationships+of+5-%2C+6-%2C+and+7-Methyl-Substituted+Azepan-3-one+Cathepsin+K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050915u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050915u%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DNidamarthy%26aufirst%3DS.%2BD.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DOffen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DNarducci%26aufirst%3DS.%26aulast%3DAmy%26aufirst%3DA.%26aulast%3DLiable-Sands%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcQueney%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DZembryki%26aufirst%3DD.%2BL.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%25205-%252C%25206-%252C%2520and%25207-Methyl-Substituted%2520Azepan-3-one%2520Cathepsin%2520K%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1597%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dare, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko-Moser, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G.</span><span> </span><span class="NLM_article-title">A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys</span> <span class="citation_source-journal">Bone (San Diego, CA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12ktrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=122-131&author=S.+Kumarauthor=L.+Dareauthor=J.+A.+Vasko-Moserauthor=I.+E.+Jamesauthor=S.+M.+Blakeauthor=D.+J.+Rickardauthor=S.+Hwangauthor=T.+Tomaszekauthor=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=H.+Ohauthor=J.+U.+Jeongauthor=D.+F.+Veberauthor=M.+Gowenauthor=M.+W.+Larkauthor=G.+Stroup&title=A+highly+potent+inhibitor+of+cathepsin+K+%28relacatib%29+reduces+biomarkers+of+bone+resorption+both+in+vitro+and+in+an+acute+model+of+elevated+bone+turnover+in+vivo+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys</span></div><div class="casAuthors">Kumar, S.; Dare, L.; Vasko-Moser, J. A.; James, I. E.; Blake, S. M.; Rickard, D. J.; Hwang, S.-M.; Tomaszek, T.; Yamashita, D. S.; Marquis, R. W.; Oh, H.; Jeong, J. U.; Veber, D. F.; Gowen, M.; Lark, M. W.; Stroup, G.</div><div class="citationInfo"><span class="NLM_cas:title">Bone (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-131</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cathepsin K is an osteoclast-derived cysteine protease that has been implicated as playing a major role in bone resorption.  A substantial body of evidence indicates that cathepsin K is crit. in osteoclast-mediated bone resorption and suggests that its pharmacol. inhibition should result in inhibition of bone resorption in vivo.  Here we report the pharmacol. characterization of SB-462795 (relacatib) as a potent and orally bioavailable small mol. inhibitor of cathepsin K that inhibits bone resorption both in vitro in human tissue and in vivo in cynomolgus monkeys.  SB-462795 is a potent inhibitor of human cathepsins K, L, and V (K i, app = 41, 68, and 53 pM, resp.) that exhibits 39-300-fold selectivity over other cathepsins.  SB-462795 inhibited endogenous cathepsin K in situ in human osteoclasts and human osteoclast-mediated bone resorption with IC50 values of â¼ 45 nM and â¼ 70 nM, resp.  The anti-resorptive potential of SB-462795 was evaluated in normal as well as medically ovariectomized (Ovx) female cynomolgus monkeys.  Serum levels of the C- and N-terminal telopeptides of Type I collagen (CTx and NTx, resp.) and urinary levels of NTx were monitored as biomarkers of bone resorption.  Administration of SB-462795 to medically ovariectomized or normal monkeys resulted in an acute redn. in both serum and urinary markers of bone resorption within 1.5 h after dosing, and this effect lasted up to 48 h depending on the dose administered.  Our data indicate that SB-462795 potently inhibits human cathepsin K in osteoclasts, resulting in a rapid inhibition of bone resorption both in vitro and in vivo in the monkey.  These studies also demonstrate the therapeutic potential of relacatib in the treatment of postmenopausal osteoporosis and serves to model the planned clin. trials in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyXueELl98GLVg90H21EOLACvtfcHk0ljd0MAnRlrp9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12ktrrF&md5=714403b214942c266acc686243f74ceb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DVasko-Moser%26aufirst%3DJ.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DBlake%26aufirst%3DS.%2BM.%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DStroup%26aufirst%3DG.%26atitle%3DA%2520highly%2520potent%2520inhibitor%2520of%2520cathepsin%2520K%2520%2528relacatib%2529%2520reduces%2520biomarkers%2520of%2520bone%2520resorption%2520both%2520in%2520vitro%2520and%2520in%2520an%2520acute%2520model%2520of%2520elevated%2520bone%2520turnover%2520in%2520vivo%2520in%2520monkeys%26jtitle%3DBone%2520%2528San%2520Diego%252C%2520CA%252C%2520U.%2520S.%2529%26date%3D2007%26volume%3D40%26spage%3D122%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bailey, A.; Pairaudeau, G.; Patel, A.; Thom, S.</span>WO2004000825A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bailey%2C+A.%3B+Pairaudeau%2C+G.%3B+Patel%2C+A.%3B+Thom%2C+S.WO2004000825A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DA.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">The consequences of lysosomotropism on the design of selective cathepsin K inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">â</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1525-1535&author=W.+C.+Blackauthor=M.+D.+Percival&title=The+consequences+of+lysosomotropism+on+the+design+of+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DThe%2520consequences%2520of%2520lysosomotropism%2520on%2520the%2520design%2520of%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2006%26volume%3D7%26spage%3D1525%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">â</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Masseauthor=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+Basic+Cathepsin+K+Inhibitors+Contributes+to+Increased+Cellular+Potencies+against+Off-Target+Cathepsins+and+Reduced+Functional+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are â¼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0ljd0MAnRlrp9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520Basic%2520Cathepsin%2520K%2520Inhibitors%2520Contributes%2520to%2520Increased%2520Cellular%2520Potencies%2520against%2520Off-Target%2520Cathepsins%2520and%2520Reduced%2520Functional%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, G.</span><span> </span><span class="NLM_article-title">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci000403i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=856-864&author=M.+M.+Hannauthor=A.+R.+Leachauthor=G.+Harper&title=Molecular+Complexity+and+Its+Impact+on+the+Probability+of+Finding+Leads+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span></div><div class="casAuthors">Hann, Michael M.; Leach, Andrew R.; Harper, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a simple model of ligand-receptor interactions, the interactions between ligands and receptors of varying complexities are studied and the probabilities of binding calcd.  It is obsd. that as the systems become more complex the chance of observing a useful interaction for a randomly chosen ligand falls dramatically.  The implications of this for the design of combinatorial libraries is explored.  A large set of drug leads and optimized compds. is profiled using several different properties relevant to mol. recognition.  The changes obsd. for these properties during the drug optimization phase support the hypothesis that less complex mols. are more common starting points for the discovery of drugs.  An extreme example of the use of simple mols. for directed screening against thrombin is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ed40mt9qb7Vg90H21EOLACvtfcHk0lguodVyyTz7Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D&md5=e89e76c8fb83fc5012369ae30f20e6b7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fci000403i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000403i%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHarper%26aufirst%3DG.%26atitle%3DMolecular%2520Complexity%2520and%2520Its%2520Impact%2520on%2520the%2520Probability%2520of%2520Finding%2520Leads%2520for%2520Drug%2520Discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D856%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span> </span><span class="NLM_article-title">Î²-Substituted Cyclohexanecarboxamide: A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">â</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051059p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1066-1079&author=S.+N.+Craneauthor=W.+C.+Blackauthor=J.+T.+Palmerauthor=D.+E.+Davisauthor=E.+Settiauthor=J.+Robichaudauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=J.+R.+Somozaauthor=N.+Chauretauthor=C.+Setoauthor=J.+Scheigetzauthor=G.+Wesolowskiauthor=F.+Masseauthor=S.+Desmaraisauthor=M.+Ouellet&title=%CE%B2-Substituted+Cyclohexanecarboxamide%3A+A+Nonpeptidic+Framework+for+the+Design+of+Potent+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm051059p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051059p%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOuellet%26aufirst%3DM.%26atitle%3D%25CE%25B2-Substituted%2520Cyclohexanecarboxamide%253A%2520A%2520Nonpeptidic%2520Framework%2520for%2520the%2520Design%2520of%2520Potent%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1066%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">Î²-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3146</span><span class="NLM_x">â</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3146-3151&author=J.+Robichaudauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=S.+Legerauthor=F.+Masseauthor=D.+J.+McKayauthor=R.+M.+Oballaauthor=J.+Paquetauthor=M.+D.+Percivalauthor=J.+Truchonauthor=G.+Wesolowskiauthor=S.+N.+Crane&title=%CE%B2-Substituted+cyclohexanecarboxamide+cathepsin+K+inhibitors%3A+Modification+of+the+1%2C2-disubstituted+aromatic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%2520cathepsin%2520K%2520inhibitors%253A%2520Modification%2520of%2520the%25201%252C2-disubstituted%2520aromatic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3146%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Berkessel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaubitz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lex, J.</span><span> </span><span class="NLM_article-title">Enantiomerically pure Î²-amino acids: a convenient access to both enantiomers of trans-2-aminocyclohexanecarboxylic acid</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">2948</span><span class="NLM_x">â</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=2948-2952&author=A.+Berkesselauthor=K.+Glaubitzauthor=J.+Lex&title=Enantiomerically+pure+%CE%B2-amino+acids%3A+a+convenient+access+to+both+enantiomers+of+trans-2-aminocyclohexanecarboxylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerkessel%26aufirst%3DA.%26aulast%3DGlaubitz%26aufirst%3DK.%26aulast%3DLex%26aufirst%3DJ.%26atitle%3DEnantiomerically%2520pure%2520%25CE%25B2-amino%2520acids%253A%2520a%2520convenient%2520access%2520to%2520both%2520enantiomers%2520of%2520trans-2-aminocyclohexanecarboxylic%2520acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2002%26spage%3D2948%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Harbert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koe, B. K.</span><span> </span><span class="NLM_article-title">Neuroleptic activity in 5-aryltetrahydro-Î³-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">â</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00180a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=635-643&author=C.+A.+Harbertauthor=J.+J.+Plattnerauthor=W.+M.+Welchauthor=A.+Weissmanauthor=B.+K.+Koe&title=Neuroleptic+activity+in+5-aryltetrahydro-%CE%B3-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00180a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00180a011%26sid%3Dliteratum%253Aachs%26aulast%3DHarbert%26aufirst%3DC.%2BA.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DWelch%26aufirst%3DW.%2BM.%26aulast%3DWeissman%26aufirst%3DA.%26aulast%3DKoe%26aufirst%3DB.%2BK.%26atitle%3DNeuroleptic%2520activity%2520in%25205-aryltetrahydro-%25CE%25B3-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D635%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, L. D.</span><span> </span><span class="NLM_article-title">Debenzylation of N-benzylamino derivatives by catalytic transfer hydrogenation with ammonium formate</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1080%2F00397918708063919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL1cXlsFCntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=415-418&author=S.+Ramauthor=L.+D.+Spicer&title=Debenzylation+of+N-benzylamino+derivatives+by+catalytic+transfer+hydrogenation+with+ammonium+formate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Debenzylation of N-benzylamino derivatives by catalytic transfer hydrogenation with ammonium formate</span></div><div class="casAuthors">Ram, Siya; Spicer, Leonard D.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-18</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">RR1NCH2Ph [R = H, Me; R1 = Ph, PhCH2CH2, HO(CH2)n (n = 2, 3)] are debenzylated with HCO2NH4 and Pd-C in MeOH to give 76-95% RR1NH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZX--7OMrW7Vg90H21EOLACvtfcHk0lguodVyyTz7Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsFCntA%253D%253D&md5=db9d7e505c0f5b62a471ad155f9194bb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F00397918708063919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918708063919%26sid%3Dliteratum%253Aachs%26aulast%3DRam%26aufirst%3DS.%26aulast%3DSpicer%26aufirst%3DL.%2BD.%26atitle%3DDebenzylation%2520of%2520N-benzylamino%2520derivatives%2520by%2520catalytic%2520transfer%2520hydrogenation%2520with%2520ammonium%2520formate%26jtitle%3DSynth.%2520Commun.%26date%3D1987%26volume%3D17%26spage%3D415%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lh4QE7KT0MJLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Andersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elebring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannesson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsgren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemurell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittamore, P.</span><span> </span><span class="NLM_article-title">Making medicinal chemistry more effective-application of Lean Sigma to improve processes, speed and quality</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=598-604&author=S.+Anderssonauthor=A.+Armstrongauthor=A.+Bjoereauthor=S.+Bowkerauthor=S.+Chapmanauthor=R.+Daviesauthor=C.+Donaldauthor=B.+Egnerauthor=T.+Elebringauthor=S.+Holmqvistauthor=T.+Inghardtauthor=P.+Johannessonauthor=M.+Johanssonauthor=C.+Johnstoneauthor=P.+Kemmittauthor=J.+Kihlbergauthor=P.+Korsgrenauthor=M.+Lemurellauthor=J.+Mooreauthor=J.+A.+Petterssonauthor=H.+Pointonauthor=F.+Pontenauthor=P.+Schofieldauthor=N.+Selmiauthor=P.+Whittamore&title=Making+medicinal+chemistry+more+effective-application+of+Lean+Sigma+to+improve+processes%2C+speed+and+quality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DBjoere%26aufirst%3DA.%26aulast%3DBowker%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DDonald%26aufirst%3DC.%26aulast%3DEgner%26aufirst%3DB.%26aulast%3DElebring%26aufirst%3DT.%26aulast%3DHolmqvist%26aufirst%3DS.%26aulast%3DInghardt%26aufirst%3DT.%26aulast%3DJohannesson%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26aulast%3DKorsgren%26aufirst%3DP.%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DJ.%2BA.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DPonten%26aufirst%3DF.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DWhittamore%26aufirst%3DP.%26atitle%3DMaking%2520medicinal%2520chemistry%2520more%2520effective-application%2520of%2520Lean%2520Sigma%2520to%2520improve%2520processes%252C%2520speed%2520and%2520quality%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D598%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oprea, T.</span><span> </span><span class="NLM_article-title">The design of leadlike combinatorial libraries</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3743</span><span class="NLM_x">â</span> <span class="NLM_lpage">3748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms12i" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3743-3748&author=S.+J.+Teagueauthor=A.+M.+Davisauthor=P.+D.+Leesonauthor=T.+Oprea&title=The+design+of+leadlike+combinatorial+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The design of leadlike combinatorial libraries</span></div><div class="casAuthors">Teague, Simon J.; Davis, Andrew M.; Leeson, Paul D.; Oprea, Tudor</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3743-3748</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with 26 refs.  The authors proposed that the properties required of library compds. intended to provide leads suitable for further optimization may be rather different.  The selection of leadlike compds. for further optimization eases the pressure on subsequent and more labor-intensive parts of drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7NQbjg0mN9bVg90H21EOLACvtfcHk0lh4QE7KT0MJLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms12i&md5=3918b1a2fdea3b814528f12487614a5f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991216%252938%253A24%253C3743%253A%253AAID-ANIE3743%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DOprea%26aufirst%3DT.%26atitle%3DThe%2520design%2520of%2520leadlike%2520combinatorial%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D3743%26epage%3D3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">Is There a Difference between Leads and Drugs? A Historical Perspective</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">â</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+Leeson&title=Is+There+a+Difference+between+Leads+and+Drugs%3F+A+Historical+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ÎMW = 69; ÎCMR = 1.8; ÎRNG = ÎHAC =1; ÎRTB = 2; ÎCLogP = 0.43; ÎLogD74 = 0.97; ÎHDO = 0; ÎDFPS = 0.15; ÎPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0lh4QE7KT0MJLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DIs%2520There%2520a%2520Difference%2520between%2520Leads%2520and%2520Drugs%253F%2520A%2520Historical%2520Perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D1308%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Williams, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The kinetics of reversible tight-binding inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2F0076-6879%2879%2963019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=502865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamsauthor=J.+F.+Morrison&title=The+kinetics+of+reversible+tight-binding+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of reversible tight-binding inhibition</span></div><div class="casAuthors">Williams, Jeffrey W.; Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Enzyme Kinet. Mech., Part A</span>),
    <span class="NLM_cas:pages">437-67</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">In addn. to a general discussion of the kinetics of reversible tight-binding inhibitors, which exert their effect at a concn. comparable to that of the enzyme, and for which steady-state theory is used, exptl. results are given of the tight-binding inhibition of creatine kinase by Eu3+ (actually Eu-ADP) under steady-state conditions.  The inhibition of creatine kinase by fixed concns. of Eu3+ in the presence of varying concns. of Mg-ADP indicated that the inhibition is competitive, suggesting that Eu-ADP acts as a structural analog of Mg-ADP.  The inhibition was noncompetitive with respect to creatine phosphate.  The dissocn. consts. for binding of Eu-ADP to the free enzyme and the enzyme-phosphocreatine complex were 1.5 and 2.2 nM, resp., as detd. from Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CwV3voXt27Vg90H21EOLACvtfcHk0ljuZ17AaNSEaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D&md5=a770f91b51661c9502d0aca44a24e1c7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2879%2963019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252879%252963019-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520kinetics%2520of%2520reversible%2520tight-binding%2520inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">â</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+Therienauthor=V.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0ljuZ17AaNSEaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">â</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0lj7Bz4AbXJk1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, B.</span><span> </span><span class="NLM_article-title">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">â</span> <span class="NLM_lpage">6682</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+Molecular+Pairs+as+a+Guide+in+the+Optimization+of+Pharmaceutical+Properties%3B+a+Study+of+Aqueous+Solubility%2C+Plasma+Protein+Binding+and+Oral+Exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lj7Bz4AbXJk1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520Molecular%2520Pairs%2520as%2520a%2520Guide%2520in%2520the%2520Optimization%2520of%2520Pharmaceutical%2520Properties%253B%2520a%2520Study%2520of%2520Aqueous%2520Solubility%252C%2520Plasma%2520Protein%2520Binding%2520and%2520Oral%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Dossetter, A. G.</span><span> </span><span class="NLM_article-title">A statistical analysis of in vitro human microsomal metabolic stability of small phenyl group substituents, leading to improved design sets for parallel SAR exploration of a chemical series</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">â</span> <span class="NLM_lpage">4414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmc.2010.04.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=20510621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntV2rurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4405-4414&author=A.+G.+Dossetter&title=A+statistical+analysis+of+in+vitro+human+microsomal+metabolic+stability+of+small+phenyl+group+substituents%2C+leading+to+improved+design+sets+for+parallel+SAR+exploration+of+a+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A statistical analysis of in vitro human microsomal metabolic stability of small phenyl group substituents, leading to improved design sets for parallel SAR exploration of a chemical series</span></div><div class="casAuthors">Dossetter, Alexander G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4405-4414</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An anal. of in vitro human liver microsomal turnover assay results from a large dataset (â¼75 K) of exptl. compds. tested is presented.  Combined with an anal. of small (<6 Ha) substituents on known drugs and existing published results a new set of 29 substituents (consensus) is proposed to increase stability and probe SAR (an enhanced Topliss set').  In addn. a different group of 28 substituents are identified as unlikely to change in vitro HLM stability, and a further set of compds. focuses on increasing HLM stability only.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwR4TenuEULVg90H21EOLACvtfcHk0lj7Bz4AbXJk1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntV2rurc%253D&md5=93c9825d5da0b47e0f4c66996c883642</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26atitle%3DA%2520statistical%2520analysis%2520of%2520in%2520vitro%2520human%2520microsomal%2520metabolic%2520stability%2520of%2520small%2520phenyl%2520group%2520substituents%252C%2520leading%2520to%2520improved%2520design%2520sets%2520for%2520parallel%2520SAR%2520exploration%2520of%2520a%2520chemical%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4405%26epage%3D4414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lewis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucurull-Sanchez, L.</span><span> </span><span class="NLM_article-title">Structural pairwise comparisons of HLM stability of phenyl derivatives: Introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE)</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1007%2Fs10822-008-9242-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18802667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFGg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=97-103&author=M.+L.+Lewisauthor=L.+Cucurull-Sanchez&title=Structural+pairwise+comparisons+of+HLM+stability+of+phenyl+derivatives%3A+Introduction+of+the+Pfizer+metabolism+index+%28PMI%29+and+metabolism-lipophilicity+efficiency+%28MLE%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural pairwise comparisons of HLM stability of phenyl derivatives: Introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE)</span></div><div class="casAuthors">Lewis, Mark L.; Cucurull-Sanchez, Lourdes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Data mining by pairwise comparison of over 150,000 human liver microsome (HLM) intrinsic clearance values stored within the internal Pfizer database has been performed by an automated tool.  Systematic probability tables of specific structural changes on the intrinsic clearance of Ph derivs. were generated.  From these data two new parameters, the Pfizer Metab. Index (PMI) and Metab.-Lipophilicity Efficiency (MLE) are introduced for each fragment.  The findings are applied to a Topliss style anal. that focuses on metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-t3Rk6sR_vLVg90H21EOLACvtfcHk0lh_X24QJr2t_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFGg&md5=5088f2c94bce164a302df21936da9a43</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-008-9242-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-008-9242-3%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BL.%26aulast%3DCucurull-Sanchez%26aufirst%3DL.%26atitle%3DStructural%2520pairwise%2520comparisons%2520of%2520HLM%2520stability%2520of%2520phenyl%2520derivatives%253A%2520Introduction%2520of%2520the%2520Pfizer%2520metabolism%2520index%2520%2528PMI%2529%2520and%2520metabolism-lipophilicity%2520efficiency%2520%2528MLE%2529%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Henderson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravis, W. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetic calculator program for generation of initial parameter estimates from a three-compartment infusion model</span> <span class="citation_source-journal">J. Pharmacol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2F0160-5402%2885%2990039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=3839870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFehsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1985&pages=13-24&author=J.+D.+Hendersonauthor=R.+D.+Olsonauthor=W.+R.+Ravis&title=Pharmacokinetic+calculator+program+for+generation+of+initial+parameter+estimates+from+a+three-compartment+infusion+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic calculator program for generation of initial parameter estimates from a three-compartment infusion model</span></div><div class="casAuthors">Henderson, James D.; Olson, Richard D.; Ravis, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Methods</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JPMED9</span>;
        ISSN:<span class="NLM_cas:issn">0160-5402</span>.
    </div><div class="casAbstract">A polyexponential curve-stripping program, KIN, is described for use on the HP-41CV programmable calculator.  The program may be used in the anal. of plasma-concn.-time curves for a 3-compartment i.v. bolus or infusion model with linear elimination processes.  The coeffs. and hybrid rate consts. of the exponential function are then used to compute pharmacokinetic parameters (vol. of the central compartment, intercompartmental rate transfer consts.), which may be used as initial ests. of model parameters in nonlinear regression curve-fitting procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqjk8-XJ34ULVg90H21EOLACvtfcHk0lh_X24QJr2t_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFehsLw%253D&md5=62866814a4181cf783202f4c4baef05b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0160-5402%2885%2990039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0160-5402%252885%252990039-7%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BD.%26aulast%3DOlson%26aufirst%3DR.%2BD.%26aulast%3DRavis%26aufirst%3DW.%2BR.%26atitle%3DPharmacokinetic%2520calculator%2520program%2520for%2520generation%2520of%2520initial%2520parameter%2520estimates%2520from%2520a%2520three-compartment%2520infusion%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Methods%26date%3D1985%26volume%3D14%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collington, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, R. J.</span><span> </span><span class="NLM_article-title">Evaluation of Human Pharmacokinetics, Therapeutic Dose and Exposure Predictions Using Marketed Oral Drugs</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.2174%2F138920007780866799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=17584017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=463-479&author=D.+F.+McGinnityauthor=J+Collingtonauthor=R.+P.+Austinauthor=R.+J.+Riley&title=Evaluation+of+Human+Pharmacokinetics%2C+Therapeutic+Dose+and+Exposure+Predictions+Using+Marketed+Oral+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span></div><div class="casAuthors">McGinnity, D. F.; Collington, J.; Austin, R. P.; Riley, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-479</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this article approaches to predict human pharmacokinetics (PK) are discussed and the capability of the exemplified methodologies to est. individual PK parameters and therapeutic dose for a set of marketed oral drugs has been assessed.  For a set of 63 drugs where the min. efficacious concn. (MEC) and human PK were known, the clin. dose was shown to be well predicted or in some cases over-estd. using a simple one-compartment oral PK model.  For a subset of these drugs, in vitro potency against the primary human targets was gathered, and compared to the obsd. MEC.  When cor. for plasma protein binding, the MEC of the majority of compds. was â¤ 3 fold over the resp. in vitro target potency value.  A series of in vitro and in vivo expts. were conducted to predict the human PK parameters.  Metabolic clearance was generally predicted well from human hepatocytes.  Interestingly, for this compd. set, allometry or glomerular filtration rate (GFR) ratio methods appeared to be applicable for renal CL even where CLrenal > GFR.  For â¼90% of compds. studied, the predicted CL using in vitro-in vivo (IVIV) extrapolation together with a CLrenal est., where appropriate, was within 2-fold of that obsd. clin.  Encouragingly vol. of distribution at steady state (Vss) estd. in preclin. species (rat and dog) when cor. for plasma protein binding, predicted human Vss successfully on the majority of occasions - 73% of compds. within 2-fold.  In this lab., absorption estd. from oral rat PK studies was lower than the obsd. human absorption for most drugs, even when soly. and permeability appeared not to be limiting.  Preliminary data indicate absorption in the dog may be more representative of human for compds. absorbed via the transcellular pathway.  Using predicted PK and MEC values estd. from in vitro potency assays there was a good correlation between predicted and obsd. dose.  This anal. suggests that for oral therapies, human PK parameters and clin. dose can be estd. from a consideration of data obtained from in vitro screens using human derived material and in vivo animal studies.  The benefits and limitations of this holistic approach to PK and dose prediction within the drug discovery process are exemplified and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdbfKDFLO_UrVg90H21EOLACvtfcHk0lh_X24QJr2t_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D&md5=765bdc4b870b660e813e36ae3719ddb5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138920007780866799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780866799%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DCollington%26aufirst%3DJ%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520Human%2520Pharmacokinetics%252C%2520Therapeutic%2520Dose%2520and%2520Exposure%2520Predictions%2520Using%2520Marketed%2520Oral%2520Drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D463%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sadick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraenzlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenberg, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schock-Kusch, D.</span><span> </span><span class="NLM_article-title">Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 T dynamic contrast-enhanced MRI and optical imaging</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">â</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1093%2Fndt%2Fgfr148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=21444361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbht1Snug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=3101-3108&author=M.+Sadickauthor=U.+Attenbergerauthor=B.+Kraenzlinauthor=H.+Kayedauthor=S.+O.+Schoenbergauthor=N.+Gretzauthor=D.+Schock-Kusch&title=Two+non-invasive+GFR-estimation+methods+in+rat+models+of+polycystic+kidney+disease%3A+3.0+T+dynamic+contrast-enhanced+MRI+and+optical+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 Tesla dynamic contrast-enhanced MRI and optical imaging</span></div><div class="casAuthors">Sadick Maliha; Attenberger Ulrike; Kraenzlin Bettina; Kayed Hany; Schoenberg Stefan O; Gretz Norbert; Schock-Kusch Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3101-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was the assessment of kidney morphology and glomerular filtration rate (GFR) in rat models of polycystic kidney disease and a healthy control group of Sprague-Dawley rats (SD rats).  The performance of two non-invasive GFR estimation methods-3.0 Tesla magnetic resonance imaging (MRI) and optical imaging were investigated.  Data of GFR assessment was compared to surrogate markers of kidney function and renal histology.  METHODS:  Optical imaging of GFR was performed transcutaneously in a small animal imaging system with the fluorescent renal marker fluorescein-isothiocyanate-labelled-sinistrin.  Morphologic and dynamic renal imaging was done on a clinical 3.0T MR scanner.  Renal perfusion analysis was performed with a two-compartment filtration model.  RESULTS:  The healthy SD rats showed physiological levels of creatinine and urea, indicating normal kidney function.  These parameters were elevated in the small animal groups of polycystic kidney disease.  For the calculation of perfusion and filtration parameters of kidney function in MRI, a 2D turbo FLASH sequence was performed and allowed to distinguish between normal GFR of healthy rats and reduced GFR of rats with polycystic kidney disease.  Also, MRI GFR varied among two different rat strains of polycystic kidney disease, according to their status of renal function impairment.  Optical imaging GFR confirmed higher GFR values in healthy rats compared to ill rats but did not show different results among the two rat strains of polycystic kidney disease.  For this reason, MRI and optical imaging GFR estimation presented an intra-method bias.  CONCLUSIONS:  Both non-invasive estimation methods of GFR, MRI and optical imaging, can differentiate between healthy rats and animals with limited kidney function.  Furthermore, optical imaging, unlike MRI, seems to consider that disease progression with increase of renal polycystic deterioration does not correlate with decrease of GFR in the initial stage of compensatory hyperfiltration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmbrKlAKtJrEodMGTatQ7LfW6udTcc2eYuI_BvZzd5Xrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbht1Snug%253D%253D&md5=916ad0c2fb6af9457adb80c15e5b6a94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfr148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfr148%26sid%3Dliteratum%253Aachs%26aulast%3DSadick%26aufirst%3DM.%26aulast%3DAttenberger%26aufirst%3DU.%26aulast%3DKraenzlin%26aufirst%3DB.%26aulast%3DKayed%26aufirst%3DH.%26aulast%3DSchoenberg%26aufirst%3DS.%2BO.%26aulast%3DGretz%26aufirst%3DN.%26aulast%3DSchock-Kusch%26aufirst%3DD.%26atitle%3DTwo%2520non-invasive%2520GFR-estimation%2520methods%2520in%2520rat%2520models%2520of%2520polycystic%2520kidney%2520disease%253A%25203.0%2520T%2520dynamic%2520contrast-enhanced%2520MRI%2520and%2520optical%2520imaging%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2011%26volume%3D26%26spage%3D3101%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rowland, M.; Tozer, T. N.</span> In  <span class="citation_source-book">Clinical Pharmacokinetics; Concepts and Application</span>; <span class="NLM_edition">3</span>rd ed., Chapter 11, p  <span class="NLM_fpage">171</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rowland%2C+M.%3B+Tozer%2C+T.+N.+In+Clinical+Pharmacokinetics%3B+Concepts+and+Application%3B+3rd+ed.%2C+Chapter+11%2C+p+171."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26btitle%3DClinical%2520Pharmacokinetics%253B%2520Concepts%2520and%2520Application%26spage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">â</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+Hydrogen+Bonding+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lhPg2hgCQefmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520Hydrogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an Intramolecular Hydrogen Bond To Increase the CNS Penetration of an NK1 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">â</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+Intramolecular+Hydrogen+Bond+To+Increase+the+CNS+Penetration+of+an+NK1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520Intramolecular%2520Hydrogen%2520Bond%2520To%2520Increase%2520the%2520CNS%2520Penetration%2520of%2520an%2520NK1%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Discovery of a Thieno[2,3-<i>d</i>]pyrimidine-2,4-dione Bearing a <i>p</i>-Methoxyureidophenyl Moiety at the 6-Position: A Highly Potent and Orally Bioavailable Nonpeptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">â</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020180i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=113-124&author=S.+Sasakiauthor=N.+Choauthor=Y.+Naraauthor=M.+Haradaauthor=S.+Endoauthor=N.+Suzukiauthor=S.+Furuyaauthor=M.+Fujino&title=Discovery+of+a+Thieno%5B2%2C3-d%5Dpyrimidine-2%2C4-dione+Bearing+a+p-Methoxyureidophenyl+Moiety+at+the+6-Position%3A+A+Highly+Potent+and+Orally+Bioavailable+Nonpeptide+Antagonist+for+the+Human+Luteinizing+Hormone-Releasing+Hormone+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm020180i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020180i%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNara%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520Thieno%255B2%252C3-d%255Dpyrimidine-2%252C4-dione%2520Bearing%2520a%2520p-Methoxyureidophenyl%2520Moiety%2520at%2520the%25206-Position%253A%2520A%2520Highly%2520Potent%2520and%2520Orally%2520Bioavailable%2520Nonpeptide%2520Antagonist%2520for%2520the%2520Human%2520Luteinizing%2520Hormone-Releasing%2520Hormone%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Rezai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokey, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">14073</span><span class="NLM_x">â</span> <span class="NLM_lpage">14080</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+Flexibility%2C+Internal+Hydrogen+Bonding%2C+and+Passive+Membrane+Permeability%3A+Successful+in+Silico+Prediction+of+the+Relative+Permeabilities+of+Cyclic+Peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0liQG8GJTHuxEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520Flexibility%252C%2520Internal%2520Hydrogen%2520Bonding%252C%2520and%2520Passive%2520Membrane%2520Permeability%253A%2520Successful%2520in%2520Silico%2520Prediction%2520of%2520the%2520Relative%2520Permeabilities%2520of%2520Cyclic%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Garnero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsdal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicamhlaoibh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risteli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foged, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaisse, J. M.</span><span> </span><span class="NLM_article-title">The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">â</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1359%2Fjbmr.2003.18.5.859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=12733725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslahsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=859-867&author=P.+Garneroauthor=M.+Ferrerasauthor=M.+Karsdalauthor=R.+Nicamhlaoibhauthor=J.+Risteliauthor=O.+Borelauthor=P.+Qvistauthor=P.+D.+Delmasauthor=N.+T.+Fogedauthor=J.+M.+Delaisse&title=The+type+I+collagen+fragments+ICTP+and+CTX+reveal+distinct+enzymatic+pathways+of+bone+collagen+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation</span></div><div class="casAuthors">Garnero, P.; Ferreras, M.; Karsdal, Ma; Nicamhlaoibh, R.; Risteli, J.; Borel, O.; Qvist, P.; Delmas, P. D.; Foged, N. T.; Delaisse, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Bone resorption may generate collagen fragments such as ICTP and CTX, which can be quantified in serum and/or urine by using specific immunoassays, and which are used as clin. markers.  However, the relative abundance of ICTP and CTX varies according to the type of bone pathol., suggesting that these two fragments are generated via distinct collagenolytic pathways.  Here, the authors analyzed the release of ICTP and CTX from bone collagen by the proteinases reported to play a role in the solubilization of bone matrix.  Cathepsin K released large amts. of CTX, but did not allow a detectable release of ICTP.  Conversely, the matrix metalloproteinases (MMPs) MMP-2, -9, -13, or -14 released ICTP, but did not allow a detectable release of CTX.  Next the authors analyzed the release of ICTP and CTX from bone explants cultured in the presence of well-established inhibitors of these proteinases and of matrix solubilization.  An inhibitor of cysteine proteinases including cathepsin K, inhibited the release of CTX, but not the release of ICTP.  MMP inhibitors inhibited the release of ICTP, but also that of CTX, in agreement with the putative role of MMPs in the initiation of bone resorption in addn. to matrix solubilization.  Similarly the treatment of mice bearing bone metastasis with an MMP inhibitor led to a redn. of serum ICTP and CTX, and osteolytic lesions.  Thus, the generation of ICTP and CTX depends on different collagenolytic pathways.  This finding may explain why these 2 markers may discriminate between different bone pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3gar2jdeKrVg90H21EOLACvtfcHk0liQG8GJTHuxEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslahsrY%253D&md5=c4549a3259a310457c1f8f801aeb8c32</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.5.859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.5.859%26sid%3Dliteratum%253Aachs%26aulast%3DGarnero%26aufirst%3DP.%26aulast%3DFerreras%26aufirst%3DM.%26aulast%3DKarsdal%26aufirst%3DM.%26aulast%3DNicamhlaoibh%26aufirst%3DR.%26aulast%3DRisteli%26aufirst%3DJ.%26aulast%3DBorel%26aufirst%3DO.%26aulast%3DQvist%26aufirst%3DP.%26aulast%3DDelmas%26aufirst%3DP.%2BD.%26aulast%3DFoged%26aufirst%3DN.%2BT.%26aulast%3DDelaisse%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520type%2520I%2520collagen%2520fragments%2520ICTP%2520and%2520CTX%2520reveal%2520distinct%2520enzymatic%2520pathways%2520of%2520bone%2520collagen%2520degradation%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Herrmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, M.</span><span> </span><span class="NLM_article-title">The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.cca.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18423400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKhsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2008&pages=57-75&author=M.+Herrmannauthor=M.+Seibel&title=The+amino-+and+carboxyterminal+cross-linked+telopeptides+of+collagen+type+I%2C+NTX-I+and+CTX-I%3A+A+comparative+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review</span></div><div class="casAuthors">Herrmann, Markus; Seibel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-75</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bone diseases such as osteoporosis or bone metastases are a continuously growing problem in the ageing populations across the world.  In recent years, great efforts have been made to develop specific and sensitive biochem. markers of bone turnover that could help in the assessment and monitoring of bone turnover.  The amino- and carboxyterminal cross-linked telopeptides of type I collagen (NTX-I and CTX-I, resp.) are two widely used bone resorption markers that attracted great attention due to their relatively high sensitivity and specificity for the degrdn. of type I collagen, and their rapid adaptation to automated analyzers.  However, the clin. performance of both markers differs significantly depending on the clin. situation.  These differences have caused considerable confusion and uncertainty.  If used correctly, both markers have great potential to improve the management of many bone diseases.  The authors here review the biochem., anal. background and clin. performance of NTX-I and CTX-I, as documented in the accessible literature until March 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3xolh-a6hbVg90H21EOLACvtfcHk0liQG8GJTHuxEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKhsLo%253D&md5=f50b4fbb47ee454ae4885cbae9d0a527</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSeibel%26aufirst%3DM.%26atitle%3DThe%2520amino-%2520and%2520carboxyterminal%2520cross-linked%2520telopeptides%2520of%2520collagen%2520type%2520I%252C%2520NTX-I%2520and%2520CTX-I%253A%2520A%2520comparative%2520review%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D393%26spage%3D57%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Okuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, Y.</span><span> </span><span class="NLM_article-title">Serum levels of C-terminal telopeptide of type I collagen: A useful new marker of cortical bone loss in hemodialysis patients</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">â</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1007%2Fs00198-004-1712-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=15309383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFSrsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=501-509&author=S.+Okunoauthor=M.+Inabaauthor=K.+Kitataniauthor=E.+Ishimuraauthor=T.+Yamakawaauthor=Y.+Nishizawa&title=Serum+levels+of+C-terminal+telopeptide+of+type+I+collagen%3A+A+useful+new+marker+of+cortical+bone+loss+in+hemodialysis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Serum levels of C-terminal telopeptide of type I collagen: A useful new marker of cortical bone loss in hemodialysis patients</span></div><div class="casAuthors">Okuno, Senji; Inaba, Masaaki; Kitatani, Kayoko; Ishimura, Eiji; Yamakawa, Tomoyuki; Nishizawa, Yoshiki</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer London Ltd.</span>)
        </div><div class="casAbstract">Renal osteodystrophy is a major complication in hemodialysis patients.  Measurement of serum peptide derived from the degrdn. of bone collagen could potentially provide an indirect est. of bone resorption.  The present study estd. the significance of the C-terminal telopeptide of type I collagen (Î²-CTx) as a serum bone resorption marker in male hemodialysis patients.  The mean age and hemodialysis duration of the 160 patients were 59.7 years (26-86 years) and 67.2 mo (17-142 mo), resp.  Bone mineral d. (BMD) in the distal third of the radius was measured using dual-energy x-ray absorptiometry twice with a 2-yr interval.  A blood sample was collected immediately before the hemodialysis session at the time of the second BMD measurement.  Other serum bone markers detd. were bone-specific alk. phosphatase (BAP) and intact and N-terminal midfragment (N-Mid) osteocalcin (OC) as bone-formation markers and serum pyridinoline (PYD) and deoxypyridinoline (DPD) as bone resorption markers.  Serum Î²-CTx correlated significantly in a pos. manner with serum PYD, DPD, BAP, intact OC, and N-Mid OC.  Serum Î²-CTx, as well as PYD, DPD, BAP, intact OC, and N-Mid OC, correlated significantly with BMD in the distal third of the radius at the second measurement and with the rate of BMD redn. during the preceding 2 years.  The highest quartile of serum Î²-CTx was pos. assocd. with rapid bone loss, defined as a change in the value for BMD in the distal third of the radius falling within the upper tertile of patients, in 55% of cases, and each quartile progress in serum Î²-CTx increased the odds ratio of rapid bone loss by a factor of 1.73.  Since the Youden index was twice as accurate for Î²-CTx, BAP and N-Mid OC as for intact PTH, these bone-remodeling markers may be better risk markers of cortical bone loss than intact PTH.  Inclusion in the highest quartile of PTH (above 288 pg/mL) predicted rapid bone loss with a sensitivity of only 26%.  This means that the upper limit for serum PTH level recommended by K/DOQI may be too high, since 74% of cases with rapid bone loss showed serum PTH levels of below 288 pg/mL.  In conclusion, serum measurement of Î²-CTx may provide a new com. viable and relevant serum assay to reflect cortical bone resorption in hemodialysis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosRuF9MfaY7bVg90H21EOLACvtfcHk0liQG8GJTHuxEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFSrsr4%253D&md5=63384fa1d9ad1d796c858dd0648f590d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00198-004-1712-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-004-1712-4%26sid%3Dliteratum%253Aachs%26aulast%3DOkuno%26aufirst%3DS.%26aulast%3DInaba%26aufirst%3DM.%26aulast%3DKitatani%26aufirst%3DK.%26aulast%3DIshimura%26aufirst%3DE.%26aulast%3DYamakawa%26aufirst%3DT.%26aulast%3DNishizawa%26aufirst%3DY.%26atitle%3DSerum%2520levels%2520of%2520C-terminal%2520telopeptide%2520of%2520type%2520I%2520collagen%253A%2520A%2520useful%2520new%2520marker%2520of%2520cortical%2520bone%2520loss%2520in%2520hemodialysis%2520patients%26jtitle%3DOsteoporosis%2520Int.%26date%3D2005%26volume%3D16%26spage%3D501%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Julia V. Vyalyh, Konstantin F. Suzdalev, Anton V. Lisovin, Mikhail E. Kletskii, Oleg N. Burov, <span class="NLM_string-name hlFld-ContribAuthor">Sergey V. Kurbatov</span>. </span><span class="cited-content_cbyCitation_article-title">From 3-Acyl-2-methylindoles to Î³-Carbolines: Li-Promoted Cycloaddition Reaction and Its Quantum Chemical Study. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13721-13732. <a href="https://doi.org/10.1021/acs.joc.9b01926" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01926%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFrom%252B3-Acyl-2-methylindoles%252Bto%252B%2525CE%2525B3-Carbolines%25253A%252BLi-Promoted%252BCycloaddition%252BReaction%252Band%252BIts%252BQuantum%252BChemical%252BStudy%26aulast%3DVyalyh%26aufirst%3DJulia%2BV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15072019%26date%3D08102019%26volume%3D84%26issue%3D21%26spage%3D13721%26epage%3D13732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jure  BoriÅ¡ek</span>, <span class="hlFld-ContribAuthor ">Matej  VizoviÅ¡ek</span>, <span class="hlFld-ContribAuthor ">Piotr  Sosnowski</span>, <span class="hlFld-ContribAuthor ">Boris  Turk</span>, <span class="hlFld-ContribAuthor ">DuÅ¡an  Turk</span>, <span class="hlFld-ContribAuthor ">Barbara  Mohar</span>, and <span class="hlFld-ContribAuthor ">Marjana  NoviÄ</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6928-6937. <a href="https://doi.org/10.1021/acs.jmedchem.5b00746" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00746%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BN-%252528Functionalized%252Bbenzoyl%252529-homocycloleucyl-glycinonitriles%252Bas%252BPotent%252BCathepsin%252BK%252BInhibitors%26aulast%3DBori%25C5%25A1ek%26aufirst%3DJure%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D15052015%26date%3D26082015%26date%3D10092015%26date%3D17082015%26volume%3D58%26issue%3D17%26spage%3D6928%26epage%3D6937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Peter W.  Kenny</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bowyer</span>, <span class="hlFld-ContribAuthor ">Calum R.  Cook</span>, <span class="hlFld-ContribAuthor ">Jonathan E.  Finlayson</span>, <span class="hlFld-ContribAuthor ">Christine  Heyes</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Highton</span>, <span class="hlFld-ContribAuthor ">Julian A.  Hudson</span>, <span class="hlFld-ContribAuthor ">Anja  Jestel</span>, <span class="hlFld-ContribAuthor ">Stephan  Krapp</span>, <span class="hlFld-ContribAuthor ">Scott  Martin</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  McDermott</span>, <span class="hlFld-ContribAuthor ">Thomas M.  McGuire</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Morley</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Morris</span>, <span class="hlFld-ContribAuthor ">Ken M.  Page</span>, <span class="hlFld-ContribAuthor ">Lyn Rosenbrier  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Helen  Sawney</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Caroline  Smith</span>, and <span class="hlFld-ContribAuthor ">Alexander G.  Dossetter</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic Benefits of 3,4-Dimethoxy Substitution of a Phenyl Ring and Design of Isosteres Yielding Orally Available Cathepsin K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (20)
                                     , 8827-8837. <a href="https://doi.org/10.1021/jm301119s" title="DOI URL">https://doi.org/10.1021/jm301119s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301119s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301119s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacokinetic%252BBenefits%252Bof%252B3%25252C4-Dimethoxy%252BSubstitution%252Bof%252Ba%252BPhenyl%252BRing%252Band%252BDesign%252Bof%252BIsosteres%252BYielding%252BOrally%252BAvailable%252BCathepsin%252BK%252BInhibitors%26aulast%3DCrawford%26aufirst%3DJames%2BJ.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D31072012%26date%3D11102012%26date%3D25102012%26date%3D17092012%26volume%3D55%26issue%3D20%26spage%3D8827%26epage%3D8837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mochihito  Suzuki</span>, <span class="hlFld-ContribAuthor ">Nobunori  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yasumori  Sobue</span>, <span class="hlFld-ContribAuthor ">Yoshifumi  Ohashi</span>, <span class="hlFld-ContribAuthor ">Kenji  Kishimoto</span>, <span class="hlFld-ContribAuthor ">Kyosuke  Hattori</span>, <span class="hlFld-ContribAuthor ">Naoki  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Toshihisa  Kojima</span>. </span><span class="cited-content_cbyCitation_article-title">Hyaluronan suppresses enhanced cathepsin K expression via activation of NF-ÎºB with mechanical stress loading in a human chondrocytic HCS-2/8 cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-57073-8" title="DOI URL">https://doi.org/10.1038/s41598-019-57073-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-57073-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-57073-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DHyaluronan%252Bsuppresses%252Benhanced%252Bcathepsin%252BK%252Bexpression%252Bvia%252Bactivation%252Bof%252BNF-%2525CE%2525BAB%252Bwith%252Bmechanical%252Bstress%252Bloading%252Bin%252Ba%252Bhuman%252Bchondrocytic%252BHCS-2%25252F8%252Bcells%26aulast%3DSuzuki%26aufirst%3DMochihito%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taynara L.  Silva</span>, <span class="hlFld-ContribAuthor ">Deborah A.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Hugo C.R.  de Jesus</span>, <span class="hlFld-ContribAuthor ">Dieter  BrÃ¶mme</span>, <span class="hlFld-ContribAuthor ">JoÃ£o B.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Marcio W.  PaixÃ£o</span>, <span class="hlFld-ContribAuthor ">Arlene G.  CorrÃªa</span>, <span class="hlFld-ContribAuthor ">Paulo C.  Vieira</span>. </span><span class="cited-content_cbyCitation_article-title">Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (15)
                                     , 115597. <a href="https://doi.org/10.1016/j.bmc.2020.115597" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115597%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DGreen%252Basymmetric%252Bsynthesis%252Bof%252Bepoxypeptidomimetics%252Band%252Bevaluation%252Bas%252Bhuman%252Bcathepsin%252BK%252Binhibitors%26aulast%3DSilva%26aufirst%3DTaynara%2BL.%26date%3D2020%26volume%3D28%26issue%3D15%26spage%3D115597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Si-tu  Xue</span>, <span class="hlFld-ContribAuthor ">Ya-li  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-wan  Han</span>, <span class="hlFld-ContribAuthor ">Hong  Yi</span>, <span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Shu-yi  Si</span>, <span class="hlFld-ContribAuthor ">Hui-fang  Guo</span>, <span class="hlFld-ContribAuthor ">Zhuo-rong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cathepsin K inhibitors block osteoclasts
              in vitro
              and increase spinal bone density in zebrafish. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (15)
                                     , 8600-8607. <a href="https://doi.org/10.1039/C8RA10338K" title="DOI URL">https://doi.org/10.1039/C8RA10338K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA10338K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA10338K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNovel%252Bcathepsin%252BK%252Binhibitors%252Bblock%252Bosteoclasts%252Bin%252Bvitro%252Band%252Bincrease%252Bspinal%252Bbone%252Bdensity%252Bin%252Bzebrafish%26aulast%3DXue%26aufirst%3DSi-tu%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D15%26spage%3D8600%26epage%3D8607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nejc  Petek</span>, <span class="hlFld-ContribAuthor ">Bogdan  Å tefane</span>, <span class="hlFld-ContribAuthor ">Marko  Novinec</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 226-238. <a href="https://doi.org/10.1016/j.bioorg.2018.11.029" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B7-%252528aminoalkyl%252529pyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bas%252Bcathepsin%252BK%252Binhibitors%26aulast%3DPetek%26aufirst%3DNejc%26date%3D2019%26volume%3D84%26spage%3D226%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiangkun  Dai</span>, <span class="hlFld-ContribAuthor ">Wenjia  Dan</span>, <span class="hlFld-ContribAuthor ">Yunyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Junru  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments on synthesis and biological activities of Î³-carboline. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 447-461. <a href="https://doi.org/10.1016/j.ejmech.2018.08.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bon%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252B%2525CE%2525B3-carboline%26aulast%3DDai%26aufirst%3DJiangkun%26date%3D2018%26volume%3D157%26spage%3D447%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">DÃ©bora A.  Rocha</span>, <span class="hlFld-ContribAuthor ">Elany B.  Silva</span>, <span class="hlFld-ContribAuthor ">Isadora S.  Fortes</span>, <span class="hlFld-ContribAuthor ">Marcela S.  Lopes</span>, <span class="hlFld-ContribAuthor ">Rafaela S.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Saulo F.  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1426-1459. <a href="https://doi.org/10.1016/j.ejmech.2018.08.079" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.079%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252Bcruzain%252Band%252Brhodesain%252Binhibitors%26aulast%3DRocha%26aufirst%3DD%25C3%25A9bora%2BA.%26date%3D2018%26volume%3D157%26spage%3D1426%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moses  Moustakim</span>, <span class="hlFld-ContribAuthor ">Kerstin  Riedel</span>, <span class="hlFld-ContribAuthor ">Marion  Schuller</span>, <span class="hlFld-ContribAuthor ">AndrÃ¨ P.  Gehring</span>, <span class="hlFld-ContribAuthor ">Octovia P.  Monteiro</span>, <span class="hlFld-ContribAuthor ">Sarah P.  Martin</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Jag  Heer</span>, <span class="hlFld-ContribAuthor ">Darren J.  Dixon</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Franz  Bracher</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 2965-2972. <a href="https://doi.org/10.1016/j.bmc.2018.03.020" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Ballosteric%252Binhibitor%252Bscaffold%252Bfor%252Bpolyadenosine-diphosphate-ribose%252Bpolymerase%252B14%252B%252528PARP14%252529%252Bmacrodomain%252B2%26aulast%3DMoustakim%26aufirst%3DMoses%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D2965%26epage%3D2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto Monteiro  Dos Santos</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Cianni</span>, <span class="hlFld-ContribAuthor ">Daniela  De Vita</span>, <span class="hlFld-ContribAuthor ">Fabiana  Rosini</span>, <span class="hlFld-ContribAuthor ">Andrei  LeitÃ£o</span>, <span class="hlFld-ContribAuthor ">Charles A.  Laughton</span>, <span class="hlFld-ContribAuthor ">JerÃ´nimo  Lameira</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Montanari</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental study and computational modelling of cruzain cysteine protease inhibition by dipeptidyl nitriles. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2018,</strong> <em>20 </em>
                                    (37)
                                     , 24317-24328. <a href="https://doi.org/10.1039/C8CP03320J" title="DOI URL">https://doi.org/10.1039/C8CP03320J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CP03320J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CP03320J%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DExperimental%252Bstudy%252Band%252Bcomputational%252Bmodelling%252Bof%252Bcruzain%252Bcysteine%252Bprotease%252Binhibition%252Bby%252Bdipeptidyl%252Bnitriles%26aulast%3DDos%2BSantos%26aufirst%3DAlberto%2BMonteiro%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D37%26spage%3D24317%26epage%3D24328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyue  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongqi  Fu</span>, <span class="hlFld-ContribAuthor ">Aiping  Lu</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery of cathepsin K inhibitors on bone resorption. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 890-904. <a href="https://doi.org/10.1080/14756366.2018.1465417" title="DOI URL">https://doi.org/10.1080/14756366.2018.1465417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1465417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1465417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bcathepsin%252BK%252Binhibitors%252Bon%252Bbone%252Bresorption%26aulast%3DLu%26aufirst%3DJun%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D890%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lovro  Kramer</span>, <span class="hlFld-ContribAuthor ">DuÅ¡an  Turk</span>, <span class="hlFld-ContribAuthor ">Boris  Turk</span>. </span><span class="cited-content_cbyCitation_article-title">The Future of Cysteine Cathepsins in Disease Management. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (10)
                                     , 873-898. <a href="https://doi.org/10.1016/j.tips.2017.06.003" title="DOI URL">https://doi.org/10.1016/j.tips.2017.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2017.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2017.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DThe%252BFuture%252Bof%252BCysteine%252BCathepsins%252Bin%252BDisease%252BManagement%26aulast%3DKramer%26aufirst%3DLovro%26date%3D2017%26volume%3D38%26issue%3D10%26spage%3D873%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabahuddin  Ahmad</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2017,</strong> <em>23 </em>
                                    (3)
                                     <a href="https://doi.org/10.1007/s00894-017-3255-6" title="DOI URL">https://doi.org/10.1007/s00894-017-3255-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-017-3255-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-017-3255-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DInsights%252Bfrom%252Bmolecular%252Bmodeling%252Binto%252Bthe%252Bselective%252Binhibition%252Bof%252Bcathepsin%252BS%252Bby%252Bits%252Binhibitor%26aulast%3DAhmad%26aufirst%3DSabahuddin%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Law</span>, <span class="hlFld-ContribAuthor ">Pierre-Marie  Andrault</span>, <span class="hlFld-ContribAuthor ">Adeleke H.  Aguda</span>, <span class="hlFld-ContribAuthor ">Nham T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Natasha  Kruglyak</span>, <span class="hlFld-ContribAuthor ">Gary D.  Brayer</span>, <span class="hlFld-ContribAuthor ">Dieter  BrÃ¶mme</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2017,</strong> <em>474 </em>
                                    (5)
                                     , 851-864. <a href="https://doi.org/10.1042/BCJ20160985" title="DOI URL">https://doi.org/10.1042/BCJ20160985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20160985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20160985%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DIdentification%252Bof%252Bmouse%252Bcathepsin%252BK%252Bstructural%252Belements%252Bthat%252Bregulate%252Bthe%252Bpotency%252Bof%252Bodanacatib%26aulast%3DLaw%26aufirst%3DSimon%26date%3D2017%26date%3D2017%26volume%3D474%26issue%3D5%26spage%3D851%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio C. B.  Burtoloso</span>, <span class="hlFld-ContribAuthor ">SÃ©rgio  de Albuquerque</span>, <span class="hlFld-ContribAuthor ">Mark  Furber</span>, <span class="hlFld-ContribAuthor ">Juliana C.  Gomes</span>, <span class="hlFld-ContribAuthor ">Cristiana  GonÃ§alez</span>, <span class="hlFld-ContribAuthor ">Peter W.  Kenny</span>, <span class="hlFld-ContribAuthor ">Andrei  LeitÃ£o</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Montanari</span>, <span class="hlFld-ContribAuthor ">JosÃ© Carlos  Quilles</span>, <span class="hlFld-ContribAuthor ">Jean F. R.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Josmar R.  Rocha</span>, . </span><span class="cited-content_cbyCitation_article-title">Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2017,</strong> <em>11 </em>
                                    (2)
                                     , e0005343. <a href="https://doi.org/10.1371/journal.pntd.0005343" title="DOI URL">https://doi.org/10.1371/journal.pntd.0005343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0005343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0005343%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DAnti-trypanosomal%252Bactivity%252Bof%252Bnon-peptidic%252Bnitrile-based%252Bcysteine%252Bprotease%252Binhibitors%26aulast%3DBurtoloso%26aufirst%3DAntonio%2BC.%2BB.%26date%3D2017%26date%3D2017%26volume%3D11%26issue%3D2%26spage%3De0005343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul E.  Di Cesare</span>, <span class="hlFld-ContribAuthor ">Dominik R.  Haudenschild</span>, <span class="hlFld-ContribAuthor ">Jonathan  Samuels</span>, <span class="hlFld-ContribAuthor ">Steven B.  Abramson</span>. </span><span class="cited-content_cbyCitation_article-title">Pathogenesis of Osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1685-1704.e8. <a href="https://doi.org/10.1016/B978-0-323-31696-5.00098-X" title="DOI URL">https://doi.org/10.1016/B978-0-323-31696-5.00098-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-31696-5.00098-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-31696-5.00098-X%26sid%3Dliteratum%253Aachs%26atitle%3DPathogenesis%252Bof%252BOsteoarthritis%26aulast%3DDi%2BCesare%26aufirst%3DPaul%2BE.%26date%3D2017%26spage%3D1685%26epage%3D1704.e8%26pub%3DElsevier%26atitle%3DKelley%252Band%252BFirestein%252527s%252BTextbook%252Bof%252BRheumatology%26date%3D2017%26volume%3D83-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjana  NoviÄ</span>, <span class="hlFld-ContribAuthor ">TjaÅ¡a  Tibaut</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Jure  BoriÅ¡ek</span>, <span class="hlFld-ContribAuthor ">Tihomir  TomaÅ¡iÄ</span>. </span><span class="cited-content_cbyCitation_article-title">The Comparison of Docking Search Algorithms and Scoring Functions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 820-849. <a href="https://doi.org/10.4018/978-1-5225-1762-7.ch032" title="DOI URL">https://doi.org/10.4018/978-1-5225-1762-7.ch032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-1762-7.ch032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-1762-7.ch032%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BComparison%252Bof%252BDocking%252BSearch%252BAlgorithms%252Band%252BScoring%252BFunctions%26aulast%3DNovi%25C4%258D%26aufirst%3DMarjana%26date%3D2017%26spage%3D820%26epage%3D849%26pub%3DIGI%2520Global%26atitle%3DPharmaceutical%252BSciences%26aulast%3DManagement%2BAssociation%26aufirst%3DInformation%2BResources%26date%3D2017%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Ruolan  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Yi</span>, <span class="hlFld-ContribAuthor ">Zhuorong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel cathepsin K inhibitors using ligand-based virtual screening and structure-based docking. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (86)
                                     , 82961-82968. <a href="https://doi.org/10.1039/C6RA14251F" title="DOI URL">https://doi.org/10.1039/C6RA14251F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA14251F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA14251F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIdentification%252Bof%252Bnovel%252Bcathepsin%252BK%252Binhibitors%252Busing%252Bligand-based%252Bvirtual%252Bscreening%252Band%252Bstructure-based%252Bdocking%26aulast%3DWang%26aufirst%3DYali%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D86%26spage%3D82961%26epage%3D82968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preety  Panwar</span>, <span class="hlFld-ContribAuthor ">Kent  SÃ¸e</span>, <span class="hlFld-ContribAuthor ">Rafael VC  Guido</span>, <span class="hlFld-ContribAuthor ">Renata V C  Bueno</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Delaisse</span>, <span class="hlFld-ContribAuthor ">Dieter  BrÃ¶mme</span>. </span><span class="cited-content_cbyCitation_article-title">A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2016,</strong> <em>173 </em>
                                    (2)
                                     , 396-410. <a href="https://doi.org/10.1111/bph.13383" title="DOI URL">https://doi.org/10.1111/bph.13383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13383%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bnovel%252Bapproach%252Bto%252Binhibit%252Bbone%252Bresorption%25253A%252Bexosite%252Binhibitors%252Bagainst%252Bcathepsin%252BK%26aulast%3DPanwar%26aufirst%3DPreety%26date%3D2016%26date%3D2015%26volume%3D173%26issue%3D2%26spage%3D396%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjana  NoviÄ</span>, <span class="hlFld-ContribAuthor ">TjaÅ¡a  Tibaut</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Jure  BoriÅ¡ek</span>, <span class="hlFld-ContribAuthor ">Tihomir  TomaÅ¡iÄ</span>. </span><span class="cited-content_cbyCitation_article-title">The Comparison of Docking Search Algorithms and Scoring Functions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 99-127. <a href="https://doi.org/10.4018/978-1-5225-0115-2.ch004" title="DOI URL">https://doi.org/10.4018/978-1-5225-0115-2.ch004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4018/978-1-5225-0115-2.ch004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4018%2F978-1-5225-0115-2.ch004%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BComparison%252Bof%252BDocking%252BSearch%252BAlgorithms%252Band%252BScoring%252BFunctions%26aulast%3DNovi%25C4%258D%26aufirst%3DMarjana%26date%3D2016%26spage%3D99%26epage%3D127%26pub%3DIGI%2520Global%26atitle%3DMethods%252Band%252BAlgorithms%252Bfor%252BMolecular%252BDocking-Based%252BDrug%252BDesign%252Band%252BDiscovery%26aulast%3DDastmalchi%26aufirst%3DSiavoush%26date%3D2016%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro A. A.  Avelar</span>, <span class="hlFld-ContribAuthor ">Cristian D.  Camilo</span>, <span class="hlFld-ContribAuthor ">SÃ©rgio  de Albuquerque</span>, <span class="hlFld-ContribAuthor ">William B.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Cristiana  GonÃ§alez</span>, <span class="hlFld-ContribAuthor ">Peter W.  Kenny</span>, <span class="hlFld-ContribAuthor ">Andrei  LeitÃ£o</span>, <span class="hlFld-ContribAuthor ">James H.  McKerrow</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Montanari</span>, <span class="hlFld-ContribAuthor ">Erika V. MeÃ±aca  Orozco</span>, <span class="hlFld-ContribAuthor ">Jean F. R.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Josmar R.  Rocha</span>, <span class="hlFld-ContribAuthor ">Fabiana  Rosini</span>, <span class="hlFld-ContribAuthor ">Marta E.  Saidel</span>, . </span><span class="cited-content_cbyCitation_article-title">Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2015,</strong> <em>9 </em>
                                    (7)
                                     , e0003916. <a href="https://doi.org/10.1371/journal.pntd.0003916" title="DOI URL">https://doi.org/10.1371/journal.pntd.0003916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0003916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0003916%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DMolecular%252BDesign%25252C%252BSynthesis%252Band%252BTrypanocidal%252BActivity%252Bof%252BDipeptidyl%252BNitriles%252Bas%252BCruzain%252BInhibitors%26aulast%3DAvelar%26aufirst%3DLeandro%2BA.%2BA.%26date%3D2015%26date%3D2015%26volume%3D9%26issue%3D7%26spage%3De0003916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vidhu  Sharma</span>, <span class="hlFld-ContribAuthor ">Preety  Panwar</span>, <span class="hlFld-ContribAuthor ">AnthonyÂ J.  OâDonoghue</span>, <span class="hlFld-ContribAuthor ">Haoran  Cui</span>, <span class="hlFld-ContribAuthor ">RafaelÂ V. C.  Guido</span>, <span class="hlFld-ContribAuthor ">CharlesÂ S.  Craik</span>, <span class="hlFld-ContribAuthor ">Dieter  BrÃ¶mme</span>. </span><span class="cited-content_cbyCitation_article-title">Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2015,</strong> <em>465 </em>
                                    (1)
                                     , 163-173. <a href="https://doi.org/10.1042/BJ20140809" title="DOI URL">https://doi.org/10.1042/BJ20140809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20140809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20140809%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DStructural%252Brequirements%252Bfor%252Bthe%252Bcollagenase%252Band%252Belastase%252Bactivity%252Bof%252Bcathepsin%252BK%252Band%252Bits%252Bselective%252Binhibition%252Bby%252Ban%252Bexosite%252Binhibitor%26aulast%3DSharma%26aufirst%3DVidhu%26date%3D2015%26date%3D2014%26volume%3D465%26issue%3D1%26spage%3D163%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Petzoldt</span>, <span class="hlFld-ContribAuthor ">Oliver  Bley</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Byard</span>, <span class="hlFld-ContribAuthor ">Doris  Andert</span>, <span class="hlFld-ContribAuthor ">Bruno  Baumgartner</span>, <span class="hlFld-ContribAuthor ">Norbert  Nagel</span>, <span class="hlFld-ContribAuthor ">Christoph  Tappertzhofen</span>, <span class="hlFld-ContribAuthor ">Martin Philipp  Feth</span>. </span><span class="cited-content_cbyCitation_article-title">An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137 â A successful approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2014,</strong> <em>86 </em>
                                    (3)
                                     , 337-350. <a href="https://doi.org/10.1016/j.ejpb.2013.09.015" title="DOI URL">https://doi.org/10.1016/j.ejpb.2013.09.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2013.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2013.09.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DAn%252Bexample%252Bof%252Bhow%252Bto%252Bhandle%252Bamorphous%252Bfractions%252Bin%252BAPI%252Bduring%252Bearly%252Bpharmaceutical%252Bdevelopment%25253A%252BSAR114137%252B%2525E2%252580%252593%252BA%252Bsuccessful%252Bapproach%26aulast%3DPetzoldt%26aufirst%3DChristine%26date%3D2014%26volume%3D86%26issue%3D3%26spage%3D337%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuya  Yokosaka</span>, <span class="hlFld-ContribAuthor ">Tomoya  Kanehira</span>, <span class="hlFld-ContribAuthor ">Hiroki  Nakayama</span>, <span class="hlFld-ContribAuthor ">Tetsuhiro  Nemoto</span>, <span class="hlFld-ContribAuthor ">Yasumasa  Hamada</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of fused-tricyclic indole derivatives through an acid-promoted skeletal rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (12)
                                     , 2151-2160. <a href="https://doi.org/10.1016/j.tet.2014.01.074" title="DOI URL">https://doi.org/10.1016/j.tet.2014.01.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.01.074%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bfused-tricyclic%252Bindole%252Bderivatives%252Bthrough%252Ban%252Bacid-promoted%252Bskeletal%252Brearrangement%26aulast%3DYokosaka%26aufirst%3DTakuya%26date%3D2014%26volume%3D70%26issue%3D12%26spage%3D2151%26epage%3D2160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Fei  Chiou</span>, <span class="hlFld-ContribAuthor ">Yu-Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Yen-Wenn  Liu</span>, . </span><span class="cited-content_cbyCitation_article-title">(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , e89159. <a href="https://doi.org/10.1371/journal.pone.0089159" title="DOI URL">https://doi.org/10.1371/journal.pone.0089159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0089159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0089159%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3D%252528%25252B%252529-Vitisin%252BA%252BInhibits%252BOsteoclast%252BDifferentiation%252Bby%252BPreventing%252BTRAF6%252BUbiquitination%252Band%252BTRAF6-TAK1%252BFormation%252Bto%252BSuppress%252BNFATc1%252BActivation%26aulast%3DChiou%26aufirst%3DWen-Fei%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3De89159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raghavan  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Acintya  Bandyopadhyaya</span>, <span class="hlFld-ContribAuthor ">Desikan R.  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Rajagopalan</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (2)
                                     , 576-579. <a href="https://doi.org/10.1016/j.bmcl.2013.12.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bsynthesis%252Band%252Bcomparative%252Breceptor%252Bbinding%252Baffinities%252Bof%252Bnovel%25252C%252Bisomeric%252Bpyridoindolobenzazepine%252Bscaffolds%26aulast%3DRajagopalan%26aufirst%3DRaghavan%26date%3D2014%26volume%3D24%26issue%3D2%26spage%3D576%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  MÃ©rour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">BenoÃ®t  Joseph</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and properties of 4-, 5-, 6-Â orÂ 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (24)
                                     , 4767-4834. <a href="https://doi.org/10.1016/j.tet.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.tet.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bproperties%252Bof%252B4-%25252C%252B5-%25252C%252B6-%2525C2%2525A0or%2525C2%2525A07-azaindoles%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2013%26volume%3D69%26issue%3D24%26spage%3D4767%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin Philipp  Feth</span>, <span class="hlFld-ContribAuthor ">Winfried  Heyse</span>, <span class="hlFld-ContribAuthor ">Bruno  Baumgartner</span>, <span class="hlFld-ContribAuthor ">Norbert  Nagel</span>, <span class="hlFld-ContribAuthor ">Christoph  Tappertzhofen</span>, <span class="hlFld-ContribAuthor ">Thomas  Olpp</span>, <span class="hlFld-ContribAuthor ">JÃ¶rg  Jurascheck</span>, <span class="hlFld-ContribAuthor ">Joachim  Ulrich</span>, <span class="hlFld-ContribAuthor ">Lydia  Helmdach</span>, <span class="hlFld-ContribAuthor ">Christine  Petzoldt</span>. </span><span class="cited-content_cbyCitation_article-title">From laboratory to pilot plant: The solid-state process development of a highly potent cathepsin S/K inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2013,</strong> <em>83 </em>
                                    (3)
                                     , 436-448. <a href="https://doi.org/10.1016/j.ejpb.2012.11.007" title="DOI URL">https://doi.org/10.1016/j.ejpb.2012.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2012.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DFrom%252Blaboratory%252Bto%252Bpilot%252Bplant%25253A%252BThe%252Bsolid-state%252Bprocess%252Bdevelopment%252Bof%252Ba%252Bhighly%252Bpotent%252Bcathepsin%252BS%25252FK%252Binhibitor%26aulast%3DFeth%26aufirst%3DMartin%2BPhilipp%26date%3D2013%26volume%3D83%26issue%3D3%26spage%3D436%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Yu  Yuan</span>, <span class="hlFld-ContribAuthor ">Ding-Yi  Fu</span>, <span class="hlFld-ContribAuthor ">Xing-Feng  Ren</span>, <span class="hlFld-ContribAuthor ">Xuexun  Fang</span>, <span class="hlFld-ContribAuthor ">Lincong  Wang</span>, <span class="hlFld-ContribAuthor ">Shuxue  Zou</span>, <span class="hlFld-ContribAuthor ">Yuqing  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (35)
                                     , 5847. <a href="https://doi.org/10.1039/c3ob41165f" title="DOI URL">https://doi.org/10.1039/c3ob41165f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41165f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41165f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHighly%252Bselective%252Baza-nitrile%252Binhibitors%252Bfor%252Bcathepsin%252BK%25252C%252Bstructural%252Boptimization%252Band%252Bmolecular%252Bmodeling%26aulast%3DYuan%26aufirst%3DXiao-Yu%26date%3D2013%26volume%3D11%26issue%3D35%26spage%3D5847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander G.  Dossetter</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bowyer</span>, <span class="hlFld-ContribAuthor ">Calum R.  Cook</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Jonathan E.  Finlayson</span>, <span class="hlFld-ContribAuthor ">Nicola M.  Heron</span>, <span class="hlFld-ContribAuthor ">Christine  Heyes</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Highton</span>, <span class="hlFld-ContribAuthor ">Julian A.  Hudson</span>, <span class="hlFld-ContribAuthor ">Anja  Jestel</span>, <span class="hlFld-ContribAuthor ">Stephan  Krapp</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Thomas M.  McGuire</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Morley</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Morris</span>, <span class="hlFld-ContribAuthor ">Ken M.  Page</span>, <span class="hlFld-ContribAuthor ">Lyn Rosenbrier  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Helen  Sawney</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Caroline  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5563-5568. <a href="https://doi.org/10.1016/j.bmcl.2012.07.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.07.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.07.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIsosteric%252Breplacements%252Bfor%252Bbenzothiazoles%252Band%252Boptimisation%252Bto%252Bpotent%252BCathepsin%252BK%252Binhibitors%252Bfree%252Bfrom%252BhERG%252Bchannel%252Binhibition%26aulast%3DDossetter%26aufirst%3DAlexander%2BG.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5563%26epage%3D5568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature nitrile cathepsin K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening hits from cathepsin S program.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cyclohexyl-1,2-diamides <b>7</b>â<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, 80 Â°C, 1 h, concentrate. (b) CH<sub>2</sub>Cl<sub>2</sub>, RT, 1 h, concentrate. (c) DMF or CH<sub>2</sub>Cl<sub>2</sub>, DIPEA (5 equiv), HATU (1.1 equiv), <b>13câ17c</b> HCl salts (1.0 equiv), RT, 12 h, 12â78% yield.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Carbolines via Fischer Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) EtOH, concd HCl(aq), 80 Â°C, 3 h, 29â71% yield; or (ii) AcOH, BF<sub>3</sub>.OEt<sub>2</sub>, 80 Â°C, 3 h, 44â68% yield. (b) (i) PPA, 80 Â°C; (ii) HCO<sub>2</sub>H, NH<sub>4</sub>(HCO<sub>2</sub>), Pd(OAc)<sub>2</sub>, 40%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Metabolites Found after in Vitro Incubation of <b>14</b> with Rat Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>34</b> bound to cathepsin K (PDB 4DMY). (A) Identification of key H-bonding residues. (B) Surface of protein to illustrate the fit of the cyclohexyl and carboline moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Metabolites Found after in Vitro Incubation of <b>34</b> with Rat Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/medium/jm-2012-007257_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dog PK/PD experiment for compound <b>34</b>. Each point was mean <i>n</i> = 2 with the same blood sample taken at a given time after compound dosing split to measure [<b>34</b>] and [CTX-1]. (a) Total plasma [<b>34</b>] from the dog PK experiment: â, PK[<b>34</b>]/nM at 0.1 mg/kg uid; +, PK[<b>34</b>]/nM at 0.3 mg/kg uid/nM; â, PK[<b>34</b>]/nM at 2.0 mg/kg uid. (b) ELISA-measured reduction [CTX-1] from baseline: â, [CTX-1] as % baseline 0.1 mg/kg uid; +, [CTX-1] as % baseline 0.3 mg/kg uid; â, [CTX-1] as % baseline 2.0 mg/kg uid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm3007257/production/images/large/jm-2012-007257_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007257&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hunter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span> </span><span class="NLM_article-title">Osteoarthritis</span> <span class="citation_source-journal">BMJ [Br. Med. J.]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">â</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1136%2Fbmj.332.7542.639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=16543327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD287ltlSjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2006&pages=639-642&author=D.+J.+Hunterauthor=D.+T.+Felson&title=Osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis</span></div><div class="casAuthors">Hunter David J; Felson David T</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">7542</span>),
    <span class="NLM_cas:pages">639-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK97-ragm9Wu_Q9URG6Dx8fW6udTcc2eZn3jBQgucMH7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ltlSjtA%253D%253D&md5=5b419e3aba5f05175f6d81bebbf666a6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fbmj.332.7542.639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.332.7542.639%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26atitle%3DOsteoarthritis%26jtitle%3DBMJ%2520%255BBr.%2520Med.%2520J.%255D%26date%3D2006%26volume%3D332%26spage%3D639%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lawrence, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmick, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunder, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, F.</span><span> </span><span class="NLM_article-title">National Arthritis Data Workgroup Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">â</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2Fart.23176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18163497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252Flt1Ghsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=26-35&author=R.+C.+Lawrenceauthor=D.+T.+Felsonauthor=C.+G.+Helmickauthor=L.+M.+Arnoldauthor=H.+Choiauthor=R.+A.+Deyoauthor=S.+Gabrielauthor=R.+Hirschauthor=M.+C.+Hochbergauthor=G.+G.+Hunderauthor=J.+M.+Jordanauthor=J.+N.+Katzauthor=H.+M.+Kremersauthor=F.+Wolfe&title=National+Arthritis+Data+Workgroup+Estimates+of+the+prevalence+of+arthritis+and+other+rheumatic+conditions+in+the+United+States.+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II</span></div><div class="casAuthors">Lawrence Reva C; Felson David T; Helmick Charles G; Arnold Lesley M; Choi Hyon; Deyo Richard A; Gabriel Sherine; Hirsch Rosemarie; Hochberg Marc C; Hunder Gene G; Jordan Joanne M; Katz Jeffrey N; Kremers Hilal Maradit; Wolfe Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-35</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To provide a single source for the best available estimates of the US prevalence of and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell arteritis, gout, fibromyalgia, and carpal tunnel syndrome, as well as the symptoms of neck and back pain.  A companion article (part I) addresses additional conditions.  METHODS:  The National Arthritis Data Workgroup reviewed published analyses from available national surveys, such as the National Health and Nutrition Examination Survey and the National Health Interview Survey.  Because data based on national population samples are unavailable for most specific rheumatic conditions, we derived estimates from published studies of smaller, defined populations.  For specific conditions, the best available prevalence estimates were applied to the corresponding 2005 US population estimates from the Census Bureau, to estimate the number affected with each condition.  RESULTS:  We estimated that among US adults, nearly 27 million have clinical osteoarthritis (up from the estimate of 21 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteritis, up to 3.0 million have had self-reported gout in the past year (up from the estimate of 2.1 million for 1995), 5.0 million have fibromyalgia, 4-10 million have carpal tunnel syndrome, 59 million have had low back pain in the past 3 months, and 30.1 million have had neck pain in the past 3 months.  CONCLUSION:  Estimates for many specific rheumatic conditions rely on a few, small studies of uncertain generalizability to the US population.  This report provides the best available prevalence estimates for the US, but for most specific conditions more studies generalizable to the US or addressing understudied populations are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRoGBggfl_DDdblLE_E9PWfW6udTcc2eZn3jBQgucMH7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252Flt1Ghsw%253D%253D&md5=8fb852bfb01285c89db9c7d87369e167</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fart.23176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23176%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DR.%2BC.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DHelmick%26aufirst%3DC.%2BG.%26aulast%3DArnold%26aufirst%3DL.%2BM.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DDeyo%26aufirst%3DR.%2BA.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DHirsch%26aufirst%3DR.%26aulast%3DHochberg%26aufirst%3DM.%2BC.%26aulast%3DHunder%26aufirst%3DG.%2BG.%26aulast%3DJordan%26aufirst%3DJ.%2BM.%26aulast%3DKatz%26aufirst%3DJ.%2BN.%26aulast%3DKremers%26aufirst%3DH.%2BM.%26aulast%3DWolfe%26aufirst%3DF.%26atitle%3DNational%2520Arthritis%2520Data%2520Workgroup%2520Estimates%2520of%2520the%2520prevalence%2520of%2520arthritis%2520and%2520other%2520rheumatic%2520conditions%2520in%2520the%2520United%2520States.%2520Part%2520II%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">WHO</span><span class="NLM_x"> Disease and Injury country estimates </span><a href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html" class="extLink">http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Disease+and+Injury+country+estimates+http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Felson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totterman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, D. R.</span><span> </span><span class="NLM_article-title">The association of bone marrow lesions with pain in knee osteoarthritis</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">â</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.7326%2F0003-4819-134-7-200104030-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=11281736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gslOqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=541-549&author=D.+T.+Felsonauthor=C.+E.+Chaissonauthor=C.+L.+Hillauthor=S.+M.+Tottermanauthor=M.+E.+Galeauthor=K.+M.+Skinnerauthor=L.+Kazisauthor=D.+R.+Gale&title=The+association+of+bone+marrow+lesions+with+pain+in+knee+osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The association of bone marrow lesions with pain in knee osteoarthritis</span></div><div class="casAuthors">Felson D T; Chaisson C E; Hill C L; Totterman S M; Gale M E; Skinner K M; Kazis L; Gale D R</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">541-9</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">BACKGROUND:  The cause of pain in osteoarthritis is unknown.  Bone has pain fibers, and marrow lesions, which are thought to represent edema, have been noted in osteoarthritis.  OBJECTIVE:  To determine whether bone marrow lesions on magnetic resonance imaging (MRI) are associated with pain in knee osteoarthritis.  DESIGN:  Cross-sectional observational study.  SETTING:  Veterans Affairs Medical Center.  PATIENTS:  401 persons (mean age, 66.8 years) with knee osteoarthritis on radiography who were drawn from clinics in the Veterans Administration health care system and from the community.  Of these persons, 351 had knee pain and 50 had no knee pain.  MEASUREMENTS:  Knee radiography and MRI of one knee were performed in all participants.  Those with knee pain quantified the severity of their pain.  On MRI, coronal T(2)-weighted fat-saturated images were used to score the size of bone marrow lesions, and each knee was characterized as having any lesion or any large lesion.  The prevalence of lesions and large lesions in persons with and without knee pain was compared; in participants with knee pain, the presence of lesions was correlated with severity of pain.  RESULTS:  Bone marrow lesions were found in 272 of 351 (77.5%) persons with painful knees compared with 15 of 50 (30%) persons with no knee pain (P < 0.001).  Large lesions were present almost exclusively in persons with knee pain (35.9% vs. 2%; P < 0.001).  After adjustment for severity of radiographic disease, effusion, age, and sex, lesions and large lesions remained associated with the occurrence of knee pain.  Among persons with knee pain, bone marrow lesions were not associated with pain severity.  CONCLUSIONS:  Bone marrow lesions on MRI are strongly associated with the presence of pain in knee osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeVmLO2JfoRO-MdeMhXAHkfW6udTcc2eabLxvFmcb1S7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gslOqtg%253D%253D&md5=b7f66455dfc4ffa17405f4eafcff1b8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-134-7-200104030-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-134-7-200104030-00007%26sid%3Dliteratum%253Aachs%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DChaisson%26aufirst%3DC.%2BE.%26aulast%3DHill%26aufirst%3DC.%2BL.%26aulast%3DTotterman%26aufirst%3DS.%2BM.%26aulast%3DGale%26aufirst%3DM.%2BE.%26aulast%3DSkinner%26aufirst%3DK.%2BM.%26aulast%3DKazis%26aufirst%3DL.%26aulast%3DGale%26aufirst%3DD.%2BR.%26atitle%3DThe%2520association%2520of%2520bone%2520marrow%2520lesions%2520with%2520pain%2520in%2520knee%2520osteoarthritis%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2001%26volume%3D134%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Alzahrani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruccelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahomed, N.</span><span> </span><span class="NLM_article-title">Prevalence of clinically significant improvement following total knee replacement</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">â</span> <span class="NLM_lpage">759</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.3899%2Fjrheum.100233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=21239743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvgt1Cjsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=753-759&author=K.+Alzahraniauthor=R.+Gandhiauthor=J.+Debeerauthor=D.+Petruccelliauthor=N.+Mahomed&title=Prevalence+of+clinically+significant+improvement+following+total+knee+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of clinically significant improvement following total knee replacement</span></div><div class="casAuthors">Alzahrani Khalid; Gandhi Rajiv; Debeer Justin; Petruccelli Danielle; Mahomed Nizar</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-9</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Although total knee replacement (TKR) has a high reported success rate, the pain relief and functional improvement after surgery vary.  The purpose of our retrospective cohort study was to determine the prevalence of patients showing no clinically important improvement 1 year after TKR, and patient factors that may predict this outcome.  METHODS:  We reviewed primary TKR registry data that were collected from 2 academic hospitals: the Toronto Western Hospital and the Hamilton Health Sciences Henderson Hospital in Ontario, Canada.  Relevant covariates including demographic data, body mass index, and comorbidity were recorded.  Knee joint pain and functional status were assessed at baseline and at 1-year followup with the Western Ontario McMaster University Osteoarthritis Index (WOMAC) and Oxford Knee Score (OKS) to measure the change using the minimal clinically important difference (MCID).  Logistic regression modeling was used to identify the predictors of interest.  RESULTS:  Overall, 11.7% (373/3177) of patients reported no clinically important improvement 1 year after surgery.  Logistic regression modeling showed that a greater patient age independently predicted no clinically important improvement on the WOMAC scale 1 year after surgery (p = 0.0003), while being male independently predicted no clinically important improvement on the OKS 1 year after surgery (p = 0.008).  CONCLUSION:  Awareness of the prevalence of patients who may show no clinically important improvement and factors that predict this outcome will help patients and surgeons set realistic expectations of surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPBTsv0kk_AMERNNga7KD-fW6udTcc2eabLxvFmcb1S7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvgt1Cjsw%253D%253D&md5=278477c306b846ce3720a7ed49764f99</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.100233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.100233%26sid%3Dliteratum%253Aachs%26aulast%3DAlzahrani%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DR.%26aulast%3DDebeer%26aufirst%3DJ.%26aulast%3DPetruccelli%26aufirst%3DD.%26aulast%3DMahomed%26aufirst%3DN.%26atitle%3DPrevalence%2520of%2520clinically%2520significant%2520improvement%2520following%2520total%2520knee%2520replacement%26jtitle%3DJ.%2520Rheumatol.%26date%3D2011%26volume%3D38%26spage%3D753%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Bone resorption by osteoclasts</span> <span class="citation_source-journal">Science (Washington, D. C.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">â</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1126%2Fscience.289.5484.1504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=10968780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1KgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1504-1508&author=S.+L.+Teitelbaum&title=Bone+resorption+by+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Bone resorption by osteoclasts</span></div><div class="casAuthors">Teitelbaum, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5484</span>),
    <span class="NLM_cas:pages">1504-1508</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 57 refs.  Osteoporosis, a disease endemic in Western society, typically reflects an imbalance in skeletal turnover so that bone resorption exceeds bone formation.  Bone resorption is the unique function of the osteoclast, and anti-osteoporosis therapy to date has targeted this cell.  The osteoclast is a specialized macrophage polykaryon whose differentiation is principally regulated by macrophage colony-stimulating factor, RANK ligand, and osteoprotegerin.  Reflecting integrin-mediated signals, the osteoclast develops a specialized cytoskeleton that permits it to establish an isolated microenvironment between itself and bone, wherein matrix degrdn. occurs by a process involving proton transport.  Osteopetrotic mutants have provided a wealth of information about.the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqtaM613uBLVg90H21EOLACvtfcHk0ljBBYd1k0MWhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1KgsLk%253D&md5=ac72d05b78ad3ae84b3fcd1a4a3e8e1f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5484.1504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5484.1504%26sid%3Dliteratum%253Aachs%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DBone%2520resorption%2520by%2520osteoclasts%26jtitle%3DScience%2520%2528Washington%252C%2520D.%2520C.%2529%26date%3D2000%26volume%3D289%26spage%3D1504%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feild, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavaria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertoncello, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavarselk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzog, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span> </span><span class="NLM_article-title">Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1654</span><span class="NLM_x">â</span> <span class="NLM_lpage">1663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1359%2Fjbmr.1999.14.10.1654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=10491212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOis7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=1654-1663&author=M.+Gowenauthor=F.+Laznerauthor=R.+Doddsauthor=R.+Kapadiaauthor=J.+Feildauthor=M.+Tavariaauthor=I.+Bertoncelloauthor=F.+Drakeauthor=S.+Zavarselkauthor=I.+Tellisauthor=P.+Hertzogauthor=C.+Debouckauthor=I.+Kola&title=Cathepsin+K+knockout+mice+develop+osteopetrosis+due+to+a+deficit+in+matrix+degradation+but+not+demineralization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization</span></div><div class="casAuthors">Gowen, Maxine; Lazner, Francesca; Dodds, Robert; Kapadia, Rasesh; Feild, John; Tavaria, Michael; Bertoncello, Ivan; Drake, Fred; Zavarselk, Silva; Tellis, Irene; Hertzog, Paul; Debouck, Christine; Kola, Ismail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1654-1663</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">Cathepsin K is a cysteine protease expressed predominantly in osteoclasts.  Activated cathepsin K cleaves key bone matrix proteins and is believed to play an important role in degrading the org. phase of bone during bone resorption.  Mutations in the human cathepsin K gene have been demonstrated to be assocd. with a rare skeletal dysplasia, pycnodysostosis.  The degree of functional activity of the mutated forms of cathepsin K in these individuals has not been elucidated, but is predicted to be low or absent.  To study the role of cathepsin K in bone resorption, we have generated mice deficient in the cathepsin K gene.  Histol. and radiog. anal. of the mice revealed osteopetrosis of the long bones and vertebrae, and abnormal joint morphol.  X-ray microcomputerized tomog. images allowed quantitation of the increase in bone vol., trabecular thickness, and trabecular no. in both the primary spongiosa and the metaphysis of the proximal tibia.  Not all bones were similarly affected.  Chondrocyte differentiation was normal.  The mice also had abnormalities in hematopoietic compartments, particularly decreased bone marrow cellularity and splenomegaly.  The heterozygous animals appeared normal.  Close histol. examn. of bone histol. revealed fully differentiated osteoclasts apposed to small regions of demineralized bone.  This strongly suggests that cathepsin K-deficient osteoclasts are capable of demineralizing the extracellular matrix but are unable to adequately remove the demineralized bone.  This is entirely consistent with the proposed function of cathepsin K as a matrix-degrading proteinase in bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71C1bZXpqO7Vg90H21EOLACvtfcHk0ljDOX3odLgqNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOis7c%253D&md5=a549ea562d98908719cb52c6a7e66366</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.1999.14.10.1654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.1999.14.10.1654%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLazner%26aufirst%3DF.%26aulast%3DDodds%26aufirst%3DR.%26aulast%3DKapadia%26aufirst%3DR.%26aulast%3DFeild%26aufirst%3DJ.%26aulast%3DTavaria%26aufirst%3DM.%26aulast%3DBertoncello%26aufirst%3DI.%26aulast%3DDrake%26aufirst%3DF.%26aulast%3DZavarselk%26aufirst%3DS.%26aulast%3DTellis%26aufirst%3DI.%26aulast%3DHertzog%26aufirst%3DP.%26aulast%3DDebouck%26aufirst%3DC.%26aulast%3DKola%26aufirst%3DI.%26atitle%3DCathepsin%2520K%2520knockout%2520mice%2520develop%2520osteopetrosis%2520due%2520to%2520a%2520deficit%2520in%2520matrix%2520degradation%2520but%2520not%2520demineralization%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1999%26volume%3D14%26spage%3D1654%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Cysteine cathepsin S as an immunomodulatory target: present and future trends</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1517%2F14728222.12.3.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18269339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslKqur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=291-299&author=S.+Guptaauthor=R.+K.+Singhauthor=S.+Dastidarauthor=A.+Ray&title=Cysteine+cathepsin+S+as+an+immunomodulatory+target%3A+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsin S as an immunomodulatory target: present and future trends</span></div><div class="casAuthors">Gupta, Suman; Singh, Rakesh Kumar; Dastidar, Sunanda; Ray, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-299</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Objective: Antigen presentation is the key to immune response.  Cathepsin S plays a major role in the degrdn. of the invariant peptide chain assocd. with the major histocompatibility complex and thus affects antigen presentation.  This review will focus on the recent developments made in field of cysteine cathepsins esp. cathepsin S and their future prospects as a therapeutic target.  Methods: Selective cathepsin inhibitors for targeting autoimmune disorders, atherosclerosis, osteoporosis, osteoarthritis and cancer are being pursued by many pharmaceutical companies.  Recent publications in this field have been used as refs. to evaluate the current and future trends in cathepsin S inhibitors as an immunomodulatory target.  Conclusions: The temporal and spatial position occupied by cathepsin S in immune presentation, gives rise to the hope that an inhibitor would impart selectivity with a lesser propensity for side effects than other immunosuppressive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQiiKL4FULMbVg90H21EOLACvtfcHk0ljDOX3odLgqNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslKqur0%253D&md5=78ff33141475b8f6239ea76a6b342f1b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.3.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.3.291%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26aulast%3DDastidar%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DCysteine%2520cathepsin%2520S%2520as%2520an%2520immunomodulatory%2520target%253A%2520present%2520and%2520future%2520trends%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D291%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors: a novel target for osteoporosis therapy</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1038%2Fsj.clpt.6100450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18073778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVylt7bM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=172-176&author=S.+A.+Stochauthor=J.+A.+Wagner&title=Cathepsin+K+inhibitors%3A+a+novel+target+for+osteoporosis+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy</span></div><div class="casAuthors">Stoch, Sa; Wagner, Ja</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-176</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is characterized by low bone mass with skeletal fragility and an increased risk of fracture.  This bone loss is brought about by an imbalance between bone resorption and formation.  Cathepsin K is the most abundant cysteine protease expressed in the osteoclast and is believed to be instrumental in bone matrix degrdn. necessary for bone resorption.  Cathepsin K inhibitors represent a novel target for developing agents to treat osteoporosis and other disorders characterized by increased bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr489JhmTXx8LVg90H21EOLACvtfcHk0ljDOX3odLgqNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVylt7bM&md5=4c77fe3842044d99fbef8cf78f054bac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.clpt.6100450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.clpt.6100450%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DCathepsin%2520K%2520inhibitors%253A%2520a%2520novel%2520target%2520for%2520osteoporosis%2520therapy%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D83%26spage%3D172%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaleta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broemme, D.</span><span> </span><span class="NLM_article-title">The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">â</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=973-993&author=Y.+Yasudaauthor=J.+Kaletaauthor=D.+Broemme&title=The+role+of+cathepsins+in+osteoporosis+and+arthritis%3A+rationale+for+the+design+of+new+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DKaleta%26aufirst%3DJ.%26aulast%3DBroemme%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520osteoporosis%2520and%2520arthritis%253A%2520rationale%2520for%2520the%2520design%2520of%2520new%2520therapeutics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D973%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darakhshan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerre-Millo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgnov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.</span><span> </span><span class="NLM_article-title">Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2202</span><span class="NLM_x">â</span> <span class="NLM_lpage">2208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1161%2FATVBAHA.108.172320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18818416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKrtrzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=2202-2208&author=M.+Yangauthor=J.+Sunauthor=T.+Zhangauthor=J.+Liuauthor=J.+Zhangauthor=M.+A.+Shiauthor=F.+Darakhshanauthor=M.+Guerre-Milloauthor=K.+Clementauthor=B.+D.+Gelbauthor=G.+Dolgnovauthor=G.+Shi&title=Deficiency+and+Inhibition+of+Cathepsin+K+Reduce+Body+Weight+Gain+and+Increase+Glucose+Metabolism+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice</span></div><div class="casAuthors">Yang, Min; Sun, Jiusong; Zhang, Tinghu; Liu, Jian; Zhang, Jie; Shi, Michael A.; Darakhshan, Froogh; Guerre-Millo, Michele; Clement, Karine; Gelb, Bruce D.; Dolgnov, Gregory; Shi, Guo-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2202-2208</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Previous studies demonstrated increased levels of cysteine proteases cathepsins in serum and adipose tissues from obese patients.  We now provide evidence from a mouse model of obesity to suggest a direct participation of cathepsin K (CatK) in mouse body wt. gain and glucose metab.  Using real-time polymerase chain reaction, we detected 12-fold increase in CatK transcripts after adipogenesis of human preadipocytes.  Using an immunohistol. anal., we consistently obsd. high levels of CatK expression in adipose tissues from obese humans and mice.  Selective inhibition of CatK activity blocked the lipid accumulation in human and mouse preadipocytes.  In mice, CatK deficiency reduced significantly diet-induced body wt. gain and serum glucose and insulin levels.  Similar results were obtained in diet-induced and genetically created (ob/ob) obese mice after animals were treated with a CatK-selective inhibitor.  Mechanistic study demonstrated a role for CatK in degrading fibronectin, a matrix protein that controls adipogenesis.  Deficiency or inhibition of CatK leads to fibronectin accumulation in muscle and adipose tissues.  This study demonstrates an essential role of CatK in adipogenesis and mouse body wt. gain, possibly via degrdn. of fibronectin, thus suggesting a novel therapeutic strategy for the control of obesity by regulating CatK activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KxuB1AW1J7Vg90H21EOLACvtfcHk0lizypvKe39hxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKrtrzM&md5=89f5b4a58bd4af9992ff235305e61b4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.108.172320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.108.172320%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DM.%2BA.%26aulast%3DDarakhshan%26aufirst%3DF.%26aulast%3DGuerre-Millo%26aufirst%3DM.%26aulast%3DClement%26aufirst%3DK.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DDolgnov%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DG.%26atitle%3DDeficiency%2520and%2520Inhibition%2520of%2520Cathepsin%2520K%2520Reduce%2520Body%2520Weight%2520Gain%2520and%2520Increase%2520Glucose%2520Metabolism%2520in%2520Mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D2202%26epage%3D2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.2174%2F138161207780162962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=17311556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=387-403&author=O.+Vasiljevaauthor=T.+Reinheckelauthor=C.+Petersauthor=D.+Turkauthor=V.+Turkauthor=B.+Turk&title=Emerging+roles+of+cysteine+cathepsins+in+disease+and+their+potential+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span></div><div class="casAuthors">Vasiljeva, Olga; Reinheckel, Thomas; Peters, Christoph; Turk, Dusan; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The general view on Cys cathepsins, which were long believed to be primarily involved in intracellular protein turnover, has dramatically changed in last 10 to 15 years.  The discovery of new cathepsins, such as cathepsins K, V, X, F and O, and their tissue distribution suggested that at least some of them are involved in very specific cellular processes.  Moreover, gene ablation expts. revealed that cathepsins play a vital role in numerous physiol. processes, such as antigen processing and presentation, bone remodeling, prohormone processing and wound healing.  Their involvement in several pathologies, including osteoporosis, rheumatoid arthritis, osteoarthritis, bronchial asthma and cancer were also confirmed and today several of them were validated as relevant targets for therapies.  Compds. targeting cathepsins S and K are already in clin. evaluation, whereas others are in exptl. phases.  The cathepsin K inhibitor AAE-581 (balicatib) as the most advanced of them passed Phase II clin. trials in 2005.  In this review, we discuss the current view on cathepsins as an emerging group of targets for several diseases and the development of cathepsin K and S inhibitors for treatment of osteoporosis and various immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpl43svUGSDrVg90H21EOLACvtfcHk0lizypvKe39hxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D&md5=50a14bd3146b8c29e745f4bb3af85af7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161207780162962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780162962%26sid%3Dliteratum%253Aachs%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DEmerging%2520roles%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520and%2520their%2520potential%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">â</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lizypvKe39hxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, D., K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, D., M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panebianco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. A.</span><span> </span><span class="NLM_article-title">Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies</span> <span class="citation_source-journal">Clin. Pharmacol. Ther. (N. Y., NY, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">â</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1038%2Fclpt.2009.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=19421185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2009&pages=175-182&author=S.+A.+Stochauthor=S.+Zajicauthor=J.+Stoneauthor=D.+L.+Millerauthor=D.%2C+K.+Vanauthor=M.+J.+Gutierrezauthor=D.%2C+M.+Deauthor=L.+Liuauthor=Q.+Liuauthor=B.+B.+Scottauthor=D.+Panebiancoauthor=B.+Jinauthor=L.+T.+Duongauthor=K.+Gottesdienerauthor=J.+A.+Wagner&title=Effect+of+the+Cathepsin+K+Inhibitor+Odanacatib+on+Bone+Resorption+Biomarkers+in+Healthy+Postmenopausal+Women%3A+Two+Double-Blind%2C+Randomized%2C+Placebo-Controlled+Phase+I+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies</span></div><div class="casAuthors">Stoch, S. A.; Zajic, S.; Stone, J.; Miller, D. L.; Van Dyck, K.; Gutierrez, M. J.; De Decker, M.; Liu, L.; Liu, Q.; Scott, B. B.; Panebianco, D.; Jin, B.; Duong, L. T.; Gottesdiener, K.; Wagner, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of cathepsin K (CatK) is a potential new treatment for osteoporosis.  In two double-blind, randomized, placebo-controlled phase I studies, postmenopausal female subjects received odanacatib (ODN), an orally active, potent, and selective CatK inhibitor, once weekly for 3 wk or once daily for 21 days.  Bone turnover biomarkers, safety monitoring, and plasma ODN concns. were assessed.  These studies showed ODN to be well tolerated.  Pharmacokinetic (PK) anal. revealed a long half-life (t1/2; 66-93 h) consistent with once-weekly dosing.  Pronounced redns. in C-terminal telopeptide of type I collagen (62%) and N-terminal telopeptide of type I collagen normalized to creatinine (NTx/Cr) (62%) at trough (C168 h) were seen following weekly administration.  Robust redns. in CTx (up to 81%) and NTx/Cr (up to 81%) were seen following daily administration.  ODN exhibits robust and sustained suppression of bone resorption biomarkers (CTx and NTx/Cr) at weekly doses â¥25 mg and daily doses â¥2.5 mg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtXIERVbQBorVg90H21EOLACvtfcHk0lgc1sr12JgDfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFOrt7c%253D&md5=e3e5a79ea2704e208701b4dc95b1bbe4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2009.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2009.60%26sid%3Dliteratum%253Aachs%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DZajic%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DD.%2BL.%26aulast%3DVan%26aufirst%3DD.%252C%2BK.%26aulast%3DGutierrez%26aufirst%3DM.%2BJ.%26aulast%3DDe%26aufirst%3DD.%252C%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DPanebianco%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DB.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520the%2520Cathepsin%2520K%2520Inhibitor%2520Odanacatib%2520on%2520Bone%2520Resorption%2520Biomarkers%2520in%2520Healthy%2520Postmenopausal%2520Women%253A%2520Two%2520Double-Blind%252C%2520Randomized%252C%2520Placebo-Controlled%2520Phase%2520I%2520Studies%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%2520%2528N.%2520Y.%252C%2520NY%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D86%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Eisman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hustad, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santora, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ince, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, A.</span><span> </span><span class="NLM_article-title">Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">â</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2Fjbmr.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=20740685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wru7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=242-251&author=J.+A.+Eismanauthor=H.+G.+Boneauthor=D.+J.+Hoskingauthor=M.+R.+McClungauthor=I.+R.+Reidauthor=R.+Rizzoliauthor=H.+Reschauthor=N.+Verbruggenauthor=C.+M.+Hustadauthor=S.+C.+Daauthor=R.+Petrovicauthor=A.+C.+Santoraauthor=B.+A.+Inceauthor=A.+Lombardi&title=Odanacatib+in+the+treatment+of+postmenopausal+women+with+low+bone+mineral+density%3A+three-year+continued+therapy+and+resolution+of+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect</span></div><div class="casAuthors">Eisman, John A.; Bone, Henry G.; Hosking, David J.; McClung, Michael R.; Reid, Ian R.; Rizzoli, Rene; Resch, Heinrich; Verbruggen, Nadia; Hustad, Carolyn M.; Da Silva, Carolyn; Petrovic, Romana; Santora, Arthur C.; Ince, B. Avery; Lombardi, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-251</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral d. (BMD) and decreased bone resorption markers during 2 years of treatment in postmenopausal women with low BMD.  A 1-yr extension study further assessed ODN efficacy and safety and the effects of discontinuing therapy.  In the base study, postmenopausal women with BMD T-scores between -2.0 and -3.5 at the lumbar spine or femur received placebo or ODN 3, 10, 25, or 50 mg weekly.  After 2 years, patients were rerandomized to ODN 50 mg weekly or placebo for an addnl. year.  Endpoints included BMD at the lumbar spine (primary), total hip, and hip subregions; levels of bone turnover markers; and safety assessments.  Continued treatment with 50 mg of ODN for 3 years produced significant increases from baseline and from year 2 in BMD at the spine (7.9 and 2.3%) and total hip (5.8 and 2.4%).  Urine cross-linked N-telopeptide of type I collagen (NTx) remained suppressed at year 3 (-50.5%), but bone-specific alk. phosphatase (BSAP) was relatively unchanged from baseline.  Treatment discontinuation resulted in bone loss at all sites, but BMD remained at or above baseline.  After ODN discontinuation at month 24, bone turnover markers increased transiently above baseline, but this increase largely resolved by month 36.  There were similar overall adverse-event rates in both treatment groups.  Thus, 3 years of ODN treatment resulted in progressive increases in BMD and was generally well tolerated.  Bone-resorption markers remained suppressed, whereas bone-formation markers returned to near baseline.  ODN effects were reversible: bone resorption increased transiently and BMD decreased following treatment discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMafU1lcX2E7Vg90H21EOLACvtfcHk0lgc1sr12JgDfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wru7g%253D&md5=991c9a3ecb048737459c327c344d28bd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.212%26sid%3Dliteratum%253Aachs%26aulast%3DEisman%26aufirst%3DJ.%2BA.%26aulast%3DBone%26aufirst%3DH.%2BG.%26aulast%3DHosking%26aufirst%3DD.%2BJ.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DResch%26aufirst%3DH.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DHustad%26aufirst%3DC.%2BM.%26aulast%3DDa%26aufirst%3DS.%2BC.%26aulast%3DPetrovic%26aufirst%3DR.%26aulast%3DSantora%26aufirst%3DA.%2BC.%26aulast%3DInce%26aufirst%3DB.%2BA.%26aulast%3DLombardi%26aufirst%3DA.%26atitle%3DOdanacatib%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%2520three-year%2520continued%2520therapy%2520and%2520resolution%2520of%2520effect%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2011%26volume%3D26%26spage%3D242%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nidamarthy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liable-Sands, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembryki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">StructureâActivity Relationships of 5-, 6-, and 7-Methyl-Substituted Azepan-3-one Cathepsin K Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1597</span><span class="NLM_x">â</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050915u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1597-1612&author=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=R.+Xieauthor=S.+D.+Nidamarthyauthor=H.+Ohauthor=J.+U.+Jeongauthor=K.+F.+Erhardauthor=K.+W.+Wardauthor=T.+J.+Roethkeauthor=B.+R.+Smithauthor=H.+Chengauthor=X.+Gengauthor=F.+Linauthor=P.+H.+Offenauthor=B.+Wangauthor=N.+Nevinsauthor=M.+S.+Headauthor=R.+C.+Haltiwangerauthor=S.+Narducciauthor=A.+Amyauthor=L.+M.+Liable-Sandsauthor=B.+Zhaoauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=E.+Gaoauthor=T.+Tomaszekauthor=M.+McQueneyauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=D.+L.+Zembrykiauthor=M.+W.+Larkauthor=D.+F.+Veber&title=Structure%E2%80%93Activity+Relationships+of+5-%2C+6-%2C+and+7-Methyl-Substituted+Azepan-3-one+Cathepsin+K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050915u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050915u%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DNidamarthy%26aufirst%3DS.%2BD.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DOffen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DNarducci%26aufirst%3DS.%26aulast%3DAmy%26aufirst%3DA.%26aulast%3DLiable-Sands%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcQueney%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DZembryki%26aufirst%3DD.%2BL.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520of%25205-%252C%25206-%252C%2520and%25207-Methyl-Substituted%2520Azepan-3-one%2520Cathepsin%2520K%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1597%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dare, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko-Moser, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G.</span><span> </span><span class="NLM_article-title">A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys</span> <span class="citation_source-journal">Bone (San Diego, CA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12ktrrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=122-131&author=S.+Kumarauthor=L.+Dareauthor=J.+A.+Vasko-Moserauthor=I.+E.+Jamesauthor=S.+M.+Blakeauthor=D.+J.+Rickardauthor=S.+Hwangauthor=T.+Tomaszekauthor=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=H.+Ohauthor=J.+U.+Jeongauthor=D.+F.+Veberauthor=M.+Gowenauthor=M.+W.+Larkauthor=G.+Stroup&title=A+highly+potent+inhibitor+of+cathepsin+K+%28relacatib%29+reduces+biomarkers+of+bone+resorption+both+in+vitro+and+in+an+acute+model+of+elevated+bone+turnover+in+vivo+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys</span></div><div class="casAuthors">Kumar, S.; Dare, L.; Vasko-Moser, J. A.; James, I. E.; Blake, S. M.; Rickard, D. J.; Hwang, S.-M.; Tomaszek, T.; Yamashita, D. S.; Marquis, R. W.; Oh, H.; Jeong, J. U.; Veber, D. F.; Gowen, M.; Lark, M. W.; Stroup, G.</div><div class="citationInfo"><span class="NLM_cas:title">Bone (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">122-131</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cathepsin K is an osteoclast-derived cysteine protease that has been implicated as playing a major role in bone resorption.  A substantial body of evidence indicates that cathepsin K is crit. in osteoclast-mediated bone resorption and suggests that its pharmacol. inhibition should result in inhibition of bone resorption in vivo.  Here we report the pharmacol. characterization of SB-462795 (relacatib) as a potent and orally bioavailable small mol. inhibitor of cathepsin K that inhibits bone resorption both in vitro in human tissue and in vivo in cynomolgus monkeys.  SB-462795 is a potent inhibitor of human cathepsins K, L, and V (K i, app = 41, 68, and 53 pM, resp.) that exhibits 39-300-fold selectivity over other cathepsins.  SB-462795 inhibited endogenous cathepsin K in situ in human osteoclasts and human osteoclast-mediated bone resorption with IC50 values of â¼ 45 nM and â¼ 70 nM, resp.  The anti-resorptive potential of SB-462795 was evaluated in normal as well as medically ovariectomized (Ovx) female cynomolgus monkeys.  Serum levels of the C- and N-terminal telopeptides of Type I collagen (CTx and NTx, resp.) and urinary levels of NTx were monitored as biomarkers of bone resorption.  Administration of SB-462795 to medically ovariectomized or normal monkeys resulted in an acute redn. in both serum and urinary markers of bone resorption within 1.5 h after dosing, and this effect lasted up to 48 h depending on the dose administered.  Our data indicate that SB-462795 potently inhibits human cathepsin K in osteoclasts, resulting in a rapid inhibition of bone resorption both in vitro and in vivo in the monkey.  These studies also demonstrate the therapeutic potential of relacatib in the treatment of postmenopausal osteoporosis and serves to model the planned clin. trials in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyXueELl98GLVg90H21EOLACvtfcHk0lhJzMDZprrtMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12ktrrF&md5=714403b214942c266acc686243f74ceb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DVasko-Moser%26aufirst%3DJ.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DBlake%26aufirst%3DS.%2BM.%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DStroup%26aufirst%3DG.%26atitle%3DA%2520highly%2520potent%2520inhibitor%2520of%2520cathepsin%2520K%2520%2528relacatib%2529%2520reduces%2520biomarkers%2520of%2520bone%2520resorption%2520both%2520in%2520vitro%2520and%2520in%2520an%2520acute%2520model%2520of%2520elevated%2520bone%2520turnover%2520in%2520vivo%2520in%2520monkeys%26jtitle%3DBone%2520%2528San%2520Diego%252C%2520CA%252C%2520U.%2520S.%2529%26date%3D2007%26volume%3D40%26spage%3D122%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bailey, A.; Pairaudeau, G.; Patel, A.; Thom, S.</span>WO2004000825A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bailey%2C+A.%3B+Pairaudeau%2C+G.%3B+Patel%2C+A.%3B+Thom%2C+S.WO2004000825A1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DA.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">The consequences of lysosomotropism on the design of selective cathepsin K inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">â</span> <span class="NLM_lpage">1535</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1525-1535&author=W.+C.+Blackauthor=M.+D.+Percival&title=The+consequences+of+lysosomotropism+on+the+design+of+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DThe%2520consequences%2520of%2520lysosomotropism%2520on%2520the%2520design%2520of%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2006%26volume%3D7%26spage%3D1525%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">â</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Masseauthor=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+Basic+Cathepsin+K+Inhibitors+Contributes+to+Increased+Cellular+Potencies+against+Off-Target+Cathepsins+and+Reduced+Functional+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are â¼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0liOj2FAAOfSrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520Basic%2520Cathepsin%2520K%2520Inhibitors%2520Contributes%2520to%2520Increased%2520Cellular%2520Potencies%2520against%2520Off-Target%2520Cathepsins%2520and%2520Reduced%2520Functional%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, G.</span><span> </span><span class="NLM_article-title">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci000403i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=856-864&author=M.+M.+Hannauthor=A.+R.+Leachauthor=G.+Harper&title=Molecular+Complexity+and+Its+Impact+on+the+Probability+of+Finding+Leads+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span></div><div class="casAuthors">Hann, Michael M.; Leach, Andrew R.; Harper, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a simple model of ligand-receptor interactions, the interactions between ligands and receptors of varying complexities are studied and the probabilities of binding calcd.  It is obsd. that as the systems become more complex the chance of observing a useful interaction for a randomly chosen ligand falls dramatically.  The implications of this for the design of combinatorial libraries is explored.  A large set of drug leads and optimized compds. is profiled using several different properties relevant to mol. recognition.  The changes obsd. for these properties during the drug optimization phase support the hypothesis that less complex mols. are more common starting points for the discovery of drugs.  An extreme example of the use of simple mols. for directed screening against thrombin is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ed40mt9qb7Vg90H21EOLACvtfcHk0liOj2FAAOfSrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D&md5=e89e76c8fb83fc5012369ae30f20e6b7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fci000403i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000403i%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHarper%26aufirst%3DG.%26atitle%3DMolecular%2520Complexity%2520and%2520Its%2520Impact%2520on%2520the%2520Probability%2520of%2520Finding%2520Leads%2520for%2520Drug%2520Discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D856%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span> </span><span class="NLM_article-title">Î²-Substituted Cyclohexanecarboxamide: A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">â</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051059p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1066-1079&author=S.+N.+Craneauthor=W.+C.+Blackauthor=J.+T.+Palmerauthor=D.+E.+Davisauthor=E.+Settiauthor=J.+Robichaudauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=J.+R.+Somozaauthor=N.+Chauretauthor=C.+Setoauthor=J.+Scheigetzauthor=G.+Wesolowskiauthor=F.+Masseauthor=S.+Desmaraisauthor=M.+Ouellet&title=%CE%B2-Substituted+Cyclohexanecarboxamide%3A+A+Nonpeptidic+Framework+for+the+Design+of+Potent+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm051059p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051059p%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOuellet%26aufirst%3DM.%26atitle%3D%25CE%25B2-Substituted%2520Cyclohexanecarboxamide%253A%2520A%2520Nonpeptidic%2520Framework%2520for%2520the%2520Design%2520of%2520Potent%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1066%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">Î²-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3146</span><span class="NLM_x">â</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3146-3151&author=J.+Robichaudauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=S.+Legerauthor=F.+Masseauthor=D.+J.+McKayauthor=R.+M.+Oballaauthor=J.+Paquetauthor=M.+D.+Percivalauthor=J.+Truchonauthor=G.+Wesolowskiauthor=S.+N.+Crane&title=%CE%B2-Substituted+cyclohexanecarboxamide+cathepsin+K+inhibitors%3A+Modification+of+the+1%2C2-disubstituted+aromatic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%2520cathepsin%2520K%2520inhibitors%253A%2520Modification%2520of%2520the%25201%252C2-disubstituted%2520aromatic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3146%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Berkessel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaubitz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lex, J.</span><span> </span><span class="NLM_article-title">Enantiomerically pure Î²-amino acids: a convenient access to both enantiomers of trans-2-aminocyclohexanecarboxylic acid</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">2948</span><span class="NLM_x">â</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=2948-2952&author=A.+Berkesselauthor=K.+Glaubitzauthor=J.+Lex&title=Enantiomerically+pure+%CE%B2-amino+acids%3A+a+convenient+access+to+both+enantiomers+of+trans-2-aminocyclohexanecarboxylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerkessel%26aufirst%3DA.%26aulast%3DGlaubitz%26aufirst%3DK.%26aulast%3DLex%26aufirst%3DJ.%26atitle%3DEnantiomerically%2520pure%2520%25CE%25B2-amino%2520acids%253A%2520a%2520convenient%2520access%2520to%2520both%2520enantiomers%2520of%2520trans-2-aminocyclohexanecarboxylic%2520acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2002%26spage%3D2948%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Harbert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koe, B. K.</span><span> </span><span class="NLM_article-title">Neuroleptic activity in 5-aryltetrahydro-Î³-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">â</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00180a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=635-643&author=C.+A.+Harbertauthor=J.+J.+Plattnerauthor=W.+M.+Welchauthor=A.+Weissmanauthor=B.+K.+Koe&title=Neuroleptic+activity+in+5-aryltetrahydro-%CE%B3-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00180a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00180a011%26sid%3Dliteratum%253Aachs%26aulast%3DHarbert%26aufirst%3DC.%2BA.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DWelch%26aufirst%3DW.%2BM.%26aulast%3DWeissman%26aufirst%3DA.%26aulast%3DKoe%26aufirst%3DB.%2BK.%26atitle%3DNeuroleptic%2520activity%2520in%25205-aryltetrahydro-%25CE%25B3-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D635%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, L. D.</span><span> </span><span class="NLM_article-title">Debenzylation of N-benzylamino derivatives by catalytic transfer hydrogenation with ammonium formate</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1080%2F00397918708063919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL1cXlsFCntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=415-418&author=S.+Ramauthor=L.+D.+Spicer&title=Debenzylation+of+N-benzylamino+derivatives+by+catalytic+transfer+hydrogenation+with+ammonium+formate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Debenzylation of N-benzylamino derivatives by catalytic transfer hydrogenation with ammonium formate</span></div><div class="casAuthors">Ram, Siya; Spicer, Leonard D.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-18</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">RR1NCH2Ph [R = H, Me; R1 = Ph, PhCH2CH2, HO(CH2)n (n = 2, 3)] are debenzylated with HCO2NH4 and Pd-C in MeOH to give 76-95% RR1NH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZX--7OMrW7Vg90H21EOLACvtfcHk0lhh4KBATJAVNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsFCntA%253D%253D&md5=db9d7e505c0f5b62a471ad155f9194bb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F00397918708063919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918708063919%26sid%3Dliteratum%253Aachs%26aulast%3DRam%26aufirst%3DS.%26aulast%3DSpicer%26aufirst%3DL.%2BD.%26atitle%3DDebenzylation%2520of%2520N-benzylamino%2520derivatives%2520by%2520catalytic%2520transfer%2520hydrogenation%2520with%2520ammonium%2520formate%26jtitle%3DSynth.%2520Commun.%26date%3D1987%26volume%3D17%26spage%3D415%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liSt7ycdfHcPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Andersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjoere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elebring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannesson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsgren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemurell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittamore, P.</span><span> </span><span class="NLM_article-title">Making medicinal chemistry more effective-application of Lean Sigma to improve processes, speed and quality</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=598-604&author=S.+Anderssonauthor=A.+Armstrongauthor=A.+Bjoereauthor=S.+Bowkerauthor=S.+Chapmanauthor=R.+Daviesauthor=C.+Donaldauthor=B.+Egnerauthor=T.+Elebringauthor=S.+Holmqvistauthor=T.+Inghardtauthor=P.+Johannessonauthor=M.+Johanssonauthor=C.+Johnstoneauthor=P.+Kemmittauthor=J.+Kihlbergauthor=P.+Korsgrenauthor=M.+Lemurellauthor=J.+Mooreauthor=J.+A.+Petterssonauthor=H.+Pointonauthor=F.+Pontenauthor=P.+Schofieldauthor=N.+Selmiauthor=P.+Whittamore&title=Making+medicinal+chemistry+more+effective-application+of+Lean+Sigma+to+improve+processes%2C+speed+and+quality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DArmstrong%26aufirst%3DA.%26aulast%3DBjoere%26aufirst%3DA.%26aulast%3DBowker%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DDonald%26aufirst%3DC.%26aulast%3DEgner%26aufirst%3DB.%26aulast%3DElebring%26aufirst%3DT.%26aulast%3DHolmqvist%26aufirst%3DS.%26aulast%3DInghardt%26aufirst%3DT.%26aulast%3DJohannesson%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26aulast%3DKorsgren%26aufirst%3DP.%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DJ.%2BA.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DPonten%26aufirst%3DF.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DWhittamore%26aufirst%3DP.%26atitle%3DMaking%2520medicinal%2520chemistry%2520more%2520effective-application%2520of%2520Lean%2520Sigma%2520to%2520improve%2520processes%252C%2520speed%2520and%2520quality%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D598%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oprea, T.</span><span> </span><span class="NLM_article-title">The design of leadlike combinatorial libraries</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3743</span><span class="NLM_x">â</span> <span class="NLM_lpage">3748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms12i" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3743-3748&author=S.+J.+Teagueauthor=A.+M.+Davisauthor=P.+D.+Leesonauthor=T.+Oprea&title=The+design+of+leadlike+combinatorial+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The design of leadlike combinatorial libraries</span></div><div class="casAuthors">Teague, Simon J.; Davis, Andrew M.; Leeson, Paul D.; Oprea, Tudor</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3743-3748</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with 26 refs.  The authors proposed that the properties required of library compds. intended to provide leads suitable for further optimization may be rather different.  The selection of leadlike compds. for further optimization eases the pressure on subsequent and more labor-intensive parts of drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7NQbjg0mN9bVg90H21EOLACvtfcHk0liSt7ycdfHcPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms12i&md5=3918b1a2fdea3b814528f12487614a5f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991216%252938%253A24%253C3743%253A%253AAID-ANIE3743%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DOprea%26aufirst%3DT.%26atitle%3DThe%2520design%2520of%2520leadlike%2520combinatorial%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D3743%26epage%3D3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">Is There a Difference between Leads and Drugs? A Historical Perspective</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">â</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+Leeson&title=Is+There+a+Difference+between+Leads+and+Drugs%3F+A+Historical+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ÎMW = 69; ÎCMR = 1.8; ÎRNG = ÎHAC =1; ÎRTB = 2; ÎCLogP = 0.43; ÎLogD74 = 0.97; ÎHDO = 0; ÎDFPS = 0.15; ÎPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0lja7w-OWn-pZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DIs%2520There%2520a%2520Difference%2520between%2520Leads%2520and%2520Drugs%253F%2520A%2520Historical%2520Perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D1308%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Williams, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The kinetics of reversible tight-binding inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2F0076-6879%2879%2963019-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=502865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamsauthor=J.+F.+Morrison&title=The+kinetics+of+reversible+tight-binding+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of reversible tight-binding inhibition</span></div><div class="casAuthors">Williams, Jeffrey W.; Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">Enzyme Kinet. Mech., Part A</span>),
    <span class="NLM_cas:pages">437-67</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">In addn. to a general discussion of the kinetics of reversible tight-binding inhibitors, which exert their effect at a concn. comparable to that of the enzyme, and for which steady-state theory is used, exptl. results are given of the tight-binding inhibition of creatine kinase by Eu3+ (actually Eu-ADP) under steady-state conditions.  The inhibition of creatine kinase by fixed concns. of Eu3+ in the presence of varying concns. of Mg-ADP indicated that the inhibition is competitive, suggesting that Eu-ADP acts as a structural analog of Mg-ADP.  The inhibition was noncompetitive with respect to creatine phosphate.  The dissocn. consts. for binding of Eu-ADP to the free enzyme and the enzyme-phosphocreatine complex were 1.5 and 2.2 nM, resp., as detd. from Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2CwV3voXt27Vg90H21EOLACvtfcHk0lja7w-OWn-pZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXovF2ntw%253D%253D&md5=a770f91b51661c9502d0aca44a24e1c7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2879%2963019-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252879%252963019-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520kinetics%2520of%2520reversible%2520tight-binding%2520inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">â</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+Therienauthor=V.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0lja7w-OWn-pZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">â</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0lja7w-OWn-pZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, B.</span><span> </span><span class="NLM_article-title">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">â</span> <span class="NLM_lpage">6682</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+Molecular+Pairs+as+a+Guide+in+the+Optimization+of+Pharmaceutical+Properties%3B+a+Study+of+Aqueous+Solubility%2C+Plasma+Protein+Binding+and+Oral+Exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lje3Nx596PhJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520Molecular%2520Pairs%2520as%2520a%2520Guide%2520in%2520the%2520Optimization%2520of%2520Pharmaceutical%2520Properties%253B%2520a%2520Study%2520of%2520Aqueous%2520Solubility%252C%2520Plasma%2520Protein%2520Binding%2520and%2520Oral%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Dossetter, A. G.</span><span> </span><span class="NLM_article-title">A statistical analysis of in vitro human microsomal metabolic stability of small phenyl group substituents, leading to improved design sets for parallel SAR exploration of a chemical series</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">â</span> <span class="NLM_lpage">4414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.bmc.2010.04.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=20510621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntV2rurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4405-4414&author=A.+G.+Dossetter&title=A+statistical+analysis+of+in+vitro+human+microsomal+metabolic+stability+of+small+phenyl+group+substituents%2C+leading+to+improved+design+sets+for+parallel+SAR+exploration+of+a+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A statistical analysis of in vitro human microsomal metabolic stability of small phenyl group substituents, leading to improved design sets for parallel SAR exploration of a chemical series</span></div><div class="casAuthors">Dossetter, Alexander G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4405-4414</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An anal. of in vitro human liver microsomal turnover assay results from a large dataset (â¼75 K) of exptl. compds. tested is presented.  Combined with an anal. of small (<6 Ha) substituents on known drugs and existing published results a new set of 29 substituents (consensus) is proposed to increase stability and probe SAR (an enhanced Topliss set').  In addn. a different group of 28 substituents are identified as unlikely to change in vitro HLM stability, and a further set of compds. focuses on increasing HLM stability only.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOwR4TenuEULVg90H21EOLACvtfcHk0lje3Nx596PhJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntV2rurc%253D&md5=93c9825d5da0b47e0f4c66996c883642</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26atitle%3DA%2520statistical%2520analysis%2520of%2520in%2520vitro%2520human%2520microsomal%2520metabolic%2520stability%2520of%2520small%2520phenyl%2520group%2520substituents%252C%2520leading%2520to%2520improved%2520design%2520sets%2520for%2520parallel%2520SAR%2520exploration%2520of%2520a%2520chemical%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4405%26epage%3D4414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lewis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucurull-Sanchez, L.</span><span> </span><span class="NLM_article-title">Structural pairwise comparisons of HLM stability of phenyl derivatives: Introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE)</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1007%2Fs10822-008-9242-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18802667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFGg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=97-103&author=M.+L.+Lewisauthor=L.+Cucurull-Sanchez&title=Structural+pairwise+comparisons+of+HLM+stability+of+phenyl+derivatives%3A+Introduction+of+the+Pfizer+metabolism+index+%28PMI%29+and+metabolism-lipophilicity+efficiency+%28MLE%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural pairwise comparisons of HLM stability of phenyl derivatives: Introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE)</span></div><div class="casAuthors">Lewis, Mark L.; Cucurull-Sanchez, Lourdes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Data mining by pairwise comparison of over 150,000 human liver microsome (HLM) intrinsic clearance values stored within the internal Pfizer database has been performed by an automated tool.  Systematic probability tables of specific structural changes on the intrinsic clearance of Ph derivs. were generated.  From these data two new parameters, the Pfizer Metab. Index (PMI) and Metab.-Lipophilicity Efficiency (MLE) are introduced for each fragment.  The findings are applied to a Topliss style anal. that focuses on metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-t3Rk6sR_vLVg90H21EOLACvtfcHk0lje3Nx596PhJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFGg&md5=5088f2c94bce164a302df21936da9a43</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-008-9242-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-008-9242-3%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DM.%2BL.%26aulast%3DCucurull-Sanchez%26aufirst%3DL.%26atitle%3DStructural%2520pairwise%2520comparisons%2520of%2520HLM%2520stability%2520of%2520phenyl%2520derivatives%253A%2520Introduction%2520of%2520the%2520Pfizer%2520metabolism%2520index%2520%2528PMI%2529%2520and%2520metabolism-lipophilicity%2520efficiency%2520%2528MLE%2529%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Henderson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravis, W. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetic calculator program for generation of initial parameter estimates from a three-compartment infusion model</span> <span class="citation_source-journal">J. Pharmacol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2F0160-5402%2885%2990039-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=3839870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADyaL2MXlsFehsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1985&pages=13-24&author=J.+D.+Hendersonauthor=R.+D.+Olsonauthor=W.+R.+Ravis&title=Pharmacokinetic+calculator+program+for+generation+of+initial+parameter+estimates+from+a+three-compartment+infusion+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic calculator program for generation of initial parameter estimates from a three-compartment infusion model</span></div><div class="casAuthors">Henderson, James D.; Olson, Richard D.; Ravis, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Methods</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JPMED9</span>;
        ISSN:<span class="NLM_cas:issn">0160-5402</span>.
    </div><div class="casAbstract">A polyexponential curve-stripping program, KIN, is described for use on the HP-41CV programmable calculator.  The program may be used in the anal. of plasma-concn.-time curves for a 3-compartment i.v. bolus or infusion model with linear elimination processes.  The coeffs. and hybrid rate consts. of the exponential function are then used to compute pharmacokinetic parameters (vol. of the central compartment, intercompartmental rate transfer consts.), which may be used as initial ests. of model parameters in nonlinear regression curve-fitting procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqjk8-XJ34ULVg90H21EOLACvtfcHk0ljepc_Rs4mDyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlsFehsLw%253D&md5=62866814a4181cf783202f4c4baef05b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0160-5402%2885%2990039-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0160-5402%252885%252990039-7%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BD.%26aulast%3DOlson%26aufirst%3DR.%2BD.%26aulast%3DRavis%26aufirst%3DW.%2BR.%26atitle%3DPharmacokinetic%2520calculator%2520program%2520for%2520generation%2520of%2520initial%2520parameter%2520estimates%2520from%2520a%2520three-compartment%2520infusion%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Methods%26date%3D1985%26volume%3D14%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">McGinnity, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collington, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, R. J.</span><span> </span><span class="NLM_article-title">Evaluation of Human Pharmacokinetics, Therapeutic Dose and Exposure Predictions Using Marketed Oral Drugs</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.2174%2F138920007780866799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=17584017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=463-479&author=D.+F.+McGinnityauthor=J+Collingtonauthor=R.+P.+Austinauthor=R.+J.+Riley&title=Evaluation+of+Human+Pharmacokinetics%2C+Therapeutic+Dose+and+Exposure+Predictions+Using+Marketed+Oral+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs</span></div><div class="casAuthors">McGinnity, D. F.; Collington, J.; Austin, R. P.; Riley, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-479</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this article approaches to predict human pharmacokinetics (PK) are discussed and the capability of the exemplified methodologies to est. individual PK parameters and therapeutic dose for a set of marketed oral drugs has been assessed.  For a set of 63 drugs where the min. efficacious concn. (MEC) and human PK were known, the clin. dose was shown to be well predicted or in some cases over-estd. using a simple one-compartment oral PK model.  For a subset of these drugs, in vitro potency against the primary human targets was gathered, and compared to the obsd. MEC.  When cor. for plasma protein binding, the MEC of the majority of compds. was â¤ 3 fold over the resp. in vitro target potency value.  A series of in vitro and in vivo expts. were conducted to predict the human PK parameters.  Metabolic clearance was generally predicted well from human hepatocytes.  Interestingly, for this compd. set, allometry or glomerular filtration rate (GFR) ratio methods appeared to be applicable for renal CL even where CLrenal > GFR.  For â¼90% of compds. studied, the predicted CL using in vitro-in vivo (IVIV) extrapolation together with a CLrenal est., where appropriate, was within 2-fold of that obsd. clin.  Encouragingly vol. of distribution at steady state (Vss) estd. in preclin. species (rat and dog) when cor. for plasma protein binding, predicted human Vss successfully on the majority of occasions - 73% of compds. within 2-fold.  In this lab., absorption estd. from oral rat PK studies was lower than the obsd. human absorption for most drugs, even when soly. and permeability appeared not to be limiting.  Preliminary data indicate absorption in the dog may be more representative of human for compds. absorbed via the transcellular pathway.  Using predicted PK and MEC values estd. from in vitro potency assays there was a good correlation between predicted and obsd. dose.  This anal. suggests that for oral therapies, human PK parameters and clin. dose can be estd. from a consideration of data obtained from in vitro screens using human derived material and in vivo animal studies.  The benefits and limitations of this holistic approach to PK and dose prediction within the drug discovery process are exemplified and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdbfKDFLO_UrVg90H21EOLACvtfcHk0ljepc_Rs4mDyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsl2jtL4%253D&md5=765bdc4b870b660e813e36ae3719ddb5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138920007780866799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007780866799%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DCollington%26aufirst%3DJ%26aulast%3DAustin%26aufirst%3DR.%2BP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520Human%2520Pharmacokinetics%252C%2520Therapeutic%2520Dose%2520and%2520Exposure%2520Predictions%2520Using%2520Marketed%2520Oral%2520Drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D463%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sadick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenberger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraenzlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenberg, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schock-Kusch, D.</span><span> </span><span class="NLM_article-title">Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 T dynamic contrast-enhanced MRI and optical imaging</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">â</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1093%2Fndt%2Fgfr148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=21444361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbht1Snug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=3101-3108&author=M.+Sadickauthor=U.+Attenbergerauthor=B.+Kraenzlinauthor=H.+Kayedauthor=S.+O.+Schoenbergauthor=N.+Gretzauthor=D.+Schock-Kusch&title=Two+non-invasive+GFR-estimation+methods+in+rat+models+of+polycystic+kidney+disease%3A+3.0+T+dynamic+contrast-enhanced+MRI+and+optical+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 Tesla dynamic contrast-enhanced MRI and optical imaging</span></div><div class="casAuthors">Sadick Maliha; Attenberger Ulrike; Kraenzlin Bettina; Kayed Hany; Schoenberg Stefan O; Gretz Norbert; Schock-Kusch Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3101-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was the assessment of kidney morphology and glomerular filtration rate (GFR) in rat models of polycystic kidney disease and a healthy control group of Sprague-Dawley rats (SD rats).  The performance of two non-invasive GFR estimation methods-3.0 Tesla magnetic resonance imaging (MRI) and optical imaging were investigated.  Data of GFR assessment was compared to surrogate markers of kidney function and renal histology.  METHODS:  Optical imaging of GFR was performed transcutaneously in a small animal imaging system with the fluorescent renal marker fluorescein-isothiocyanate-labelled-sinistrin.  Morphologic and dynamic renal imaging was done on a clinical 3.0T MR scanner.  Renal perfusion analysis was performed with a two-compartment filtration model.  RESULTS:  The healthy SD rats showed physiological levels of creatinine and urea, indicating normal kidney function.  These parameters were elevated in the small animal groups of polycystic kidney disease.  For the calculation of perfusion and filtration parameters of kidney function in MRI, a 2D turbo FLASH sequence was performed and allowed to distinguish between normal GFR of healthy rats and reduced GFR of rats with polycystic kidney disease.  Also, MRI GFR varied among two different rat strains of polycystic kidney disease, according to their status of renal function impairment.  Optical imaging GFR confirmed higher GFR values in healthy rats compared to ill rats but did not show different results among the two rat strains of polycystic kidney disease.  For this reason, MRI and optical imaging GFR estimation presented an intra-method bias.  CONCLUSIONS:  Both non-invasive estimation methods of GFR, MRI and optical imaging, can differentiate between healthy rats and animals with limited kidney function.  Furthermore, optical imaging, unlike MRI, seems to consider that disease progression with increase of renal polycystic deterioration does not correlate with decrease of GFR in the initial stage of compensatory hyperfiltration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmbrKlAKtJrEodMGTatQ7LfW6udTcc2eb4nkxMegCeabntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbht1Snug%253D%253D&md5=916ad0c2fb6af9457adb80c15e5b6a94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfr148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfr148%26sid%3Dliteratum%253Aachs%26aulast%3DSadick%26aufirst%3DM.%26aulast%3DAttenberger%26aufirst%3DU.%26aulast%3DKraenzlin%26aufirst%3DB.%26aulast%3DKayed%26aufirst%3DH.%26aulast%3DSchoenberg%26aufirst%3DS.%2BO.%26aulast%3DGretz%26aufirst%3DN.%26aulast%3DSchock-Kusch%26aufirst%3DD.%26atitle%3DTwo%2520non-invasive%2520GFR-estimation%2520methods%2520in%2520rat%2520models%2520of%2520polycystic%2520kidney%2520disease%253A%25203.0%2520T%2520dynamic%2520contrast-enhanced%2520MRI%2520and%2520optical%2520imaging%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2011%26volume%3D26%26spage%3D3101%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rowland, M.; Tozer, T. N.</span> In  <span class="citation_source-book">Clinical Pharmacokinetics; Concepts and Application</span>; <span class="NLM_edition">3</span>rd ed., Chapter 11, p  <span class="NLM_fpage">171</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rowland%2C+M.%3B+Tozer%2C+T.+N.+In+Clinical+Pharmacokinetics%3B+Concepts+and+Application%3B+3rd+ed.%2C+Chapter+11%2C+p+171."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26btitle%3DClinical%2520Pharmacokinetics%253B%2520Concepts%2520and%2520Application%26spage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">â</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+Hydrogen+Bonding+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lhn1sjwJasiCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520Hydrogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an Intramolecular Hydrogen Bond To Increase the CNS Penetration of an NK1 Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">â</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+Intramolecular+Hydrogen+Bond+To+Increase+the+CNS+Penetration+of+an+NK1+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520Intramolecular%2520Hydrogen%2520Bond%2520To%2520Increase%2520the%2520CNS%2520Penetration%2520of%2520an%2520NK1%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, M.</span><span> </span><span class="NLM_article-title">Discovery of a Thieno[2,3-<i>d</i>]pyrimidine-2,4-dione Bearing a <i>p</i>-Methoxyureidophenyl Moiety at the 6-Position: A Highly Potent and Orally Bioavailable Nonpeptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">â</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020180i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=113-124&author=S.+Sasakiauthor=N.+Choauthor=Y.+Naraauthor=M.+Haradaauthor=S.+Endoauthor=N.+Suzukiauthor=S.+Furuyaauthor=M.+Fujino&title=Discovery+of+a+Thieno%5B2%2C3-d%5Dpyrimidine-2%2C4-dione+Bearing+a+p-Methoxyureidophenyl+Moiety+at+the+6-Position%3A+A+Highly+Potent+and+Orally+Bioavailable+Nonpeptide+Antagonist+for+the+Human+Luteinizing+Hormone-Releasing+Hormone+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm020180i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020180i%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNara%26aufirst%3DY.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520Thieno%255B2%252C3-d%255Dpyrimidine-2%252C4-dione%2520Bearing%2520a%2520p-Methoxyureidophenyl%2520Moiety%2520at%2520the%25206-Position%253A%2520A%2520Highly%2520Potent%2520and%2520Orally%2520Bioavailable%2520Nonpeptide%2520Antagonist%2520for%2520the%2520Human%2520Luteinizing%2520Hormone-Releasing%2520Hormone%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Rezai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyanaraman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokey, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span> </span><span class="NLM_article-title">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">14073</span><span class="NLM_x">â</span> <span class="NLM_lpage">14080</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+Flexibility%2C+Internal+Hydrogen+Bonding%2C+and+Passive+Membrane+Permeability%3A+Successful+in+Silico+Prediction+of+the+Relative+Permeabilities+of+Cyclic+Peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0lhn1sjwJasiCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520Flexibility%252C%2520Internal%2520Hydrogen%2520Bonding%252C%2520and%2520Passive%2520Membrane%2520Permeability%253A%2520Successful%2520in%2520Silico%2520Prediction%2520of%2520the%2520Relative%2520Permeabilities%2520of%2520Cyclic%2520Peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Garnero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsdal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicamhlaoibh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risteli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foged, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaisse, J. M.</span><span> </span><span class="NLM_article-title">The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">â</span> <span class="NLM_lpage">867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1359%2Fjbmr.2003.18.5.859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=12733725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslahsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=859-867&author=P.+Garneroauthor=M.+Ferrerasauthor=M.+Karsdalauthor=R.+Nicamhlaoibhauthor=J.+Risteliauthor=O.+Borelauthor=P.+Qvistauthor=P.+D.+Delmasauthor=N.+T.+Fogedauthor=J.+M.+Delaisse&title=The+type+I+collagen+fragments+ICTP+and+CTX+reveal+distinct+enzymatic+pathways+of+bone+collagen+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation</span></div><div class="casAuthors">Garnero, P.; Ferreras, M.; Karsdal, Ma; Nicamhlaoibh, R.; Risteli, J.; Borel, O.; Qvist, P.; Delmas, P. D.; Foged, N. T.; Delaisse, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">859-867</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Bone resorption may generate collagen fragments such as ICTP and CTX, which can be quantified in serum and/or urine by using specific immunoassays, and which are used as clin. markers.  However, the relative abundance of ICTP and CTX varies according to the type of bone pathol., suggesting that these two fragments are generated via distinct collagenolytic pathways.  Here, the authors analyzed the release of ICTP and CTX from bone collagen by the proteinases reported to play a role in the solubilization of bone matrix.  Cathepsin K released large amts. of CTX, but did not allow a detectable release of ICTP.  Conversely, the matrix metalloproteinases (MMPs) MMP-2, -9, -13, or -14 released ICTP, but did not allow a detectable release of CTX.  Next the authors analyzed the release of ICTP and CTX from bone explants cultured in the presence of well-established inhibitors of these proteinases and of matrix solubilization.  An inhibitor of cysteine proteinases including cathepsin K, inhibited the release of CTX, but not the release of ICTP.  MMP inhibitors inhibited the release of ICTP, but also that of CTX, in agreement with the putative role of MMPs in the initiation of bone resorption in addn. to matrix solubilization.  Similarly the treatment of mice bearing bone metastasis with an MMP inhibitor led to a redn. of serum ICTP and CTX, and osteolytic lesions.  Thus, the generation of ICTP and CTX depends on different collagenolytic pathways.  This finding may explain why these 2 markers may discriminate between different bone pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3gar2jdeKrVg90H21EOLACvtfcHk0lgk38XyBnWaAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslahsrY%253D&md5=c4549a3259a310457c1f8f801aeb8c32</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.5.859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.5.859%26sid%3Dliteratum%253Aachs%26aulast%3DGarnero%26aufirst%3DP.%26aulast%3DFerreras%26aufirst%3DM.%26aulast%3DKarsdal%26aufirst%3DM.%26aulast%3DNicamhlaoibh%26aufirst%3DR.%26aulast%3DRisteli%26aufirst%3DJ.%26aulast%3DBorel%26aufirst%3DO.%26aulast%3DQvist%26aufirst%3DP.%26aulast%3DDelmas%26aufirst%3DP.%2BD.%26aulast%3DFoged%26aufirst%3DN.%2BT.%26aulast%3DDelaisse%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520type%2520I%2520collagen%2520fragments%2520ICTP%2520and%2520CTX%2520reveal%2520distinct%2520enzymatic%2520pathways%2520of%2520bone%2520collagen%2520degradation%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D859%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Herrmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibel, M.</span><span> </span><span class="NLM_article-title">The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1016%2Fj.cca.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=18423400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKhsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2008&pages=57-75&author=M.+Herrmannauthor=M.+Seibel&title=The+amino-+and+carboxyterminal+cross-linked+telopeptides+of+collagen+type+I%2C+NTX-I+and+CTX-I%3A+A+comparative+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review</span></div><div class="casAuthors">Herrmann, Markus; Seibel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-75</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bone diseases such as osteoporosis or bone metastases are a continuously growing problem in the ageing populations across the world.  In recent years, great efforts have been made to develop specific and sensitive biochem. markers of bone turnover that could help in the assessment and monitoring of bone turnover.  The amino- and carboxyterminal cross-linked telopeptides of type I collagen (NTX-I and CTX-I, resp.) are two widely used bone resorption markers that attracted great attention due to their relatively high sensitivity and specificity for the degrdn. of type I collagen, and their rapid adaptation to automated analyzers.  However, the clin. performance of both markers differs significantly depending on the clin. situation.  These differences have caused considerable confusion and uncertainty.  If used correctly, both markers have great potential to improve the management of many bone diseases.  The authors here review the biochem., anal. background and clin. performance of NTX-I and CTX-I, as documented in the accessible literature until March 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3xolh-a6hbVg90H21EOLACvtfcHk0lgk38XyBnWaAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKhsLo%253D&md5=f50b4fbb47ee454ae4885cbae9d0a527</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSeibel%26aufirst%3DM.%26atitle%3DThe%2520amino-%2520and%2520carboxyterminal%2520cross-linked%2520telopeptides%2520of%2520collagen%2520type%2520I%252C%2520NTX-I%2520and%2520CTX-I%253A%2520A%2520comparative%2520review%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D393%26spage%3D57%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Okuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitatani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimura, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizawa, Y.</span><span> </span><span class="NLM_article-title">Serum levels of C-terminal telopeptide of type I collagen: A useful new marker of cortical bone loss in hemodialysis patients</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">â</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3007257&amp;key=10.1007%2Fs00198-004-1712-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3007257&amp;key=15309383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3007257&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFSrsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=501-509&author=S.+Okunoauthor=M.+Inabaauthor=K.+Kitataniauthor=E.+Ishimuraauthor=T.+Yamakawaauthor=Y.+Nishizawa&title=Serum+levels+of+C-terminal+telopeptide+of+type+I+collagen%3A+A+useful+new+marker+of+cortical+bone+loss+in+hemodialysis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Serum levels of C-terminal telopeptide of type I collagen: A useful new marker of cortical bone loss in hemodialysis patients</span></div><div class="casAuthors">Okuno, Senji; Inaba, Masaaki; Kitatani, Kayoko; Ishimura, Eiji; Yamakawa, Tomoyuki; Nishizawa, Yoshiki</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer London Ltd.</span>)
        </div><div class="casAbstract">Renal osteodystrophy is a major complication in hemodialysis patients.  Measurement of serum peptide derived from the degrdn. of bone collagen could potentially provide an indirect est. of bone resorption.  The present study estd. the significance of the C-terminal telopeptide of type I collagen (Î²-CTx) as a serum bone resorption marker in male hemodialysis patients.  The mean age and hemodialysis duration of the 160 patients were 59.7 years (26-86 years) and 67.2 mo (17-142 mo), resp.  Bone mineral d. (BMD) in the distal third of the radius was measured using dual-energy x-ray absorptiometry twice with a 2-yr interval.  A blood sample was collected immediately before the hemodialysis session at the time of the second BMD measurement.  Other serum bone markers detd. were bone-specific alk. phosphatase (BAP) and intact and N-terminal midfragment (N-Mid) osteocalcin (OC) as bone-formation markers and serum pyridinoline (PYD) and deoxypyridinoline (DPD) as bone resorption markers.  Serum Î²-CTx correlated significantly in a pos. manner with serum PYD, DPD, BAP, intact OC, and N-Mid OC.  Serum Î²-CTx, as well as PYD, DPD, BAP, intact OC, and N-Mid OC, correlated significantly with BMD in the distal third of the radius at the second measurement and with the rate of BMD redn. during the preceding 2 years.  The highest quartile of serum Î²-CTx was pos. assocd. with rapid bone loss, defined as a change in the value for BMD in the distal third of the radius falling within the upper tertile of patients, in 55% of cases, and each quartile progress in serum Î²-CTx increased the odds ratio of rapid bone loss by a factor of 1.73.  Since the Youden index was twice as accurate for Î²-CTx, BAP and N-Mid OC as for intact PTH, these bone-remodeling markers may be better risk markers of cortical bone loss than intact PTH.  Inclusion in the highest quartile of PTH (above 288 pg/mL) predicted rapid bone loss with a sensitivity of only 26%.  This means that the upper limit for serum PTH level recommended by K/DOQI may be too high, since 74% of cases with rapid bone loss showed serum PTH levels of below 288 pg/mL.  In conclusion, serum measurement of Î²-CTx may provide a new com. viable and relevant serum assay to reflect cortical bone resorption in hemodialysis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosRuF9MfaY7bVg90H21EOLACvtfcHk0lgk38XyBnWaAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFSrsr4%253D&md5=63384fa1d9ad1d796c858dd0648f590d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00198-004-1712-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00198-004-1712-4%26sid%3Dliteratum%253Aachs%26aulast%3DOkuno%26aufirst%3DS.%26aulast%3DInaba%26aufirst%3DM.%26aulast%3DKitatani%26aufirst%3DK.%26aulast%3DIshimura%26aufirst%3DE.%26aulast%3DYamakawa%26aufirst%3DT.%26aulast%3DNishizawa%26aufirst%3DY.%26atitle%3DSerum%2520levels%2520of%2520C-terminal%2520telopeptide%2520of%2520type%2520I%2520collagen%253A%2520A%2520useful%2520new%2520marker%2520of%2520cortical%2520bone%2520loss%2520in%2520hemodialysis%2520patients%26jtitle%3DOsteoporosis%2520Int.%26date%3D2005%26volume%3D16%26spage%3D501%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DMY','PDB','4DMY'); return false;">PDB: 4DMY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a href="/doi/suppl/10.1021/jm3007257">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01062"></div></div></div></div></div><hr /></hr><p class="last">Details of synthesis of final compounds and intermediates; <sup>1</sup>H NMR for compounds <b>13</b>, <b>14</b>, and <b>39</b> at 373 K; rat and human hepatic metabolite identification for <b>14</b> and <b>34</b>, and rat in vivo urinalysis metabolite identification for <b>39</b>. Table of data: dog PK/PD [CTX-1] for <b>34</b>; baseline [CTX-1] levels over 48 h for comparison of the magnitude of effect; dose to man prediction calculations; crystallization coordinates for Cat K/<b>34</b> cocomplex. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3007257/suppl_file/jm3007257_si_001.pdf">jm3007257_si_001.pdf (1.67 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3007257&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm3007257%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3007257" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679929a6cff421be","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
